{
  "id": "1729551174-adfeae6e-e29f-4e5d-9c43-12babba41e64",
  "title": "fanoutqa: What codons encode the essential amino acids? (71552a38345f892e)",
  "last_modified": 1729551745.2793121,
  "n_events": 319,
  "state": [
    {
      "id": "617f69ea-8218-47b4-897a-b68bd2c12594",
      "depth": 0,
      "parent": null,
      "children": [],
      "always_included_messages": [],
      "chat_history": [
        {
          "role": "user",
          "content": "What codons encode the essential amino acids?",
          "name": null,
          "tool_call_id": null,
          "tool_calls": null,
          "is_tool_call_error": null
        },
        {
          "role": "assistant",
          "content": "",
          "name": null,
          "tool_call_id": null,
          "tool_calls": [
            {
              "id": "a6c3f1e6-9d79-41b0-8195-2f27ebc4d99f",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the list of essential amino acids.\"}"
              }
            },
            {
              "id": "2a42806f-8d66-4021-a1cb-f8e5e6b00f15",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode the essential amino acids.\"}"
              }
            }
          ],
          "is_tool_call_error": null
        },
        {
          "role": "function",
          "content": "### List of Essential Amino Acids\n\nEssential amino acids are those that the body cannot produce on its own and must be obtained through diet. Here are the nine essential amino acids:\n\n1. **Histidine (H)**\n2. **Isoleucine (I)**\n3. **Leucine (L)**\n4. **Lysine (K)**\n5. **Methionine (M)**\n6. **Phenylalanine (F)**\n7. **Threonine (T)**\n8. **Tryptophan (W)**\n9. **Valine (V)**\n\nAdditionally, there are six conditionally essential amino acids that may need to be supplemented in specific situations:\n\n1. **Arginine (R)**\n2. **Cysteine (C)**\n3. **Glutamine (Q)**\n4. **Glycine (G)**\n5. **Proline (P)**\n6. **Tyrosine (Y)**\n\nThese amino acids are crucial for various bodily functions and maintaining overall health.</s>",
          "name": "delegate",
          "tool_call_id": "a6c3f1e6-9d79-41b0-8195-2f27ebc4d99f",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "You shouldn't delegate the entire task to a helper. Handle it yourself, or if it's still too complex, try breaking it up into smaller steps and call this again.",
          "name": "delegate",
          "tool_call_id": "2a42806f-8d66-4021-a1cb-f8e5e6b00f15",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "assistant",
          "content": "",
          "name": null,
          "tool_call_id": null,
          "tool_calls": [
            {
              "id": "657a8026-bc1f-43f5-8b35-858c40177e36",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Histidine.\"}"
              }
            },
            {
              "id": "47051da1-4edd-4d7c-9264-f49f90685c01",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Isoleucine.\"}"
              }
            },
            {
              "id": "a00ba94c-7cea-4c7b-9eb4-00892c35180f",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Leucine.\"}"
              }
            },
            {
              "id": "599aae3f-9e86-4bfa-9c40-9d23561d5e7f",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Lysine.\"}"
              }
            },
            {
              "id": "1f56c0d1-c641-46f5-9515-439034ef01cb",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Methionine.\"}"
              }
            },
            {
              "id": "25d843a0-dab1-4e63-9be5-21d31e065e91",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Phenylalanine.\"}"
              }
            },
            {
              "id": "89880a51-3baf-4d0c-8e23-38a5622f5f29",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Threonine.\"}"
              }
            },
            {
              "id": "99626bee-40e7-435e-bc49-7b9303186b44",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Tryptophan.\"}"
              }
            },
            {
              "id": "95809b23-7b40-4bc3-b063-5c2ba3857c62",
              "type": "function",
              "function": {
                "name": "delegate",
                "arguments": "{\"instructions\": \"Find the codons that encode Valine.\"}"
              }
            }
          ],
          "is_tool_call_error": null
        },
        {
          "role": "function",
          "content": "Understood, I'll break it down into smaller steps. Can you first look up the amino acid code for Histidine?</s>",
          "name": "delegate",
          "tool_call_id": "657a8026-bc1f-43f5-8b35-858c40177e36",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "Here is a table listing the codons that code for Isoleucine:\n\n| Codon | Amino Acid |\n|-------|-------------|\n| AUU    | Isoleucine  |\n| AUC    | Isoleucine  |\n| AUA    | Isoleucine  |</s>",
          "name": "delegate",
          "tool_call_id": "47051da1-4edd-4d7c-9264-f49f90685c01",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "Okay, let's break it down.\n\nFirst, I'll search for the Wikipedia article on Leucine to get the relevant information, and then extract the codons that encode Leucine from it. Does that sound good?</s>",
          "name": "delegate",
          "tool_call_id": "a00ba94c-7cea-4c7b-9eb4-00892c35180f",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "The codons that encode Lysine are AAA and AAG.</s>",
          "name": "delegate",
          "tool_call_id": "599aae3f-9e86-4bfa-9c40-9d23561d5e7f",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "The DNA codon for Methionine is ATG, and the RNA codon for Methionine is AUG.</s>",
          "name": "delegate",
          "tool_call_id": "1f56c0d1-c641-46f5-9515-439034ef01cb",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "The amino acid Phenylalanine is encoded by the codons UUU and UUC.</s>",
          "name": "delegate",
          "tool_call_id": "25d843a0-dab1-4e63-9be5-21d31e065e91",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "My apologies, I'll need to look up codons and Threonine.</s>",
          "name": "delegate",
          "tool_call_id": "89880a51-3baf-4d0c-8e23-38a5622f5f29",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "The codon that encodes Tryptophan is UGG.</s>",
          "name": "delegate",
          "tool_call_id": "99626bee-40e7-435e-bc49-7b9303186b44",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "I apologize, but I can't delegate that task. Could you please provide more specific instructions?</s>",
          "name": "delegate",
          "tool_call_id": "95809b23-7b40-4bc3-b063-5c2ba3857c62",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "assistant",
          "content": "",
          "name": null,
          "tool_call_id": null,
          "tool_calls": [
            {
              "id": "03d2d098-c052-4f60-84f2-660bb60755e6",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Lysine\"}"
              }
            },
            {
              "id": "22935ebd-d50d-458c-82bb-a1865ba99f2d",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Leucine\"}"
              }
            },
            {
              "id": "54edf902-909b-4c57-92c8-4a4b67e9dfa3",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Methionine\"}"
              }
            },
            {
              "id": "4b6223fb-5b1e-4ef9-9203-d8dabbdbb7c8",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Phenylalanine\"}"
              }
            },
            {
              "id": "573132ef-c28c-48e3-bd92-e1e3609c1c97",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Threonine\"}"
              }
            },
            {
              "id": "a0ee5f9f-4f4f-4bb2-9eb7-dcdbb27260e8",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Tryptophan\"}"
              }
            },
            {
              "id": "8ba5c58f-46f9-4d06-a6ab-0191f7784ccd",
              "type": "function",
              "function": {
                "name": "search",
                "arguments": "{\"query\": \"Valine\"}"
              }
            }
          ],
          "is_tool_call_error": null
        },
        {
          "role": "function",
          "content": "<document>\n<title>Lysine</title>\n<fragment>\n104. **^** Wu G (May 2009). \"Amino acids: metabolism, functions, and nutrition\". *Amino Acids*. **37** (1): 1\u201317. doi:10.1007/s00726-009-0269-0. PMID\u00a019301095. S2CID\u00a01870305.\n105. **^** Connor JM (2008). *Global Price Fixing* (2nd\u00a0ed.). Heidelberg: Springer-Verlag. ISBN\u00a0978-3-540-78669-6.\n106. **^** Eichenwald K (2000). *The Informant: a true story*. New York: Broadway Books. ISBN\u00a0978-0-7679-0326-4.\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n\n</fragment>\n<fragment>\n1. ^ ***a*** ***b*** Williams, P. A.; Hughes, C. E.; Harris, K. D. M (2015). \"L\u2010Lysine: Exploiting Powder X\u2010ray Diffraction to Complete the Set of Crystal Structures of the 20 Directly Encoded Proteinogenic Amino Acids\". *Angew. Chem. Int. Ed.* **54** (13): 3973\u20133977. doi:10.1002/anie.201411520. PMID\u00a025651303.\n2. **^** \"IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983\". *Biochemical Journal*. **219** (2): 345\u2013373. 15 April 1984. doi:10.1042/bj2190345. PMC\u00a01153490. PMID\u00a06743224.\n3. **^** Lysine. The Biology Project, Department of Biochemistry and Molecular Biophysics, University of Arizona.\n\n</fragment>\n<fragment>\n47. **^** Sauer SW (October 2007). \"Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency\". *Journal of Inherited Metabolic Disease*. **30** (5): 673\u2013680. doi:10.1007/s10545-007-0678-8. PMID\u00a017879145. S2CID\u00a020609879.\n48. **^** Nelson DL, Cox MM, Lehninger AL (2013). *Lehninger principles of biochemistry* (6th\u00a0ed.). New York: W.H. Freeman and Company. ISBN\u00a0978-1-4641-0962-1. OCLC\u00a0824794893.\n49. ^ ***a*** ***b*** Galili G, Amir R (February 2013). \"Fortifying plants with the essential amino acids lysine and methionine to improve nutritional quality\". *Plant Biotechnology Journal*. **11** (2): 211\u2013222. doi:10.1111/pbi.12025. PMID\u00a023279001.\n50. ^ ***a*** ***b*** Wang G, Xu M, Wang W, Galili G (June 2017). \"Fortifying Horticultural Crops with Essential Amino Acids: A Review\". *International Journal of Molecular Sciences*. **18** (6): 1306. doi:10.3390/ijms18061306. PMC\u00a05486127. PMID\u00a028629176.\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n\n</fragment>\n<fragment>\n21. ^ ***a*** ***b*** Jander G, Joshi V (1 January 2009). \"Aspartate-Derived Amino Acid Biosynthesis in Arabidopsis thaliana\". *The Arabidopsis Book*. **7**: e0121. doi:10.1199/tab.0121. PMC\u00a03243338. PMID\u00a022303247.\n22. **^** Andi B, West AH, Cook PF (September 2004). \"Kinetic mechanism of histidine-tagged homocitrate synthase from Saccharomyces cerevisiae\". *Biochemistry*. **43** (37): 11790\u201311795. doi:10.1021/bi048766p. PMID\u00a015362863.\n23. **^** Bhattacharjee JK (1985). \"alpha-Aminoadipate pathway for the biosynthesis of lysine in lower eukaryotes\". *Critical Reviews in Microbiology*. **12** (2): 131\u2013151. doi:10.3109/10408418509104427. PMID\u00a03928261.\n24. **^** Bhattacharjee JK, Strassman M (May 1967). \"Accumulation of tricarboxylic acids related to lysine biosynthesis in a yeast mutant\". *The Journal of Biological Chemistry*. **242** (10): 2542\u20132546. doi:10.1016/S0021-9258(18)95997-1. PMID\u00a06026248.\n\n</fragment>\n<fragment>\n28. **^** Kobashi N, Nishiyama M, Tanokura M (March 1999). \"Aspartate kinase-independent lysine synthesis in an extremely thermophilic bacterium, Thermus thermophilus: lysine is synthesized via alpha-aminoadipic acid not via diaminopimelic acid\". *Journal of Bacteriology*. **181** (6): 1713\u20131718. doi:10.1128/JB.181.6.1713-1718.1999. PMC\u00a093567. PMID\u00a010074061.\n29. **^** Kosuge T, Hoshino T (1999). \"The alpha-aminoadipate pathway for lysine biosynthesis is widely distributed among Thermus strains\". *Journal of Bioscience and Bioengineering*. **88** (6): 672\u2013675. doi:10.1016/S1389-1723(00)87099-1. PMID\u00a016232683.\n30. ^ ***a*** ***b*** ***c*** ***d*** Nishida H, Nishiyama M, Kobashi N, Kosuge T, Hoshino T, Yamane H (December 1999). \"A prokaryotic gene cluster involved in synthesis of lysine through the amino adipate pathway: a key to the evolution of amino acid biosynthesis\". *Genome Research*. **9** (12): 1175\u20131183. doi:10.1101/gr.9.12.1175. PMID\u00a010613839.\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n\n</fragment>\n<fragment>\nmore traditional selective breeding techniques have allowed for the isolation of \"Quality Protein Maize\", which has significantly increased levels of lysine and tryptophan, also an essential amino acid. This increase in lysine content is attributed to an *opaque-2* mutation that reduced the transcription of lysine-lacking zein-related seed storage proteins and, as a result, increased the abundance of other proteins that are rich in lysine.[54][55] Commonly, to overcome the limiting abundance of lysine in livestock feed, industrially produced lysine is added.[56][57] The industrial process includes the fermentative culturing of *Corynebacterium glutamicum* and the subsequent purification of lysine.[56]\n\n\n\n### Dietary sources\n\n[edit]\n\n\n</fragment>\n<fragment>\n64. **^** Blickling S, Renner C, Laber B, Pohlenz HD, Holak TA, Huber R (January 1997). \"Reaction mechanism of Escherichia coli dihydrodipicolinate synthase investigated by X-ray crystallography and NMR spectroscopy\". *Biochemistry*. **36** (1): 24\u201333. doi:10.1021/bi962272d. PMID\u00a08993314. S2CID\u00a023072673.\n65. **^** Kumar S, Tsai CJ, Nussinov R (March 2000). \"Factors enhancing protein thermostability\". *Protein Engineering*. **13** (3): 179\u201391. doi:10.1093/protein/13.3.179. PMID\u00a010775659.\n66. **^** Sokalingam S, Raghunathan G, Soundrarajan N, Lee SG (9 July 2012). \"A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein\". *PLOS ONE*. **7** (7): e40410. Bibcode:2012PLoSO...740410S. doi:10.1371/journal.pone.0040410. PMC\u00a03392243. PMID\u00a022792305.\n\n</fragment>\n<fragment>\n\nThe human body cannot synthesize lysine. It is essential in humans and must therefore be obtained from the diet. In organisms that synthesise lysine, two main biosynthetic pathways exist, the diaminopimelate and \u03b1-aminoadipate pathways, which employ distinct enzymes and substrates and are found in diverse organisms. Lysine catabolism occurs through one of several pathways, the most common of which is the saccharopine pathway.\n\n\nLysine plays several roles in humans, most importantly proteinogenesis, but also in the crosslinking of collagen polypeptides, uptake of essential mineral nutrients, and in the production of carnitine, which is key in fatty acid metabolism. Lysine is also often involved in histone modifications, and thus, impacts the epigenome. The \u03b5-amino group often participates in hydrogen bonding and as a general base in catalysis. The \u03b5-ammonium group (\u2212NH+  \n3) is attached to the fourth carbon from the \u03b1-carbon, which is attached to the carboxyl (C=OOH) group.[3]\n\n\n</fragment>\n<fragment>\n9. **^** Miyazaki T, Miyazaki J, Yamane H, Nishiyama M (July 2004). \"alpha-Aminoadipate aminotransferase from an extremely thermophilic bacterium, Thermus thermophilus\" (PDF). *Microbiology*. **150** (Pt 7): 2327\u20132334. doi:10.1099/mic.0.27037-0. PMID\u00a015256574. S2CID\u00a025416966. Archived from the original (PDF) on 28 February 2020.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n10. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** Xu H, Andi B, Qian J, West AH, Cook PF (2006). \"The alpha-aminoadipate pathway for lysine biosynthesis in fungi\". *Cell Biochemistry and Biophysics*. **46** (1): 43\u201364. doi:10.1385/CBB:46:1:43. PMID\u00a016943623. S2CID\u00a022370361.\n\n</fragment>\n<fragment>\n6. **^** Fischer E, Weigert F (1902). \"Synthese der \u03b1,\u03b5 \u2013 Diaminocaprons\u00e4ure (Inactives Lysin)\" [Synthesis of \u03b1,\u03b5-diaminohexanoic acid ([optically] inactive lysine)]. *Berichte der Deutschen Chemischen Gesellschaft* (in German). **35** (3): 3772\u20133778. doi:10.1002/cber.190203503211.\n7. ^ ***a*** ***b*** Hudson AO, Bless C, Macedo P, Chatterjee SP, Singh BK, Gilvarg C, Leustek T (January 2005). \"Biosynthesis of lysine in plants: evidence for a variant of the known bacterial pathways\". *Biochimica et Biophysica Acta (BBA) - General Subjects*. **1721** (1\u20133): 27\u201336. doi:10.1016/j.bbagen.2004.09.008. PMID\u00a015652176.\n8. **^** Velasco AM, Leguina JI, Lazcano A (October 2002). \"Molecular evolution of the lysine biosynthetic pathways\". *Journal of Molecular Evolution*. **55** (4): 445\u2013459. Bibcode:2002JMolE..55..445V. doi:10.1007/s00239-002-2340-2. PMID\u00a012355264. S2CID\u00a019460256.\n\n</fragment>\n<fragment>\n51. **^** Angelovici R, Fait A, Fernie AR, Galili G (January 2011). \"A seed high-lysine trait is negatively associated with the TCA cycle and slows down Arabidopsis seed germination\". *The New Phytologist*. **189** (1): 148\u2013159. doi:10.1111/j.1469-8137.2010.03478.x. PMID\u00a020946418.\n52. **^** Edelman M, Colt M (2016). \"Nutrient Value of Leaf vs. Seed\". *Frontiers in Chemistry*. **4**: 32. doi:10.3389/fchem.2016.00032. PMC\u00a04954856. PMID\u00a027493937.\n53. **^** Jiang SY, Ma A, Xie L, Ramachandran S (September 2016). \"Improving protein content and quality by over-expressing artificially synthetic fusion proteins with high lysine and threonine constituent in rice plants\". *Scientific Reports*. **6** (1): 34427. Bibcode:2016NatSR...634427J. doi:10.1038/srep34427. PMC\u00a05039639. PMID\u00a027677708.\n54. ^ ***a*** ***b*** Shewry PR (November 2007). \"Improving the protein content and composition of cereal grain\". *Journal of Cereal Science*. **46** (3): 239\u2013250. doi:10.1016/j.jcs.2007.06.006.\n\n</fragment>\n<fragment>\n59. **^** Young VR, Pellett PL (1994). \"Plant proteins in relation to human protein and amino acid nutrition\". *American Journal of Clinical Nutrition*. **59** (5 Suppl): 1203S\u20131212S. doi:10.1093/ajcn/59.5.1203s. PMID\u00a08172124. S2CID\u00a035271281.\n60. **^** Landon, Amanda J. (2008). \"The 'How' of the Three Sisters: The Origins of Agriculture in Mesoamerica and the Human Niche\". *Nebraska Anthropologist*: 110\u2013124. Retrieved 9 August 2022.\n61. **^** Institute of Medicine of the National Academies (2005). *Dietary Reference Intakes for Macronutrients*. p.\u00a0589. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0. Retrieved 29 October 2017.\n62. **^** \"Dietary Supplement Database: Blend Information (DSBI)\". L-Lysine HCl 10000820 80.03% lysine\n63. ^ ***a*** ***b*** Betts MJ, Russell RB (2003). Barnes MR, Gray IC (eds.). *Bioinformatics for Geneticists*. John Wiley & Sons, Ltd. pp.\u00a0289\u2013316. doi:10.1002/0470867302.ch14. ISBN\u00a0978-0-470-86730-3.\n\n</fragment>\n<fragment>\n75. ^ ***a*** ***b*** ***c*** ***d*** Vaz FM, Wanders RJ (February 2002). \"Carnitine biosynthesis in mammals\". *The Biochemical Journal*. **361** (Pt 3): 417\u2013429. doi:10.1042/bj3610417. PMC\u00a01222323. PMID\u00a011802770.\n76. **^** Yamauchi M, Sricholpech M (25 May 2012). \"Lysine post-translational modifications of collagen\". *Essays in Biochemistry*. **52**: 113\u2013133. doi:10.1042/bse0520113. PMC\u00a03499978. PMID\u00a022708567.\n77. **^** Vollmer W, Blanot D, de Pedro MA (March 2008). \"Peptidoglycan structure and architecture\". *FEMS Microbiology Reviews*. **32** (2): 149\u2013167. doi:10.1111/j.1574-6976.2007.00094.x. PMID\u00a018194336.\n78. **^** Curtiss R (May 1978). \"Biological containment and cloning vector transmissibility\". *The Journal of Infectious Diseases*. **137** (5): 668\u2013675. doi:10.1093/infdis/137.5.668. PMID\u00a0351084.\n\n</fragment>\n<fragment>\n**Lysine** (symbol **Lys** or **K**)[2] is an \u03b1-amino acid that is a precursor to many proteins. It contains an \u03b1-amino group (which is in the protonated \u2212NH+  \n3 form under biological conditions), an \u03b1-carboxylic acid group (which is in the deprotonated \u2212COO\u2212 form under biological conditions), and a side chain lysyl ((CH2)4NH2), classifying it as a basic, charged (at physiological pH), aliphatic amino acid. It is encoded by the codons AAA and AAG. Like almost all other amino acids, the \u03b1-carbon is chiral and lysine may refer to either enantiomer or a racemic mixture of both. For the purpose of this article, lysine will refer to the biologically active enantiomer L-lysine, where the \u03b1-carbon is in the *S* configuration.\n\n\n</fragment>\n<fragment>\n31. ^ ***a*** ***b*** ***c*** ***d*** Nishida H, Nishiyama M (September 2000). \"What is characteristic of fungal lysine synthesis through the alpha-aminoadipate pathway?\". *Journal of Molecular Evolution*. **51** (3): 299\u2013302. Bibcode:2000JMolE..51..299N. doi:10.1007/s002390010091. PMID\u00a011029074. S2CID\u00a01265909.\n32. **^** Zabriskie TM, Jackson MD (February 2000). \"Lysine biosynthesis and metabolism in fungi\". *Natural Product Reports*. **17** (1): 85\u201397. doi:10.1039/a801345d. PMID\u00a010714900.\n33. ^ ***a*** ***b*** Zhu X, Galili G (May 2004). \"Lysine metabolism is concurrently regulated by synthesis and catabolism in both reproductive and vegetative tissues\". *Plant Physiology*. **135** (1): 129\u2013136. doi:10.1104/pp.103.037168. PMC\u00a0429340. PMID\u00a015122025.\n34. ^ ***a*** ***b*** ***c*** ***d*** ***e*** Tom\u00e9 D, Bos C (June 2007). \"Lysine requirement through the human life cycle\". *The Journal of Nutrition*. **137** (6 Suppl 2): 1642S\u20131645S. doi:10.1093/jn/137.6.1642S. PMID\u00a017513440.\n\n</fragment>\n<fragment>\n13. **^** Soares da Costa TP, Muscroft-Taylor AC, Dobson RC, Devenish SR, Jameson GB, Gerrard JA (July 2010). \"How essential is the 'essential' active-site lysine in dihydrodipicolinate synthase?\". *Biochimie*. **92** (7): 837\u2013845. doi:10.1016/j.biochi.2010.03.004. PMID\u00a020353808.\n14. **^** Soares da Costa TP, Christensen JB, Desbois S, Gordon SE, Gupta R, Hogan CJ, Nelson TG, Downton MT, Gardhi CK, Abbott BM, Wagner J, Panjikar S, Perugini MA (2015). \"Quaternary Structure Analyses of an Essential Oligomeric Enzyme\". *Analytical Ultracentrifugation*. Methods in Enzymology. Vol.\u00a0562. pp.\u00a0205\u2013223. doi:10.1016/bs.mie.2015.06.020. ISBN\u00a09780128029084. PMID\u00a026412653.\n15. **^** Muscroft-Taylor AC, Soares da Costa TP, Gerrard JA (March 2010). \"New insights into the mechanism of dihydrodipicolinate synthase using isothermal titration calorimetry\". *Biochimie*. **92** (3): 254\u2013262. doi:10.1016/j.biochi.2009.12.004. PMID\u00a020025926.\n\n</fragment>\n<fragment>\nAmino acid\n\nNot to be confused with lysin or leucine.\n\n\n\n\n\n\n\n\nLysine\n| ![](image)Skeletal formula of L-lysine\n |\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Ball-and-stick model[1]\n | ![](image)Space-filling model[1]\n |\n\n\n</fragment>\n<fragment>\nGood sources of lysine are high-protein foods such as eggs, meat (specifically red meat, lamb, pork, and poultry), soy, beans and peas, cheese (particularly Parmesan), and certain fish (such as cod and sardines).[58] Lysine is the limiting amino acid (the essential amino acid found in the smallest quantity in the particular foodstuff) in most cereal grains, but is plentiful in most pulses (legumes).[59] Beans contain the lysine that maize lacks, and in the human archeological record beans and maize often appear together, as in the Three Sisters: beans, maize, and squash.[60]\n\n\nA food is considered to have sufficient lysine if it has at least 51\u00a0mg of lysine per gram of protein (so that the protein is 5.1% lysine).[61] L-lysine HCl is used as a dietary supplement, providing 80.03% L-lysine.[62] As such, 1\u00a0g of L-lysine is contained in 1.25\u00a0g of L-lysine HCl.\n\n\n\n## Biological roles\n\n[edit]\n\n\n</fragment>\n<fragment>\n100. ^ ***a*** ***b*** \"Norwegian granted for improving lysine production process\". *All About Feed*. 26 January 2010. Archived from the original on 11 March 2012.\n101. **^** Toride Y (2004). \"Lysine and other amino acids for feed: production and contribution to protein utilization in animal feeding\". *Protein sources for the animal feed industry; FAO Expert Consultation and Workshop on Protein Sources for the Animal Feed Industry; Bangkok, 29 April - 3 May 2002*. Rome: Food and Agriculture Organization of the United Nations. ISBN\u00a0978-92-5-105012-5.\n102. **^** Abelson PH (March 1999). \"A potential phosphate crisis\". *Science*. **283** (5410): 2015. Bibcode:1999Sci...283.2015A. doi:10.1126/science.283.5410.2015. PMID\u00a010206902. S2CID\u00a028106949.\n103. **^** Coyne JA (10 October 1999). \"The Truth Is Way Out There\". *The New York Times*. Retrieved 6 April 2008.\n\n</fragment>\n<fragment>\nLysine is an essential amino acid in humans.[48] The human daily nutritional requirement varies from ~60\u00a0mg/kg in infancy to ~30\u00a0mg/kg in adults.[34] This requirement is commonly met in a western society with the intake of lysine from meat and vegetable sources well in excess of the recommended requirement.[34] In vegetarian diets, the intake of lysine is less due to the limited quantity of lysine in cereal crops compared to meat sources.[34]\n\n\n</fragment>\n<fragment>\n38. **^** Sacksteder KA, Biery BJ, Morrell JC, Goodman BK, Geisbrecht BV, Cox RP, Gould SJ, Geraghty MT (June 2000). \"Identification of the alpha-aminoadipic semialdehyde synthase gene, which is defective in familial hyperlysinemia\". *American Journal of Human Genetics*. **66** (6): 1736\u20131743. doi:10.1086/302919. PMC\u00a01378037. PMID\u00a010775527.\n39. **^** Zhu X, Tang G, Galili G (December 2002). \"The activity of the Arabidopsis bifunctional lysine-ketoglutarate reductase/saccharopine dehydrogenase enzyme of lysine catabolism is regulated by functional interaction between its two enzyme domains\". *The Journal of Biological Chemistry*. **277** (51): 49655\u201349661. doi:10.1074/jbc.m205466200. PMID\u00a012393892.\n40. ^ ***a*** ***b*** ***c*** Kiyota E, Pena IA, Arruda P (November 2015). \"The saccharopine pathway in seed development and stress response of maize\". *Plant, Cell & Environment*. **38** (11): 2450\u20132461. doi:10.1111/pce.12563. PMID\u00a025929294.\n\n</fragment>\n<fragment>\nIt was proposed that an auxotrophic strain of *Escherichia coli* (X1776) could be used for all genetic modification practices, as the strain is unable to survive without the supplementation of DAP, and thus, cannot live outside of a laboratory environment.[78] Lysine has also been proposed to be involved in calcium intestinal absorption and renal retention, and thus, may play a role in calcium homeostasis.[74] Finally, lysine has been shown to be a precursor for carnitine, which transports fatty acids to the mitochondria, where they can be oxidised for the release of energy.[75][79] Carnitine is synthesised from trimethyllysine, which is a product of the degradation of certain proteins, as such lysine must first be incorporated into proteins and be methylated prior to being converted to carnitine.[75] However, in mammals the primary source of carnitine is through dietary sources, rather than through lysine conversion.[75]\n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n</fragment>\n<fragment>\n35. **^** Blemings KP, Crenshaw TD, Swick RW, Benevenga NJ (August 1994). \"Lysine-alpha-ketoglutarate reductase and saccharopine dehydrogenase are located only in the mitochondrial matrix in rat liver\". *The Journal of Nutrition*. **124** (8): 1215\u20131221. doi:10.1093/jn/124.8.1215. PMID\u00a08064371.\n36. **^** Galili G, Tang G, Zhu X, Gakiere B (June 2001). \"Lysine catabolism: a stress and development super-regulated metabolic pathway\". *Current Opinion in Plant Biology*. **4** (3): 261\u2013266. doi:10.1016/s1369-5266(00)00170-9. PMID\u00a011312138.\n37. **^** Arruda P, Kemper EL, Papes F, Leite A (August 2000). \"Regulation of lysine catabolism in higher plants\". *Trends in Plant Science*. **5** (8): 324\u2013330. doi:10.1016/s1360-1385(00)01688-5. PMID\u00a010908876.\n\n</fragment>\n<fragment>\nLike all amino acids, catabolism of lysine is initiated from the uptake of dietary lysine or from the breakdown of intracellular protein. \n</fragment>\n<fragment>\n![](image)**Lysine biosynthesis pathways.** Two pathways are responsible for the *de novo* biosynthesis of L-lysine, namely the (A) diaminopimelate pathway and (B) \u03b1\u2011aminoadipate pathway.\nTwo pathways have been identified in nature for the synthesis of lysine. The diaminopimelate (DAP) pathway belongs to the aspartate derived biosynthetic family, which is also involved in the synthesis of threonine, methionine and isoleucine.[7][8] Whereas the \u03b1-aminoadipate (AAA) pathway is part of the glutamate biosynthetic family.[9][10]\n\n\n</fragment>\n<fragment>\n25. **^** Gaillardin CM, Ribet AM, Heslot H (November 1982). \"Wild-type and mutant forms of homoisocitric dehydrogenase in the yeast Saccharomycopsis lipolytica\". *European Journal of Biochemistry*. **128** (2\u20133): 489\u2013494. doi:10.1111/j.1432-1033.1982.tb06991.x. PMID\u00a06759120.\n26. **^** Jaklitsch WM, Kubicek CP (July 1990). \"Homocitrate synthase from Penicillium chrysogenum. Localization, purification of the cytosolic isoenzyme, and sensitivity to lysine\". *The Biochemical Journal*. **269** (1): 247\u2013253. doi:10.1042/bj2690247. PMC\u00a01131560. PMID\u00a02115771.\n27. **^** Ye ZH, Bhattacharjee JK (December 1988). \"Lysine biosynthesis pathway and biochemical blocks of lysine auxotrophs of Schizosaccharomyces pombe\". *Journal of Bacteriology*. **170** (12): 5968\u20135970. doi:10.1128/jb.170.12.5968-5970.1988. PMC\u00a0211717. PMID\u00a03142867.\n\n</fragment>\n<fragment>\n![](image) This article was adapted from the following source under a CC BY 4.0 license (2018) (reviewer reports): \nCody J Hall; Tatiana P. Soares da Costa (1 June 2018). \"Lysine: biosynthesis, catabolism and roles\" (PDF). *WikiJournal of Science*. **1** (1): 4. doi:10.15347/WJS/2018.004. ISSN\u00a02470-6345. Wikidata\u00a0Q55120301.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n\n\n\n\n</fragment>\n<fragment>\n55. **^** Prasanna B, Vasal SK, Kassahun B, Singh NN (2001). \"Quality protein maize\". *Current Science*. **81** (10): 1308\u20131319. JSTOR\u00a024105845.\n56. ^ ***a*** ***b*** Kircher M, Pfefferle W (April 2001). \"The fermentative production of L-lysine as an animal feed additive\". *Chemosphere*. **43** (1): 27\u201331. Bibcode:2001Chmsp..43...27K. doi:10.1016/s0045-6535(00)00320-9. PMID\u00a011233822.\n57. **^** Junior L, Alberto L, Letti GV, Soccol CR, Junior L, Alberto L, Letti GV, Soccol CR (2016). \"Development of an L-Lysine Enriched Bran for Animal Nutrition via Submerged Fermentation by Corynebacterium glutamicum using Agroindustrial Substrates\". *Brazilian Archives of Biology and Technology*. **59**. doi:10.1590/1678-4324-2016150519. ISSN\u00a01516-8913.\n58. **^** University of Maryland Medical Center. \"Lysine\". Retrieved 30 December 2009.\n\n</fragment>\n<fragment>\nThe AAA pathway involves the condensation of \u03b1-ketoglutarate and acetyl-CoA via the intermediate AAA for the synthesis of L-lysine. \n</fragment>\n<fragment>\n71. **^** Shiio Y, Eisenman RN (November 2003). \"Histone sumoylation is associated with transcriptional repression\". *Proceedings of the National Academy of Sciences of the United States of America*. **100** (23): 13225\u201313230. doi:10.1073/pnas.1735528100. PMC\u00a0263760. PMID\u00a014578449.\n72. **^** Wang H, Wang L, Erdjument-Bromage H, Vidal M, Tempst P, Jones RS, Zhang Y (October 2004). \"Role of histone H2A ubiquitination in Polycomb silencing\". *Nature*. **431** (7010): 873\u2013878. Bibcode:2004Natur.431..873W. doi:10.1038/nature02985. hdl:10261/73732. PMID\u00a015386022. S2CID\u00a04344378.\n73. ^ ***a*** ***b*** Shoulders MD, Raines RT (2009). \"Collagen structure and stability\". *Annual Review of Biochemistry*. **78**: 929\u2013958. doi:10.1146/annurev.biochem.77.032207.120833. PMC\u00a02846778. PMID\u00a019344236.\n74. ^ ***a*** ***b*** Civitelli R, Villareal DT, Agnusdei D, Nardi P, Avioli LV, Gennari C (1992). \"Dietary L-lysine and calcium metabolism in humans\". *Nutrition*. **8** (6): 400\u2013405. PMID\u00a01486246.\n\n</fragment>\n<fragment>\n96. **^** Hagen J, te Brinke H, Wanders RJ, Knegt AC, Oussoren E, Hoogeboom AJ, Ruijter GJ, Becker D, Schwab KO, Franke I, Duran M, Waterham HR, Sass JO, Houten SM (September 2015). \"Genetic basis of alpha-aminoadipic and alpha-ketoadipic aciduria\". *Journal of Inherited Metabolic Disease*. **38** (5): 873\u2013879. doi:10.1007/s10545-015-9841-9. PMID\u00a025860818. S2CID\u00a020379124.\n97. **^** Hedlund GL, Longo N, Pasquali M (May 2006). \"Glutaric acidemia type 1\". *American Journal of Medical Genetics Part C: Seminars in Medical Genetics*. **142C** (2): 86\u201394. doi:10.1002/ajmg.c.30088. PMC\u00a02556991. PMID\u00a016602100.\n98. **^** \"Hyperlysinuria | Define Hyperlysinuria at Dictionary.com\".\n99. ^ ***a*** ***b*** Walter, John; John Fernandes; Jean-Marie Saudubray; Georges van den Berghe (2006). *Inborn Metabolic Diseases: Diagnosis and Treatment*. Berlin: Springer. p.\u00a0296. ISBN\u00a0978-3-540-28783-4.\n\n</fragment>\n<fragment>\n\nDue to its importance in several biological processes, a lack of lysine can lead to several disease states including defective connective tissues, impaired fatty acid metabolism, anaemia, and systemic protein-energy deficiency. In contrast, an overabundance of lysine, caused by ineffective catabolism, can cause severe neurological disorders.\n\n\nLysine was first isolated by the German biological chemist Ferdinand Heinrich Edmund Drechsel in 1889 from the protein casein in milk.[4] He named it \"*lysin*\".[5] In 1902, the German chemists Emil Fischer and Fritz Weigert determined lysine's chemical structure by synthesizing it.[6]\n\n\n\n\n## Biosynthesis\n\n[edit]\n\n\n</fragment>\n<fragment>\n11. **^** Atkinson SC, Dogovski C, Downton MT, Czabotar PE, Dobson RC, Gerrard JA, Wagner J, Perugini MA (March 2013). \"Structural, kinetic and computational investigation of Vitis vinifera DHDPS reveals new insight into the mechanism of lysine-mediated allosteric inhibition\". *Plant Molecular Biology*. **81** (4\u20135): 431\u2013446. doi:10.1007/s11103-013-0014-7. hdl:11343/282680. PMID\u00a023354837. S2CID\u00a017129774.\n12. **^** Griffin MD, Billakanti JM, Wason A, Keller S, Mertens HD, Atkinson SC, Dobson RC, Perugini MA, Gerrard JA, Pearce FG (2012). \"Characterisation of the first enzymes committed to lysine biosynthesis in Arabidopsis thaliana\". *PLOS ONE*. **7** (7): e40318. Bibcode:2012PLoSO...740318G. doi:10.1371/journal.pone.0040318. PMC\u00a03390394. PMID\u00a022792278.\n\n</fragment>\n<fragment>\nThe most common role for lysine is proteinogenesis. Lysine frequently plays an important role in protein structure. Since its side chain contains a positively charged group on one end and a long hydrophobic carbon tail close to the backbone, lysine is considered somewhat amphipathic. For this reason, lysine can be found buried as well as more commonly in solvent channels and on the exterior of proteins, where it can interact with the aqueous environment.[63] Lysine can also contribute to protein stability as its \u03b5-amino group often participates in hydrogen bonding, salt bridges and covalent interactions to form a Schiff base**.**[63][64][65][66]\n\n\n</fragment>\n<fragment>\n18. **^** Hudson AO, Gilvarg C, Leustek T (May 2008). \"Biochemical and phylogenetic characterization of a novel diaminopimelate biosynthesis pathway in prokaryotes identifies a diverged form of LL-diaminopimelate aminotransferase\". *Journal of Bacteriology*. **190** (9): 3256\u20133263. doi:10.1128/jb.01381-07. PMC\u00a02347407. PMID\u00a018310350.\n19. **^** Peverelli MG, Perugini MA (August 2015). \"An optimized coupled assay for quantifying diaminopimelate decarboxylase activity\". *Biochimie*. **115**: 78\u201385. doi:10.1016/j.biochi.2015.05.004. PMID\u00a025986217.\n20. ^ ***a*** ***b*** Soares da Costa TP, Desbois S, Dogovski C, Gorman MA, Ketaren NE, Paxman JJ, Siddiqui T, Zammit LM, Abbott BM, Robins-Browne RM, Parker MW, Jameson GB, Hall NE, Panjikar S, Perugini MA (August 2016). \"Structural Determinants Defining the Allosteric Inhibition of an Essential Antibiotic Target\". *Structure*. **24** (8): 1282\u20131291. doi:10.1016/j.str.2016.05.019. PMID\u00a027427481.\n\n</fragment>\n<fragment>\n16. **^** Christensen JB, Soares da Costa TP, Faou P, Pearce FG, Panjikar S, Perugini MA (November 2016). \"Structure and Function of Cyanobacterial DHDPS and DHDPR\". *Scientific Reports*. **6** (1): 37111. Bibcode:2016NatSR...637111C. doi:10.1038/srep37111. PMC\u00a05109050. PMID\u00a027845445.\n17. **^** McCoy AJ, Adams NE, Hudson AO, Gilvarg C, Leustek T, Maurelli AT (November 2006). \"L,L-diaminopimelate aminotransferase, a trans-kingdom enzyme shared by Chlamydia and plants for synthesis of diaminopimelate/lysine\". *Proceedings of the National Academy of Sciences of the United States of America*. **103** (47): 17909\u201317914. Bibcode:2006PNAS..10317909M. doi:10.1073/pnas.0608643103. PMC\u00a01693846. PMID\u00a017093042.\n\n</fragment>\n<fragment>\n41. **^** Serrano GC, Rezende e Silva Figueira T, Kiyota E, Zanata N, Arruda P (March 2012). \"Lysine degradation through the saccharopine pathway in bacteria: LKR and SDH in bacteria and its relationship to the plant and animal enzymes\". *FEBS Letters*. **586** (6): 905\u2013911. doi:10.1016/j.febslet.2012.02.023. PMID\u00a022449979. S2CID\u00a032385212.\n42. ^ ***a*** ***b*** ***c*** Danhauser K, Sauer SW, Haack TB, Wieland T, Staufner C, Graf E, Zschocke J, Strom TM, Traub T, Okun JG, Meitinger T, Hoffmann GF, Prokisch H, K\u00f6lker S (December 2012). \"DHTKD1 mutations cause 2-aminoadipic and 2-oxoadipic aciduria\". *American Journal of Human Genetics*. **91** (6): 1082\u20131087. doi:10.1016/j.ajhg.2012.10.006. PMC\u00a03516599. PMID\u00a023141293.\n43. **^** Sauer SW, Opp S, Hoffmann GF, Koeller DM, Okun JG, K\u00f6lker S (January 2011). \"Therapeutic modulation of cerebral L-lysine metabolism in a mouse model for glutaric aciduria type I\". *Brain*. **134** (Pt 1): 157\u2013170. doi:10.1093/brain/awq269. PMID\u00a020923787.\n\n</fragment>\n<fragment>\nwhich is subsequently enzymatically decarboxylated in an irreversible reaction catalysed by diaminopimelate decarboxylase (DAPDC) (E.C 4.1.1.20) to produce L-lysine.[19][20] The DAP pathway is regulated at multiple levels, including upstream at the enzymes involved in aspartate processing as well as at the initial DHDPS catalysed condensation step.[20][21] Lysine imparts a strong negative feedback loop on these enzymes and, subsequently, regulates the entire pathway.[21]\n\n\n</fragment>\n<fragment>\nwhich has profound and systemic effects on the health of the individual.[89][90] There is also a hereditary genetic disease that involves mutations in the enzymes responsible for lysine catabolism, namely the bifunctional AASS enzyme of the saccharopine pathway.[91] Due to a lack of lysine catabolism, the amino acid accumulates in plasma and patients develop hyperlysinaemia, which can present as asymptomatic to severe neurological disabilities, including epilepsy, ataxia, spasticity, and psychomotor impairment.[91][92] The clinical significance of hyperlysinemia is the subject of debate in the field with some studies finding no correlation between physical or mental disabilities and hyperlysinemia.[93] In addition to this, mutations in genes related to lysine metabolism have been implicated in several disease states, including pyridoxine-dependent epilepsia (ALDH7A1 gene), \u03b1-ketoadipic and \u03b1-aminoadipic aciduria (DHTKD1 gene), and glutaric aciduria type 1 (GCDH gene).[42][94][95][96][97]\n\n\n</fragment>\n<fragment>\nCatabolism is also used as a means to control the intracellular concentration of free lysine and maintain a steady-state to prevent the toxic effects of excessive free lysine.[33] There are several pathways involved in lysine catabolism but the most commonly used is the saccharopine pathway, which primarily takes place in the liver (and equivalent organs) in animals, specifically within the mitochondria.[34][33][35][36] This is the reverse of the previously described AAA pathway.[34][37] In animals and plants, the first two steps of the saccharopine pathway are catalysed by the bifunctional enzyme, \u03b1-aminoadipic semialdehyde synthase (AASS), which possess both lysine-ketoglutarate reductase (LKR) (E.C 1.5.1.8) and SDH activities, whereas in other organisms, such as bacteria and fungi, both of these enzymes are encoded by separate genes.[38][39] The first step involves the LKR catalysed reduction of L-lysine in the presence of \u03b1-ketoglutarate to produce saccharopine, \n</fragment>\n<fragment>\nLysine has also been implicated to play a key role in other biological processes including; structural proteins of connective tissues, calcium homeostasis, and fatty acid metabolism.[73][74][75] Lysine has been shown to be involved in the crosslinking between the three helical polypeptides in collagen, resulting in its stability and tensile strength.[73][76] This mechanism is akin to the role of lysine in bacterial cell walls, in which lysine (and *meso*-diaminopimelate) are critical to the formation of crosslinks, and therefore, stability of the cell wall.[77] This concept has previously been explored as a means to circumvent the unwanted release of potentially pathogenic genetically modified bacteria. \n</fragment>\n<fragment>\n91. ^ ***a*** ***b*** Houten SM, Te Brinke H, Denis S, Ruiter JP, Knegt AC, de Klerk JB, Augoustides-Savvopoulou P, H\u00e4berle J, Baumgartner MR, Co\u015fkun T, Zschocke J, Sass JO, Poll-The BT, Wanders RJ, Duran M (April 2013). \"Genetic basis of hyperlysinemia\". *Orphanet Journal of Rare Diseases*. **8**: 57. doi:10.1186/1750-1172-8-57. PMC\u00a03626681. PMID\u00a023570448.\n92. **^** Hoffmann GF, K\u00f6lker S (2016). \"Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism\". *Inborn Metabolic Diseases*. Springer, Berlin, Heidelberg. pp.\u00a0333\u2013348. doi:10.1007/978-3-662-49771-5\\_22. ISBN\u00a0978-3-662-49769-2.\n93. **^** Dancis J, Hutzler J, Ampola MG, Shih VE, van Gelderen HH, Kirby LT, Woody NC (May 1983). \"The prognosis of hyperlysinemia: an interim report\". *American Journal of Human Genetics*. **35** (3): 438\u2013442. PMC\u00a01685659. PMID\u00a06407303.\n\n</fragment>\n<fragment>\nThe role of lysine in collagen has been outlined above, however, a lack of lysine and hydroxylysine involved in the crosslinking of collagen peptides has been linked to a disease state of the connective tissue.[86] As carnitine is a key lysine-derived metabolite involved in fatty acid metabolism, a substandard diet lacking sufficient carnitine and lysine can lead to decreased carnitine levels, which can have significant cascading effects on an individual's health.[79][87] Lysine has also been shown to play a role in anaemia, as lysine is suspected to have an effect on the uptake of iron and, subsequently, the concentration of ferritin in blood plasma.[88] However, the exact mechanism of action is yet to be elucidated.[88] Most commonly, lysine deficiency is seen in non-western societies and manifests as protein-energy malnutrition, \n</fragment>\n<fragment>\nGiven the limiting concentration of lysine in cereal crops, it has long been speculated that the content of lysine can be increased through genetic modification practices.[49][50] Often these practices have involved the intentional dysregulation of the DAP pathway by means of introducing lysine feedback-insensitive orthologues of the DHDPS enzyme.[49][50] These methods have met limited success likely due to the toxic side effects of increased free lysine and indirect effects on the TCA cycle.[51] Plants accumulate lysine and other amino acids in the form of seed storage proteins, found within the seeds of the plant, and this represents the edible component of cereal crops.[52] This highlights the need to not only increase free lysine, but also direct lysine towards the synthesis of stable seed storage proteins, and subsequently, increase the nutritional value of the consumable component of crops.[53][54] While genetic modification practices have met limited success, \n</fragment>\n<fragment>\n94. **^** Mills PB, Struys E, Jakobs C, Plecko B, Baxter P, Baumgartner M, Willemsen MA, Omran H, Tacke U, Uhlenberg B, Weschke B, Clayton PT (March 2006). \"Mutations in antiquitin in individuals with pyridoxine-dependent seizures\". *Nature Medicine*. **12** (3): 307\u2013309. doi:10.1038/nm1366. PMID\u00a016491085. S2CID\u00a027940375.\n95. **^** Mills PB, Footitt EJ, Mills KA, Tuschl K, Aylett S, Varadkar S, Hemingway C, Marlow N, Rennie J, Baxter P, Dulac O, Nabbout R, Craigen WJ, Schmitt B, Feillet F, Christensen E, De Lonlay P, Pike MG, Hughes MI, Struys EA, Jakobs C, Zuberi SM, Clayton PT (July 2010). \"Genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy (ALDH7A1 deficiency)\". *Brain*. **133** (Pt 7): 2148\u20132159. doi:10.1093/brain/awq143. PMC\u00a02892945. PMID\u00a020554659.\n\n</fragment>\n</document>",
          "name": "search",
          "tool_call_id": "03d2d098-c052-4f60-84f2-660bb60755e6",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Leucine</title>\n<content>\nLeucine\n| ![](image)Skeletal formula of L-leucine\n |\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Ball-and-stick model[1]\n | ![](image)Space-filling model[1]\n |\n\n |\n| Names\n |\n| IUPAC name\nLeucine\n |\n| Other names\n2-Amino-4-methylpentanoic acid\n |\n| Identifiers\n |\n| CAS Number\n | * 61-90-5![check](image)Y\n |\n| 3D model (JSmol)\n | * Interactive image\n* Zwitterion: Interactive image\n |\n| ChEBI | * CHEBI:15603![check](image)Y\n |\n| ChEMBL | * ChEMBL291962![check](image)Y\n |\n| ChemSpider | * 5880![check](image)Y\n |\n| DrugBank | * DB00149![check](image)Y\n |\n| ECHA InfoCard | 100.000.475 ![Edit this at Wikidata](image) |\n| IUPHAR/BPS\n | * 3312\n |\n| KEGG | * D00030![check](image)Y\n |\n| PubChem CID\n | * 6106\n |\n| UNII | * GMW67QNF9C![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * DTXSID9023203 ![Edit this at Wikidata](image)\n |\n| InChI\n\n* InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1![check](image)Y\nKey:\u00a0ROHFNLRQFUQHCH-YFKPBYRVSA-N![check](image)Y\n* InChI=1/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1\nKey:\u00a0ROHFNLRQFUQHCH-YFKPBYRVBU\n |\n| SMILES\n\n* CC(C)C[C@@H](C(=O)O)N\n* Zwitterion: CC(C)C[C@@H](C(=O)[O-])[NH3+]\n |\n| Properties\n |\n| Chemical formula\n | C6H13NO2 |\n| Molar mass | 131.175\u00a0g\u00b7mol\u22121 |\n| Acidity (p*K*a)\n | 2.36 (carboxyl), 9.60 (amino)[2] |\n| Magnetic susceptibility (\u03c7)\n | -84.9\u00b710\u22126 cm3/mol\n |\n| Supplementary data page\n |\n| Leucine (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n**Leucine** (symbol **Leu** or **L**)[3] is an essential amino acid that is used in the biosynthesis of proteins. Leucine is an \u03b1-amino acid, meaning it contains an \u03b1-amino group (which is in the protonated \u2212NH3+ form under biological conditions), an \u03b1-carboxylic acid group (which is in the deprotonated \u2212COO\u2212 form under biological conditions), and a side chain isobutyl group, making it a non-polar aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, and beans and other legumes. It is encoded by the codons UUA, UUG, CUU, CUC, CUA, and CUG.\n\n\nLike valine and isoleucine, leucine is a branched-chain amino acid. The primary metabolic end products of leucine metabolism are acetyl-CoA and acetoacetate; consequently, it is one of the two exclusively ketogenic amino acids, with lysine being the other.[4] It is the most important ketogenic amino acid in humans.[5]\n\n\nLeucine and \u03b2-hydroxy \u03b2-methylbutyric acid, a minor leucine metabolite, exhibit pharmacological activity in humans and have been demonstrated to promote protein biosynthesis via the phosphorylation of the mechanistic target of rapamycin (mTOR).[6][7]\n\n\n\n\n## Dietary leucine\n\n[edit]\n\nAs a food additive, L-leucine has E number **E641** and is classified as a flavor enhancer.[8]\n\n\n\n### Requirements\n\n[edit]\n\nThe Food and Nutrition Board (FNB) of the U.S. Institute of Medicine set Recommended Dietary Allowances (RDAs) for essential amino acids in 2002. For leucine, for adults 19 years and older, 42\u00a0mg/kg body weight/day.[9]\n\n\n\n### Sources\n\n[edit]\n\n\n\nFood sources of leucine[10]\n| Food\n | g/100g\n |\n| --- | --- |\n| Whey protein concentrate, dry powder | 10.0-12.0\n |\n| Soy protein concentrate, dry powder | 7.5-8.5\n |\n| Pea protein concentrate, dry powder | 6.6\n |\n| Soybeans, mature seeds, roasted, salted | 2.87\n |\n| Hemp seed, hulled | 2.16\n |\n| Beef, round, top round, raw | 1.76\n |\n| Peanuts | 1.67\n |\n| Fish, salmon, pink, raw | 1.62\n |\n| Wheat germ | 1.57\n |\n| Almonds | 1.49\n |\n| Chicken, broilers or fryers, thigh, raw | 1.48\n |\n| Chicken egg, yolk, raw | 1.40\n |\n| Oats | 1.28\n |\n| Edamame (soybeans, green, raw) | 0.93\n |\n| Beans, pinto, cooked | 0.78\n |\n| Lentils, cooked | 0.65\n |\n| Chickpea, cooked | 0.63\n |\n| Corn, yellow | 0.35\n |\n| Cow milk, whole, 3.25% milk fat | 0.27\n |\n| Rice, brown, medium-grain, cooked | 0.19\n |\n| Milk, human, mature, fluid | 0.10\n |\n\n\n## Health effects\n\n[edit]\n\nAs a dietary supplement, leucine has been found to slow the degradation of muscle tissue by increasing the synthesis of muscle proteins in aged rats.[11] However, results of comparative studies are conflicted. Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men.[12] More studies are needed, preferably ones based on an objective, random sample of society. Factors such as lifestyle choices, age, gender, diet, exercise, etc. must be factored into the analyses to isolate the effects of supplemental leucine as a standalone, or if taken with other branched chain amino acids (BCAAs). Until then, dietary supplemental leucine cannot be associated as the prime reason for muscular growth or optimal maintenance for the entire population.\n\n\nBoth L-leucine and D-leucine protect mice against epileptic seizures.[13] D-leucine also terminates seizures in mice after the onset of seizure activity, at least as effectively as diazepam and without sedative effects.[13] Decreased dietary intake of L-leucine lessens adiposity in mice.[14] High blood levels of leucine are associated with insulin resistance in humans, mice, and rodents.[15] This might be due to the effect of leucine to stimulate mTOR signaling.[16] Dietary restriction of leucine and the other BCAAs can reverse diet-induced obesity in wild-type mice by increasing energy expenditure, and can restrict fat mass gain of hyperphagic rats.[17][18]\n\n\n\n## Safety\n\n[edit]\n\nLeucine toxicity, as seen in decompensated maple syrup urine disease, causes delirium and neurologic compromise, and can be life-threatening.[19]\n\n\nA high intake of leucine may cause or exacerbate symptoms of pellagra in people with low niacin status because it interferes with the conversion of L-tryptophan to niacin.[20]\n\n\nLeucine at a dose exceeding 500\u00a0mg/kg/d was observed with hyperammonemia.[21] As such, unofficially, a tolerable upper intake level (UL) for leucine in healthy adult men can be suggested at 500\u00a0mg/kg/d or 35 g/d under acute dietary conditions.[21][22]\n\n\n\n## Pharmacology\n\n[edit]\n\n### Pharmacodynamics\n\n[edit]\n\nLeucine is a dietary amino acid with the capacity to directly stimulate myofibrillar muscle protein synthesis.[23] This effect of leucine results from its role as an activator of the mechanistic target of rapamycin (mTOR),[7] a serine-threonine protein kinase that regulates protein biosynthesis and cell growth. The activation of mTOR by leucine is mediated through Rag GTPases,[24][25][26] leucine binding to leucyl-tRNA synthetase,[24][25] leucine binding to sestrin 2,[27][28][29] and possibly other mechanisms.\n\n\n\n### Metabolism in humans\n\n[edit]\n\n|  |\n| --- |\n| Leucine metabolism in humans\n\n![Diagram of leucine, HMB, and isovaleryl-CoA metabolism in humans](image)\n\n**L-Leucine**\n\nBranched-chain aminoacid aminotransferase\n\n\u03b1-Ketoglutarate\n\nGlutamate\n\nGlutamate\n\nAlanine\n\nPyruvate\n\nMuscle: \u03b1-Ketoisocaproate (\u03b1-KIC)\n\nLiver: \u03b1-Ketoisocaproate (\u03b1-KIC)\n\nBranched-chain \u03b1-ketoaciddehydrogenase (mitochondria)\n\nKIC-dioxygenase(cytosol)\n\nIsovaleryl-CoA\n\n**\u03b2-Hydroxy\u03b2-methylbutyrate**(**HMB**)\n\nExcretedin urine(10\u201340%)\n\n\n\nHMB-CoA\n\n\u03b2-Hydroxy \u03b2-methylglutaryl-CoA(HMG-CoA)\n\n\u03b2-Methylcrotonyl-CoA(MC-CoA)\n\n\u03b2-Methylglutaconyl-CoA(MG-CoA)\n\nCO2\n\nCO2\n\nO2\n\nCO2\n\nH2O\n\nCO2\n\nH2O\n\n(liver)HMG-CoAlyase\n\nEnoyl-CoA hydratase\n\nIsovaleryl-CoAdehydrogenase\n\nMC-CoAcarboxylase\n\nMG-CoAhydratase\n\nHMG-CoAreductase\n\nHMG-CoA\u00a0synthase\n\n\u03b2-Hydroxybutyratedehydrogenase\n\nMevalonatepathway\n\nThiolase\n\nUnknownenzyme\n\n\u03b2-Hydroxybutyrate\n\nAcetoacetyl-CoA\n\nAcetyl-CoA\n\nAcetoacetate\n\nMevalonate\n\nCholesterol\n\n[note 1]\n\n![The image above contains clickable links](image)\nHuman metabolic pathway for HMB and isovaleryl-CoA relative to L-leucine.[32][33][34] Of the two major pathways, L-leucine is mostly metabolized into isovaleryl-CoA, while only about\u00a05% is metabolized into HMB.[32][33][34]\n |\n\n  \n\nLeucine metabolism occurs in many tissues in the human body; however, most dietary leucine is metabolized within the liver, adipose tissue, and muscle tissue.[35] Adipose and muscle tissue use leucine in the formation of sterols and other compounds.[35] Combined leucine use in these two tissues is seven times greater than in the liver.[35]\n\n\nIn healthy individuals, approximately\u00a060% of dietary L-leucine is metabolized after several hours, with roughly 5% (2\u201310%\u00a0range) of dietary L-leucine being converted to \u03b2-hydroxy \u03b2-methylbutyric acid (HMB).[36][37][34] Around\u00a040% of dietary L-leucine is converted to acetyl-CoA, which is subsequently used in the synthesis of other compounds.[34]\n\n\nThe vast majority of L-leucine metabolism is initially catalyzed by the branched-chain amino acid aminotransferase enzyme, producing \u03b1-ketoisocaproate (\u03b1-KIC).[36][34] \u03b1-KIC is mostly metabolized by the mitochondrial enzyme branched-chain \u03b1-ketoacid dehydrogenase, which converts it to isovaleryl-CoA.[36][34] Isovaleryl-CoA is subsequently metabolized by isovaleryl-CoA dehydrogenase and converted to MC-CoA, which is used in the synthesis of acetyl-CoA and other compounds.[34] During biotin deficiency, HMB can be synthesized from MC-CoA via enoyl-CoA hydratase and an unknown thioesterase enzyme,[30][31][38] which convert MC-CoA into HMB-CoA and HMB-CoA into HMB respectively.[31] A relatively small amount of \u03b1-KIC is metabolized in the liver by the cytosolic enzyme 4-hydroxyphenylpyruvate dioxygenase (KIC dioxygenase), which converts \u03b1-KIC to HMB.[36][34][39] In healthy individuals, this minor pathway\u00a0\u2013 which involves the conversion of L-leucine to \u03b1-KIC and then HMB\u00a0\u2013 is the predominant route of HMB synthesis.[36][34]\n\n\nA small fraction of L-leucine metabolism\u00a0\u2013 less than\u00a05% in all tissues except the testes where it accounts for about\u00a033%\u00a0\u2013 is initially catalyzed by leucine aminomutase, producing \u03b2-leucine, which is subsequently metabolized into \u03b2-ketoisocaproate (\u03b2-KIC), \u03b2-ketoisocaproyl-CoA, and then acetyl-CoA by a series of uncharacterized enzymes.[34][40]\n\n\nThe metabolism of HMB is catalyzed by an uncharacterized enzyme which converts it to \u03b2-hydroxy \u03b2-methylbutyryl-CoA (HMB-CoA).[30][34] HMB-CoA is metabolized by either enoyl-CoA hydratase or another uncharacterized enzyme, producing \u03b2-methylcrotonyl-CoA (MC-CoA) or hydroxymethylglutaryl-CoA (HMG-CoA) respectively.[36][34] MC-CoA is then converted by the enzyme methylcrotonyl-CoA carboxylase to methylglutaconyl-CoA (MG-CoA), which is subsequently converted to HMG-CoA by methylglutaconyl-CoA hydratase.[36][34][40] HMG-CoA is then cleaved into acetyl-CoA and acetoacetate by HMG-CoA lyase or used in the production of cholesterol via the mevalonate pathway.[36][34]\n\n\n\n## Synthesis in non-human organisms\n\n[edit]\n\nLeucine is an essential amino acid in the diet of animals because they lack the complete enzyme pathway to synthesize it *de novo* from potential precursor compounds. Consequently, they must ingest it, usually as a component of proteins. Plants and microorganisms synthesize leucine from pyruvic acid with a series of enzymes:[41]\n\n\n\n* Acetolactate synthase\n* Acetohydroxy acid isomeroreductase\n* Dihydroxyacid dehydratase\n* \u03b1-Isopropylmalate synthase\n* \u03b1-Isopropylmalate isomerase\n* Leucine aminotransferase\n\n\nSynthesis of the small, hydrophobic amino acid valine also includes the initial part of this pathway.\n\n\n\n## Chemistry\n\n[edit]\n\n![](image)(*S*)-Leucine (or L-leucine), left; (*R*)-leucine (or D-leucine), right, in zwitterionic form at neutral pH\nLeucine is a branched-chain amino acid (BCAA) since it possesses an aliphatic side-chain that is not linear.\n\n\nRacemic leucine had been[*when?*] subjected to circularly polarized synchrotron radiation to better understand the origin of biomolecular asymmetry. An enantiomeric enhancement of 2.6% had been induced, indicating a possible photochemical origin of biomolecules' homochirality.[42]\n\n\n\n## See also\n\n[edit]\n\n* Leucines, the isomers and derivatives of leucine\n* Leucine zipper, a common motif in transcription factor proteins\n\n\n## Notes\n\n[edit]\n\n1. **^** This reaction is catalyzed by an unknown thioesterase enzyme.[30][31]\n\n## References\n\n[edit]\n\n1. ^ ***a*** ***b*** Binns J, Parsons S, McIntyre GJ (December 2016). \"Accurate hydrogen parameters for the amino acid L-leucine\" (PDF). *Acta Crystallographica Section B*. **72** (Pt 6): 885\u2013892. doi:10.1107/S2052520616015699. hdl:20.500.11820/c784fdaf-aa3a-48e4-86a2-d0a0bd7fdb7a. PMID\u00a027910839. S2CID\u00a019288938.\n2. **^** Dawson, R.M.C., et al., *Data for Biochemical Research*, Oxford, Clarendon Press, 1959.\n3. **^** \"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.\n4. **^** Ferrier DR (24 May 2013). *Biochemistry*. Lippincott Williams & Wilkins. ISBN\u00a09781451175622.\n5. **^** Cynober LA (13 November 2003). *Metabolic & Therapeutic Aspects of Amino Acids in Clinical Nutrition* (Second\u00a0ed.). CRC Press. p.\u00a0101. ISBN\u00a09780203010266.\n6. **^** Silva VR, Belozo FL, Micheletti TO, Conrado M, Stout JR, Pimentel GD, Gonzalez AM (September 2017). \"\u03b2-hydroxy-\u03b2-methylbutyrate free acid supplementation may improve recovery and muscle adaptations after resistance training: a systematic review\". *Nutrition Research*. **45**: 1\u20139. doi:10.1016/j.nutres.2017.07.008. hdl:11449/170023. PMID\u00a029037326. HMB's mechanisms of action are generally considered to relate to its effect on both muscle protein synthesis and muscle protein breakdown (Figure 1) [2, 3]. HMB appears to stimulate muscle protein synthesis through an up-regulation of the mammalian/mechanistic target of rapamycin complex 1 (mTORC1), a signaling cascade involved in coordination of translation initiation of muscle protein synthesis [2, 4]. Additionally, HMB may have antagonistic effects on the ubiquitin\u2013proteasome pathway, a system that degrades intracellular proteins [5, 6]. Evidence also suggests that HMB promotes myogenic proliferation, differentiation, and cell fusion [7].\u00a0... Exogenous HMB-FA administration has shown to increase intramuscular anabolic signaling, stimulate muscle protein synthesis, and attenuate muscle protein breakdown in humans [2].\n7. ^ ***a*** ***b*** Wilkinson DJ, Hossain T, Hill DS, Phillips BE, Crossland H, Williams J, et\u00a0al. (June 2013). \"Effects of leucine and its metabolite \u03b2-hydroxy-\u03b2-methylbutyrate on human skeletal muscle protein metabolism\". *The Journal of Physiology*. **591** (11): 2911\u201323. doi:10.1113/jphysiol.2013.253203. PMC\u00a03690694. PMID\u00a023551944. The stimulation of MPS through mTORc1-signalling following HMB exposure is in agreement with pre-clinical studies (Eley et al. 2008).\u00a0... Furthermore, there was clear divergence in the amplitude of phosphorylation for 4EBP1 (at Thr37/46 and Ser65/Thr70) and p70S6K (Thr389) in response to both Leu and HMB, with the latter showing more pronounced and sustained phosphorylation.\u00a0... Nonetheless, as the overall MPS response was similar, this cellular signalling distinction did not translate into statistically distinguishable anabolic effects in our primary outcome measure of MPS.\u00a0... Interestingly, although orally supplied HMB produced no increase in plasma insulin, it caused a depression in MPB (\u221257%). Normally, postprandial decreases in MPB (of ~50%) are attributed to the nitrogen-sparing effects of insulin since clamping insulin at post-absorptive concentrations (5\u00a0\u03bcU\u00a0ml\u22121) while continuously infusing AAs (18\u00a0g\u00a0h\u22121) did not suppress MPB (Greenhaff et al. 2008), which is why we chose not to measure MPB in the Leu group, due to an anticipated hyperinsulinaemia (Fig. 3C). Thus, HMB reduces MPB in a fashion similar to, but independent of, insulin. These findings are in-line with reports of the anti-catabolic effects of HMB suppressing MPB in pre-clinical models, via attenuating proteasomal-mediated proteolysis in response to LPS (Eley et al. 2008).\n8. **^** Winter R (2009). *A consumer's dictionary of food additives* (7th\u00a0ed.). New York: Three Rivers Press. ISBN\u00a0978-0307408921.\n9. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0.\n10. **^** *National Nutrient Database for Standard Reference*. U.S. Department of Agriculture. Archived from the original on 3 March 2015. Retrieved 16 September 2009.\n11. **^** Combaret L, Dardevet D, Rieu I, Pouch MN, B\u00e9chet D, Taillandier D, et\u00a0al. (December 2005). \"A leucine-supplemented diet restores the defective postprandial inhibition of proteasome-dependent proteolysis in aged rat skeletal muscle\". *The Journal of Physiology*. **569** (Pt 2): 489\u201399. doi:10.1113/jphysiol.2005.098004. PMC\u00a01464228. PMID\u00a016195315.\n12. **^** Verhoeven S, Vanschoonbeek K, Verdijk LB, Koopman R, Wodzig WK, Dendale P, van Loon LJ (May 2009). \"Long-term leucine supplementation does not increase muscle mass or strength in healthy elderly men\". *The American Journal of Clinical Nutrition*. **89** (5): 1468\u201375. doi:10.3945/ajcn.2008.26668. PMID\u00a019321567.\n13. ^ ***a*** ***b*** Hartman AL, Santos P, O'Riordan KJ, Stafstrom CE, Marie Hardwick J (October 2015). \"Potent anti-seizure effects of D-leucine\". *Neurobiology of Disease*. **82**: 46\u201353. doi:10.1016/j.nbd.2015.05.013. PMC\u00a04640989. PMID\u00a026054437.\n14. **^** Fontana L, Cummings NE, Arriola Apelo SI, Neuman JC, Kasza I, Schmidt BA, et\u00a0al. (July 2016). \"Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health\". *Cell Reports*. **16** (2): 520\u2013530. doi:10.1016/j.celrep.2016.05.092. PMC\u00a04947548. PMID\u00a027346343.\n15. **^** Lynch CJ, Adams SH (December 2014). \"Branched-chain amino acids in metabolic signalling and insulin resistance\". *Nature Reviews. Endocrinology*. **10** (12): 723\u201336. doi:10.1038/nrendo.2014.171. PMC\u00a04424797. PMID\u00a025287287.\n16. **^** Caron A, Richard D, Laplante M (2015). \"The Roles of mTOR Complexes in Lipid Metabolism\". *Annual Review of Nutrition*. **35**: 321\u201348. doi:10.1146/annurev-nutr-071714-034355. PMID\u00a026185979.\n17. **^** Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, Schmidt BA, et\u00a0al. (February 2018). \"Restoration of metabolic health by decreased consumption of branched-chain amino acids\". *The Journal of Physiology*. **596** (4): 623\u2013645. doi:10.1113/JP275075. PMC\u00a05813603. PMID\u00a029266268.\n18. **^** White PJ, Lapworth AL, An J, Wang L, McGarrah RW, Stevens RD, et\u00a0al. (July 2016). \"Branched-chain amino acid restriction in Zucker-fatty rats improves muscle insulin sensitivity by enhancing efficiency of fatty acid oxidation and acyl-glycine export\". *Molecular Metabolism*. **5** (7): 538\u2013551. doi:10.1016/j.molmet.2016.04.006. PMC\u00a04921791. PMID\u00a027408778.\n19. **^** Yudkoff, Marc; Daikhin, Yevgeny; Nissim, Ilana; Horyn, Oksana; Luhovyy, Bohdan; Lazarow, Adam; Nissim, Itzhak (1 June 2005). \"Brain Amino Acid Requirements and Toxicity: The Example of Leucine\". *The Journal of Nutrition*. **135** (6): 1531S\u20131538S. doi:10.1093/jn/135.6.1531S. ISSN\u00a00022-3166. PMID\u00a015930465.\n20. **^** Badawy AA, Lake SL, Dougherty DM (2014). \"Mechanisms of the pellagragenic effect of leucine: stimulation of hepatic tryptophan oxidation by administration of branched-chain amino acids to healthy human volunteers and the role of plasma free tryptophan and total kynurenines\". *International Journal of Tryptophan Research*. **7**: 23\u201332. doi:10.4137/IJTR.S18231. PMC\u00a04259507. PMID\u00a025520560.\n21. ^ ***a*** ***b*** Elango R, Chapman K, Rafii M, Ball RO, Pencharz PB (October 2012). \"Determination of the tolerable upper intake level of leucine in acute dietary studies in young men\". *The American Journal of Clinical Nutrition*. **96** (4): 759\u201367. doi:10.3945/ajcn.111.024471. PMID\u00a022952178. A significant increase in blood ammonia concentrations above normal values, plasma leucine concentrations, and urinary leucine excretion were observed with leucine intakes >500 mg \u00b7 kg\u22121 \u00b7 d\u22121. The oxidation of l-[1-13C]-leucine expressed as label tracer oxidation in breath (F13CO2), leucine oxidation, and \u03b1-ketoisocaproic acid (KIC) oxidation led to different results: a plateau in F13CO2 observed after 500 mg \u00b7 kg\u22121 \u00b7 d\u22121, no clear plateau observed in leucine oxidation, and KIC oxidation appearing to plateau after 750 mg \u00b7 kg\u22121 \u00b7 d\u22121. On the basis of plasma and urinary variables, the UL for leucine in healthy adult men can be suggested at 500 mg \u00b7 kg\u22121 \u00b7 d\u22121 or ~35 g/d as a cautious estimate under acute dietary conditions.\n22. **^** Rasmussen B, Gilbert E, Turki A, Madden K, Elango R (July 2016). \"Determination of the safety of leucine supplementation in healthy elderly men\". *Amino Acids*. **48** (7): 1707\u201316. doi:10.1007/s00726-016-2241-0. PMID\u00a027138628. S2CID\u00a03708265. the upper limit for leucine intake in healthy elderly could be set similar to young men at 500 mg kg-1 day-1 or ~35 g/day for an individual weighing 70 kg\n23. **^** Etzel MR (April 2004). \"Manufacture and use of dairy protein fractions\". *The Journal of Nutrition*. **134** (4): 996S\u20131002S. doi:10.1093/jn/134.4.996S. PMID\u00a015051860.\n24. ^ ***a*** ***b*** Kim JH, Lee C, Lee M, Wang H, Kim K, Park SJ, et\u00a0al. (September 2017). \"Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction\". *Nature Communications*. **8** (1): 732. Bibcode:2017NatCo...8..732K. doi:10.1038/s41467-017-00785-0. PMC\u00a05622079. PMID\u00a028963468.\n25. ^ ***a*** ***b*** Jewell JL, Russell RC, Guan KL (March 2013). \"Amino acid signalling upstream of mTOR\". *Nature Reviews. Molecular Cell Biology*. **14** (3): 133\u20139. doi:10.1038/nrm3522. PMC\u00a03988467. PMID\u00a023361334.\n26. **^** Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC, Bar-Peled L, Sabatini DM (June 2008). \"The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1\". *Science*. **320** (5882): 1496\u2013501. Bibcode:2008Sci...320.1496S. doi:10.1126/science.1157535. PMC\u00a02475333. PMID\u00a018497260.\n27. **^** Wolfson RL, Chantranupong L, Saxton RA, Shen K, Scaria SM, Cantor JR, Sabatini DM (January 2016). \"Sestrin2 is a leucine sensor for the mTORC1 pathway\". *Science*. **351** (6268): 43\u20138. Bibcode:2016Sci...351...43W. doi:10.1126/science.aab2674. PMC\u00a04698017. PMID\u00a026449471.\n28. **^** Saxton RA, Knockenhauer KE, Wolfson RL, Chantranupong L, Pacold ME, Wang T, et\u00a0al. (January 2016). \"Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway\". *Science*. **351** (6268): 53\u20138. Bibcode:2016Sci...351...53S. doi:10.1126/science.aad2087. PMC\u00a04698039. PMID\u00a026586190.\n29. **^** Chantranupong L, Wolfson RL, Orozco JM, Saxton RA, Scaria SM, Bar-Peled L, et\u00a0al. (October 2014). \"The Sestrins interact with GATOR2 to negatively regulate the amino-acid-sensing pathway upstream of mTORC1\". *Cell Reports*. **9** (1): 1\u20138. doi:10.1016/j.celrep.2014.09.014. PMC\u00a04223866. PMID\u00a025263562.\n30. ^ ***a*** ***b*** ***c*** \"KEGG Reaction: R10759\". *Kyoto Encyclopedia of Genes and Genomes*. Kanehisa Laboratories. Archived from the original on 1 July 2016. Retrieved 24 June 2016.\n31. ^ ***a*** ***b*** ***c*** Mock DM, Stratton SL, Horvath TD, Bogusiewicz A, Matthews NI, Henrich CL, Dawson AM, Spencer HJ, Owen SN, Boysen G, Moran JH (November 2011). \"Urinary excretion of 3-hydroxyisovaleric acid and 3-hydroxyisovaleryl carnitine increases in response to a leucine challenge in marginally biotin-deficient humans\". primary source. *The Journal of Nutrition*. **141** (11): 1925\u20131930. doi:10.3945/jn.111.146126. PMC\u00a03192457. PMID\u00a021918059. Reduced activity of MCC impairs catalysis of an essential step in the mitochondrial catabolism of the BCAA leucine. Metabolic impairment diverts methylcrotonyl CoA to 3-hydroxyisovaleryl CoA in a reaction catalyzed by enoyl-CoA hydratase (22, 23). 3-Hydroxyisovaleryl CoA accumulation can inhibit cellular respiration either directly or via effects on the ratios of acyl CoA:free CoA if further metabolism and detoxification of 3-hydroxyisovaleryl CoA does not occur (22). The transfer to carnitine by 4 carnitine acyl-CoA transferases distributed in subcellular compartments likely serves as an important reservoir for acyl moieties (39\u201341). 3-Hydroxyisovaleryl CoA is likely detoxified by carnitine acetyltransferase producing 3HIA-carnitine, which is transported across the inner mitochondrial membrane (and hence effectively out of the mitochondria) via carnitine-acylcarnitine translocase (39). 3HIA-carnitine is thought to be either directly deacylated by a hydrolase to 3HIA or to undergo a second CoA exchange to again form 3-hydroxyisovaleryl CoA followed by release of 3HIA and free CoA by a thioesterase.\n32. ^ ***a*** ***b*** Wilson JM, Fitschen PJ, Campbell B, Wilson GJ, Zanchi N, Taylor L, Wilborn C, Kalman DS, Stout JR, Hoffman JR, Ziegenfuss TN, Lopez HL, Kreider RB, Smith-Ryan AE, Antonio J (February 2013). \"International Society of Sports Nutrition Position Stand: beta-hydroxy-beta-methylbutyrate (HMB)\". *Journal of the International Society of Sports Nutrition*. **10** (1): 6. doi:10.1186/1550-2783-10-6. PMC\u00a03568064. PMID\u00a023374455.\n33. ^ ***a*** ***b*** Zanchi NE, Gerlinger-Romero F, Guimar\u00e3es-Ferreira L, de Siqueira Filho MA, Felitti V, Lira FS, Seelaender M, Lancha AH (April 2011). \"HMB supplementation: clinical and athletic performance-related effects and mechanisms of action\". *Amino Acids*. **40** (4): 1015\u20131025. doi:10.1007/s00726-010-0678-0. PMID\u00a020607321. S2CID\u00a011120110. HMB is a metabolite of the amino acid leucine (Van Koverin and Nissen 1992), an essential amino acid. The first step in HMB metabolism is the reversible transamination of leucine to [\u03b1-KIC] that occurs mainly extrahepatically (Block and Buse 1990). Following this enzymatic reaction, [\u03b1-KIC] may follow one of two pathways. In the first, HMB is produced from [\u03b1-KIC] by the cytosolic enzyme KIC dioxygenase (Sabourin and Bieber 1983). The cytosolic dioxygenase has been characterized extensively and differs from the mitochondrial form in that the dioxygenase enzyme is a cytosolic enzyme, whereas the dehydrogenase enzyme is found exclusively in the mitochondrion (Sabourin and Bieber 1981, 1983). Importantly, this route of HMB formation is direct and completely dependent of liver KIC dioxygenase. Following this pathway, HMB in the cytosol is first converted to cytosolic \u03b2-hydroxy-\u03b2-methylglutaryl-CoA (HMG-CoA), which can then be directed for cholesterol synthesis (Rudney 1957) (Fig. 1). In fact, numerous biochemical studies have shown that HMB is a precursor of cholesterol (Zabin and Bloch 1951; Nissen et al. 2000).\n34. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** ***h*** ***i*** ***j*** ***k*** ***l*** ***m*** ***n*** Kohlmeier M (May 2015). \"Leucine\". *Nutrient Metabolism: Structures, Functions, and Genes* (2nd\u00a0ed.). Academic Press. pp.\u00a0385\u2013388. ISBN\u00a0978-0-12-387784-0. Archived from the original on 22 March 2018. Retrieved 6 June 2016. Energy fuel: Eventually, most Leu is broken down, providing about 6.0kcal/g. About 60% of ingested Leu is oxidized within a few hours\u00a0... Ketogenesis: A significant proportion (40% of an ingested dose) is converted into acetyl-CoA and thereby contributes to the synthesis of ketones, steroids, fatty acids, and other compounds  \nFigure 8.57: Metabolism of L-leucine Archived 22 March 2018 at the Wayback Machine\n35. ^ ***a*** ***b*** ***c*** Rosenthal J, Angel A, Farkas J (February 1974). \"Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle\". *The American Journal of Physiology*. **226** (2): 411\u20138. doi:10.1152/ajplegacy.1974.226.2.411. PMID\u00a04855772.\n36. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** ***h*** Zanchi NE, Gerlinger-Romero F, Guimar\u00e3es-Ferreira L, de Siqueira Filho MA, Felitti V, Lira FS, Seelaender M, Lancha AH (April 2011). \"HMB supplementation: clinical and athletic performance-related effects and mechanisms of action\". *Amino Acids*. **40** (4): 1015\u20131025. doi:10.1007/s00726-010-0678-0. PMID\u00a020607321. S2CID\u00a011120110. HMB is a metabolite of the amino acid leucine (Van Koverin and Nissen 1992), an essential amino acid. The first step in HMB metabolism is the reversible transamination of leucine to [\u03b1-KIC] that occurs mainly extrahepatically (Block and Buse 1990). Following this enzymatic reaction, [\u03b1-KIC] may follow one of two pathways. In the first, HMB is produced from [\u03b1-KIC] by the cytosolic enzyme KIC dioxygenase (Sabourin and Bieber 1983). The cytosolic dioxygenase has been characterized extensively and differs from the mitochondrial form in that the dioxygenase enzyme is a cytosolic enzyme, whereas the dehydrogenase enzyme is found exclusively in the mitochondrion (Sabourin and Bieber 1981, 1983). Importantly, this route of HMB formation is direct and completely dependent of liver KIC dioxygenase. Following this pathway, HMB in the cytosol is first converted to cytosolic \u03b2-hydroxy-\u03b2-methylglutaryl-CoA (HMG-CoA), which can then be directed for cholesterol synthesis (Rudney 1957) (Fig. 1). In fact, numerous biochemical studies have shown that HMB is a precursor of cholesterol (Zabin and Bloch 1951; Nissen et al. 2000).\n37. **^** Brioche T, Pagano AF, Py G, Chopard A (August 2016). \"Muscle wasting and aging: Experimental models, fatty infiltrations, and prevention\" (PDF). *Molecular Aspects of Medicine*. **50**: 56\u201387. doi:10.1016/j.mam.2016.04.006. PMID\u00a027106402. S2CID\u00a029717535. In conclusion, HMB treatment clearly appears to be a safe potent strategy against sarcopenia, and more generally against muscle wasting, because HMB improves muscle mass, muscle strength, and physical performance. It seems that HMB is able to act on three of the four major mechanisms involved in muscle deconditioning (protein turnover, apoptosis, and the regenerative process), whereas it is hypothesized to strongly affect the fourth (mitochondrial dynamics and functions). Moreover, HMB is inexpensive (~30\u2013 50 US dollars per month at 3 g per day) and may prevent osteopenia (Bruckbauer and Zemel, 2013; Tatara, 2009; Tatara et al., 2007, 2008, 2012) and decrease cardiovascular risks (Nissen et al., 2000). For all these reasons, HMB should be routinely used in muscle-wasting conditions especially in aged people.\u00a0... 3\u00a0g of CaHMB taken three times a day (1\u00a0g each time) is the optimal posology, which allows for continual bioavailability of HMB in the body (Wilson et al., 2013)\n38. **^** \"KEGG Reaction: R04137\". *Kyoto Encyclopedia of Genes and Genomes*. Kanehisa Laboratories. Archived from the original on 1 July 2016. Retrieved 24 June 2016.\n39. **^** \"Homo sapiens: 4-hydroxyphenylpyruvate dioxygenase reaction\". *MetaCyc*. SRI International. 20 August 2012. Retrieved 6 June 2016.\n40. ^ ***a*** ***b*** \"Leucine metabolism\". *BRENDA*. Technische Universit\u00e4t Braunschweig. Archived from the original on 17 August 2016. Retrieved 12 August 2016.\n41. **^** Lehninger AL, Nelson DL, Cox MM (2000). *Lehninger principles of biochemistry* (3rd\u00a0ed.). New York: Worth Publishers. ISBN\u00a0978-1-57259-153-0.\n42. **^** Meierhenrich: *Amino acids and the asymmetry of life*, Springer-Verlag, 2008, ISBN\u00a0978-3-540-76885-2.\n\n## External links\n\n[edit]\n\n* Leucine biosynthesis\n\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n</content>\n</document>",
          "name": "search",
          "tool_call_id": "22935ebd-d50d-458c-82bb-a1865ba99f2d",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Methionine</title>\n<content>\nSulfur-containing amino acid\n\n\n\n\nMethionine\n| ![Chemical structure of methionine](image)Skeletal formula of the canonical form of methionine\n |\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Ball-and-stick model\n | ![](image)Space-filling model\n |\n\n |\n| Names\n |\n| IUPAC name\nMethionine\n |\n| Other names\n2-amino-4-(methylthio)butanoic acid\n |\n| Identifiers\n |\n| CAS Number\n | * L: 63-68-3![check](image)Y\n* D/L: 59-51-8![check](image)Y\n* D: 348-67-4![check](image)Y\n |\n| 3D model (JSmol)\n | * L: Interactive image\n* L Zwitterion: Interactive image\n |\n| Abbreviations\n | Met, M\n |\n| ChEBI | * L: CHEBI:16643![check](image)Y\n* D/L: CHEBI:16811![check](image)Y\n* D: CHEBI:16867![check](image)Y\n |\n| ChEMBL | * L: ChEMBL42336![check](image)Y\n |\n| ChemSpider | * L: 5907![check](image)Y\n* D/L: 853![check](image)Y\n* D: 76512![check](image)Y\n |\n| DrugBank | * L: DB00134![check](image)Y\n |\n| ECHA InfoCard | 100.000.393 ![Edit this at Wikidata](image) |\n| EC Number | * L: 200-432-1\n |\n| KEGG | * L: C00073![check](image)Y\n |\n| PubChem CID\n | * L: 6137\n* D/L: 876\n* D: 84815\n |\n| UNII | * L: AE28F7PNPL![check](image)Y\n* D/L: 73JWT2K6T3![check](image)Y\n* D: 868496F25R![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * L: DTXSID9020821 ![Edit this at Wikidata](image)\n |\n| InChI\n\n* InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1![check](image)Y\nKey:\u00a0FFEARJCKVFRZRR-BYPYZUCNSA-N![check](image)Y\n* D/L: Key:\u00a0FFEARJCKVFRZRR-UHFFFAOYSA-N\n* D: Key:\u00a0FFEARJCKVFRZRR-SCSAIBSYSA-N\n |\n| SMILES\n\n* L: CSCC[C@H](N)C(=O)O\n* L Zwitterion: CSCC[C@H]([NH3+])C(=O)[O-]\n |\n| Properties[2] |\n| Chemical formula\n | C5H11NO2S |\n| Molar mass | 149.21\u00a0g\u00b7mol\u22121 |\n| Appearance\n | White crystalline powder\n |\n| Density | 1.340 g/cm3 |\n| Melting point | 281\u00a0\u00b0C (538\u00a0\u00b0F; 554\u00a0K) decomposes\n |\n| Solubility in water\n | Soluble\n |\n| Acidity (p*K*a)\n | 2.28 (carboxyl), 9.21 (amino)[1] |\n| Pharmacology\n |\n| ATC code\n | V03AB26 (WHO) QA05BA90 (WHO), QG04BA90 (WHO)\n |\n| Supplementary data page\n |\n| Methionine (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n**Methionine** (symbol **Met** or **M**)[3] (/m\u026a\u02c8\u03b8a\u026a\u0259ni\u02d0n/)[4] is an essential amino acid in humans.\n\n\nAs the precursor of other non-essential amino acids such as cysteine and taurine, versatile compounds such as SAM-e, and the important antioxidant glutathione, methionine plays a critical role in the metabolism and health of many species, including humans. Methionine is also involved in angiogenesis and various processes related to DNA transcription, epigenetic expression, and gene regulation.\n\n\nMethionine was first isolated in 1921 by John Howard Mueller.[5] It is encoded by the codon AUG. \n\n\n\n\n## Biochemical details\n\n[edit]\n\nMethionine (abbreviated as **Met** or **M**; encoded by the codon AUG) is an \u03b1-amino acid that is used in the biosynthesis of proteins. It contains a carboxyl group (which is in the deprotonated \u2212COO\u2212 form under biological pH conditions), an amino group (which is in the protonated \u2212NH+  \n3 form under biological pH conditions) located in \u03b1-position with respect to the carboxyl group, and an *S*-methyl thioether side chain, classifying it as a nonpolar, aliphatic amino acid.\n\n\nIn nuclear genes of eukaryotes and in Archaea, methionine is coded for by the start codon, meaning it indicates the start of the coding region and is the first amino acid produced in a nascent polypeptide during mRNA translation.[6]\n\n\n\n## A proteinogenic amino acid\n\n[edit]\n\nCysteine and methionine are the two sulfur-containing proteinogenic amino acids. Excluding the few exceptions where methionine may act as a redox sensor (e.g.,methionine sulfoxide[7]), methionine residues do not have a catalytic role.[8] This is in contrast to cysteine residues, where the thiol group has a catalytic role in many proteins.[8] The thioether within methionine does however have a minor structural role due to the stability effect of S/\u03c0 interactions between the side chain sulfur atom and aromatic amino acids in one-third of all known protein structures.[8] This lack of a strong role is reflected in experiments where little effect is seen in proteins where methionine is replaced by norleucine, a straight hydrocarbon sidechain amino acid which lacks the thioether.[9]\nIt has been conjectured that norleucine was present in early versions of the genetic code, but methionine intruded into the final version of the genetic code due to the fact it is used in the cofactor *S*-adenosylmethionine (SAM-e).[10] This situation is not unique and may have occurred with ornithine and arginine.[11]\n\n\n\n### Encoding\n\n[edit]\n\nMethionine is one of only two amino acids encoded by a single codon (AUG) in the standard genetic code (tryptophan, encoded by UGG, is the other). In reflection to the evolutionary origin of its codon, the other AUN codons encode isoleucine, which is also a hydrophobic amino acid. In the mitochondrial genome of several organisms, including metazoa and yeast, the codon AUA also encodes for methionine. In the standard genetic code AUA codes for isoleucine and the respective tRNA (*ileX* in *Escherichia coli*) uses the unusual base lysidine (bacteria) or agmatidine (archaea) to discriminate against AUG.[12][13]\n\n\nThe methionine codon AUG is also the most common start codon. A \"Start\" codon is message for a ribosome that signals the initiation of protein translation from mRNA when the AUG codon is in a Kozak consensus sequence. As a consequence, methionine is often incorporated into the *N*-terminal position of proteins in eukaryotes and archaea during translation, although it can be removed by post-translational modification. In bacteria, the derivative *N*-formylmethionine is used as the initial amino acid.\n\n\n\n## Derivatives\n\n[edit]\n\n### *S*-Adenosylmethionine\n\n[edit]\n\n![](image)*S*-Adenosylmethionine is a cofactor derived from methionine.\nMain article: S-Adenosylmethionine\n\nThe methionine-derivative *S*-adenosylmethionine (SAM-e) is a cofactor that serves mainly as a methyl donor. SAM-e is composed of an adenosyl molecule (via 5\u2032 carbon) attached to the sulfur of methionine, therefore making it a sulfonium cation (i.e., three substituents and positive charge). The sulfur acts as a soft Lewis acid (i.e., donor/electrophile) which allows the *S*-methyl group to be transferred to an oxygen, nitrogen, or aromatic system, often with the aid of other cofactors such as cobalamin (vitamin B12 in humans). Some enzymes use SAM-e to initiate a radical reaction; these are called radical SAM-e enzymes.\nAs a result of the transfer of the methyl group, *S*-adenosylhomocysteine is obtained. In bacteria, this is either regenerated by methylation or is salvaged by removing the adenine and the homocysteine, leaving the compound dihydroxypentandione to spontaneously convert into autoinducer-2, which is excreted as a waste product or quorum signal.\n\n\n\n## Biosynthesis\n\n[edit]\n\n![](image)Methionine biosynthesis\nAs an essential amino acid, methionine is not synthesized *de novo* in humans and other animals, which must ingest methionine or methionine-containing proteins. In plants and microorganisms, methionine biosynthesis belongs to the aspartate family, along with threonine and lysine (via diaminopimelate, but not via \u03b1-aminoadipate). The main backbone is derived from aspartic acid, while the sulfur may come from cysteine, methanethiol, or hydrogen sulfide.[8]\n\n\n\n* First, aspartic acid is converted via \u03b2-aspartyl semialdehyde into homoserine by two reduction steps of the terminal carboxyl group (homoserine has therefore a \u03b3-hydroxyl, hence the homo- series). The intermediate aspartate semialdehyde is the branching point with the lysine biosynthetic pathway, where it is instead condensed with pyruvate. Homoserine is the branching point with the threonine pathway, where instead it is isomerised after activating the terminal hydroxyl with phosphate (also used for methionine biosynthesis in plants).[8]\n* Homoserine is then activated with a phosphate, succinyl or an acetyl group on the hydroxyl.\n\t+ In plants and possibly in some bacteria,[8] phosphate is used. This step is shared with threonine biosynthesis.[8]\n\t+ In most organisms, an acetyl group is used to activate the homoserine. This can be catalysed in bacteria by an enzyme encoded by *metX* or *metA* (not homologues).[8]\n\t+ In enterobacteria and a limited number of other organisms, succinate is used. The enzyme that catalyses the reaction is MetA and the specificity for acetyl-CoA and succinyl-CoA is dictated by a single residue.[8] The physiological basis for the preference of acetyl-CoA or succinyl-CoA is unknown, but such alternative routes are present in some other pathways (*e.g.* lysine biosynthesis and arginine biosynthesis).\n* The hydroxyl activating group is then replaced with cysteine, methanethiol, or hydrogen sulfide. A replacement reaction is technically a \u03b3-elimination followed by a variant of a Michael addition. All the enzymes involved are homologues and members of the Cys/Met metabolism PLP-dependent enzyme family, which is a subset of the PLP-dependent fold type I clade. They utilise the cofactor PLP (pyridoxal phosphate), which functions by stabilising carbanion intermediates.[8]\n\t+ If it reacts with cysteine, it produces cystathionine, which is cleaved to yield homocysteine. The enzymes involved are cystathionine-\u03b3-synthase (encoded by *metB* in bacteria) and cystathionine-\u03b2-lyase (*metC*). Cystathionine is bound differently in the two enzymes allowing \u03b2 or \u03b3 reactions to occur.[8]\n\t+ If it reacts with free hydrogen sulfide, it produces homocysteine. This is catalysed by *O*-acetylhomoserine aminocarboxypropyltransferase (formerly known as *O*-acetylhomoserine (thiol)-lyase. It is encoded by either *metY* or *metZ* in bacteria.[8]\n\t+ If it reacts with methanethiol, it produces methionine directly. Methanethiol is a byproduct of catabolic pathway of certain compounds, therefore this route is more uncommon.[8]\n* If homocysteine is produced, the thiol group is methylated, yielding methionine. Two methionine synthases are known; one is cobalamin (vitamin B12) dependent and one is independent.[8]\n\n\nThe pathway using cysteine is called the \"transsulfuration pathway\", while the pathway using hydrogen sulfide (or methanethiol) is called \"direct-sulfurylation pathway\".\n\n\nCysteine is similarly produced, namely it can be made from an activated serine and either from homocysteine (\"reverse transsulfurylation route\") or from hydrogen sulfide (\"direct sulfurylation route\"); the activated serine is generally *O*-acetylserine (via CysK or CysM in *E. coli*), but in *Aeropyrum pernix* and some other archaea *O*-phosphoserine is used.[14] CysK and CysM are homologues, but belong to the PLP fold type III clade.\n\n\n\n### Transsulfurylation pathway\n\n[edit]\n\nMain article: Transsulfuration pathway\n\nEnzymes involved in the *E. coli* transsulfurylation route of methionine biosynthesis:\n\n\n\n1. Aspartokinase\n2. Aspartate-semialdehyde dehydrogenase\n3. Homoserine dehydrogenase\n4. Homoserine *O*-transsuccinylase\n5. Cystathionine-\u03b3-synthase\n6. Cystathionine-\u03b2-lyase\n7. Methionine synthase (in mammals, this step is performed by homocysteine methyltransferase or betaine\u2014homocysteine *S*-methyltransferase.)\n\n\n## Other biochemical pathways\n\n[edit]\n\n![](image)Fates of methionine\nAlthough mammals cannot synthesize methionine, they can still use it in a variety of biochemical pathways:\n\n\n\n### Catabolism\n\n[edit]\n\nMethionine is converted to *S*-adenosylmethionine (SAM-e) by (1) methionine adenosyltransferase.\n\n\nSAM-e serves as a methyl donor in many (2) methyltransferase reactions, and is converted to *S*-adenosylhomocysteine (SAH).\n\n\n(3) Adenosylhomocysteinase\ncysteine.\n\n\n\n### Regeneration\n\n[edit]\n\nMethionine can be regenerated from homocysteine via (4) methionine synthase in a reaction that requires vitamin B12 as a cofactor.\n\n\nHomocysteine can also be remethylated using glycine betaine (*N*,*N*,*N*-trimethylglycine, TMG) to methionine via the enzyme betaine-homocysteine methyltransferase (E.C.2.1.1.5, BHMT). BHMT makes up to 1.5% of all the soluble protein of the liver, and recent evidence suggests that it may have a greater influence on methionine and homocysteine homeostasis than methionine synthase.\n\n\n\n### Reverse-transulfurylation pathway: conversion to cysteine\n\n[edit]\n\nHomocysteine can be converted to cysteine.\n\n\n\n* (5) Cystathionine-\u03b2-synthase (an enzyme which requires pyridoxal phosphate, the active form of vitamin B6) combines homocysteine and serine to produce cystathionine. Instead of degrading cystathionine via cystathionine-\u03b2-lyase, as in the biosynthetic pathway, cystathionine is broken down to cysteine and \u03b1-ketobutyrate via (6) cystathionine-\u03b3-lyase.\n* (7) The enzyme \u03b1-ketoacid dehydrogenase converts \u03b1-ketobutyrate to propionyl-CoA, which is metabolized to succinyl-CoA in a three-step process (see propionyl-CoA for pathway).\n\n\n### Ethylene synthesis\n\n[edit]\n\nThis amino acid is also used by plants for synthesis of ethylene. The process is known as the Yang cycle or the methionine cycle.\n\n\n\n![](image)The Yang cycle\n## Metabolic diseases\n\n[edit]\n\nThe degradation of methionine is impaired in the following metabolic diseases:\n\n\n\n* Combined malonic and methylmalonic aciduria (CMAMMA)\n* Homocystinuria\n* Methylmalonic acidemia\n* Propionic acidemia\n\n\n## Chemical synthesis\n\n[edit]\n\nThe industrial synthesis combines acrolein, methanethiol, and cyanide, which affords the hydantoin.[15] Racemic methionine can also be synthesized from diethyl sodium phthalimidomalonate by alkylation with chloroethylmethylsulfide (ClCH2CH2SCH3) followed by hydrolysis and decarboxylation. Also see Methanol. [16]\n\n\n\n## Human nutrition\n\n[edit]\n\nMethionine supplementation benefit those suffering from copper poisoning.[17]\n\n\nOverconsumption of methionine, the methyl group donor in DNA methylation, is related to cancer growth in a number of studies.[18][19]\n\n\n\n### Requirements\n\n[edit]\n\nThe Food and Nutrition Board of the U.S. Institute of Medicine set Recommended Dietary Allowances (RDAs) for essential amino acids in 2002. For methionine combined with cysteine, for adults 19 years and older, 19\u00a0mg/kg body weight/day.[20]\n\n\nThis translates to about 1.33 grams per day for a 70 kilogram individual.\n\n\n\n### Dietary sources\n\n[edit]\n\n\n\nFood sources of methionine[*citation needed*]\n| Food\n | g/100\u00a0g\n |\n| --- | --- |\n| Egg, white, dried, powder, glucose reduced | 3.204\n |\n| Sesame seeds flour (low fat) | 1.656\n |\n| Brazil nuts | 1.124\n |\n| Cheese, Parmesan, shredded | 1.114\n |\n| hemp seed, hulled | 0.933\n |\n| Soy protein concentrate | 0.814\n |\n| Chicken, broilers or fryers, roasted | 0.801\n |\n| Fish, tuna, light, canned in water, drained solids | 0.755\n |\n| Beef, cured, dried | 0.749\n |\n| Bacon | 0.593\n |\n| chia seeds | 0.588\n |\n| Beef, ground, 95% lean meat / 5% fat, raw | 0.565\n |\n| Pork, ground, 96% lean / 4% fat, raw | 0.564\n |\n| Soybeans | 0.547\n |\n| Wheat germ | 0.456\n |\n| Egg, whole, cooked, hard-boiled | 0.392\n |\n| Oat | 0.312\n |\n| Peanuts | 0.309\n |\n| Chickpea | 0.253\n |\n| Corn, yellow | 0.197\n |\n| Almonds | 0.151\n |\n| Beans, pinto, cooked | 0.117\n |\n| Lentils, cooked | 0.077\n |\n| Rice, brown, medium-grain, cooked | 0.052\n |\n\n\nHigh levels of methionine can be found in eggs, meat, and fish; sesame seeds, Brazil nuts, and some other plant seeds; and cereal grains. Most fruits and vegetables contain very little. Most legumes, though protein dense, are low in methionine. Proteins without adequate methionine are not considered to be complete proteins.[21] For that reason, racemic methionine is sometimes added as an ingredient to pet foods.[22]\n\n\n\n## Restriction\n\n[edit]\n\nSome scientific evidence indicates restricting methionine consumption can increase lifespans in fruit flies.[23]\n\n\nA 2005 study showed methionine restriction without energy restriction extends mouse lifespans.[24] This extension requires intact growth hormone signaling, as animals without intact growth-hormone signaling do not have a further increase in lifespan when methionine restricted.[25] The metabolic response to methionine restriction is also altered in mouse growth hormone signaling mutants.[26]\n\n\nA study published in *Nature* showed adding just the essential amino acid methionine to the diet of fruit flies under dietary restriction, including restriction of essential amino acids (EAAs), restored fertility without reducing the longer lifespans that are typical of dietary restriction, leading the researchers to determine that methionine \"acts in combination with one or more other EAAs to shorten lifespan.\"[23][27][28] Restoring methionine to the diet of mice on a dietary restriction regimen blocks many acute benefits of dietary restriction, a process that may be mediated by increased production of hydrogen sulfide.[29]\n\n\nMethionine restriction can increase circulating liver hormone FGF21 between 5-fold and 10-fold in mice.[30] Several studies showed that methionine restriction also inhibits aging-related disease processes in mice[31][32] and inhibits colon carcinogenesis in rats.[33] In humans, methionine restriction through dietary modification could be achieved through a plant-based diet.[34]\n\n\nRestriction of dietary methionine reduces levels of its catabolite *S*-adenosylmethionine (SAM-e), resulting is a subsequent loss of histone methylation.[35] An active process mediated by a specific, preserved methylation of H3K9 preserves the memory of the original methylation profile, allowing the epigenome to be restored when dietary methionine levels return.[35]\n\n\nA 2009 study on rats showed \"methionine supplementation in the diet specifically increases mitochondrial ROS production and mitochondrial DNA oxidative damage in rat liver mitochondria offering a plausible mechanism for its hepatotoxicity\".[36]\n\n\nHowever, since methionine is an essential amino acid, it cannot be entirely removed from animals' diets without disease or death occurring over time.[*citation needed*] For example, rats fed a diet without methionine and choline developed steatohepatitis (fatty liver) and anemia, and lost two-thirds of their body weight over 5 weeks. Administration of methionine ameliorated the pathological consequences of methionine deprivation.[37] Short-term removal of only methionine from the diet can reverse diet-induced obesity and promotes insulin sensitivity in mice,[38] and methionine restriction also protects a mouse model of spontaneous, polygenic obesity and diabetes.[39]\n\n\n\n## Health\n\n[edit]\n\nLoss of methionine has been linked to senile greying of hair. Its lack leads to a buildup of hydrogen peroxide in hair follicles, a reduction in tyrosinase effectiveness, and a gradual loss of hair color.[40] Methionine raises the intracellular concentration of glutathione, thereby promoting antioxidant-mediated cell defense and redox regulation. It also protects cells against dopamine induced nigral cell loss by binding oxidative metabolites.[41]\n\n\nMethionine is an intermediate in the biosynthesis of cysteine, carnitine, taurine, lecithin, phosphatidylcholine, and other phospholipids. Improper conversion of methionine can lead to atherosclerosis[42] due to accumulation of homocysteine.\n\n\n\n## Other uses\n\n[edit]\n\nDL-Methionine is sometimes given as a supplement to dogs; It helps reduce the chances of kidney stones in dogs. Methionine is also known to increase the urinary excretion of quinidine by acidifying the urine. Aminoglycoside antibiotics used to treat urinary tract infections work best in alkaline conditions, and urinary acidification from using methionine can reduce its effectiveness. If a dog is on a diet that acidifies the urine, methionine should not be used.[43]\n\n\nMethionine is allowed as a supplement to organic poultry feed under the US certified organic program.[44]\n\n\nMethionine can be used as a nontoxic pesticide option against giant swallowtail caterpillars, which are a serious pest to orange crops.[45]\n\n\n\n## See also\n\n[edit]\n\n* Allantoin\n* Formylmethionine\n* Methionine oxidation\n* Paracetamol poisoning\n* Photoreactive methionine\n* *S*-Methylcysteine\n\n\n## References\n\n[edit]\n\n1. **^** Dawson RM, Elliott DC, Elliott WH, Jones KM (1959). *Data for Biochemical Research*. Oxford: Clarendon Press.\n2. **^** Weast, Robert C., ed. (1981). *CRC Handbook of Chemistry and Physics* (62nd\u00a0ed.). Boca Raton, FL: CRC Press. p.\u00a0C-374. ISBN\u00a00-8493-0462-8..\n3. **^** \"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.\n4. **^** \"Methionine\". Oxford University Press. Archived from the original on January 27, 2018.\n5. **^** Pappenheimer AM (1987). \"A Biographical Memoir of John Howard Mueller\" (PDF). Washington D.C.: National Academy of Sciences.\n6. **^** Guedes RL, Prosdocimi F, Fernandes GR, Moura LK, Ribeiro HA, Ortega JM (December 2011). \"Amino acids biosynthesis and nitrogen assimilation pathways: a great genomic deletion during eukaryotes evolution\". *BMC Genomics*. 12 Suppl 4 (Suppl 4): S2. doi:10.1186/1471-2164-12-S4-S2. PMC\u00a03287585. PMID\u00a022369087.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n7. **^** Bigelow DJ, Squier TC (January 2005). \"Redox modulation of cellular signaling and metabolism through reversible oxidation of methionine sensors in calcium regulatory proteins\". *Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics* (Submitted manuscript). **1703** (2): 121\u2013134. doi:10.1016/j.bbapap.2004.09.012. PMID\u00a015680220.\n8. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** ***h*** ***i*** ***j*** ***k*** ***l*** ***m*** ***n*** Ferla MP, Patrick WM (August 2014). \"Bacterial methionine biosynthesis\". *Microbiology*. **160** (Pt 8): 1571\u20131584. doi:10.1099/mic.0.077826-0. PMID\u00a024939187.\n9. **^** Cirino PC, Tang Y, Takahashi K, Tirrell DA, Arnold FH (September 2003). \"Global incorporation of norleucine in place of methionine in cytochrome P450 BM-3 heme domain increases peroxygenase activity\". *Biotechnology and Bioengineering*. **83** (6): 729\u2013734. doi:10.1002/bit.10718. PMID\u00a012889037. S2CID\u00a011380413.\n10. **^** Alvarez-Carre\u00f1o C, Becerra A, Lazcano A (October 2013). \"Norvaline and norleucine may have been more abundant protein components during early stages of cell evolution\". *Origins of Life and Evolution of the Biosphere*. **43** (4\u20135): 363\u2013375. Bibcode:2013OLEB...43..363A. doi:10.1007/s11084-013-9344-3. PMID\u00a024013929. S2CID\u00a017224537.\n11. **^** Jukes TH (August 1973). \"Arginine as an evolutionary intruder into protein synthesis\". *Biochemical and Biophysical Research Communications*. **53** (3): 709\u2013714. doi:10.1016/0006-291x(73)90151-4. PMID\u00a04731949.\n12. **^** Ikeuchi Y, Kimura S, Numata T, Nakamura D, Yokogawa T, Ogata T, Wada T, Suzuki T, Suzuki T (April 2010). \"Agmatine-conjugated cytidine in a tRNA anticodon is essential for AUA decoding in archaea\". *Nature Chemical Biology*. **6** (4): 277\u2013282. doi:10.1038/nchembio.323. PMID\u00a020139989.\n13. **^** Muramatsu T, Nishikawa K, Nemoto F, Kuchino Y, Nishimura S, Miyazawa T, Yokoyama S (November 1988). \"Codon and amino-acid specificities of a transfer RNA are both converted by a single post-transcriptional modification\". *Nature*. **336** (6195): 179\u2013181. Bibcode:1988Natur.336..179M. doi:10.1038/336179a0. PMID\u00a03054566. S2CID\u00a04371485.\n14. **^** Mino K, Ishikawa K (September 2003). \"A novel *O*-phospho-L-serine sulfhydrylation reaction catalyzed by *O*-acetylserine sulfhydrylase from *Aeropyrum pernix* K1\". *FEBS Letters*. **551** (1\u20133): 133\u2013138. doi:10.1016/S0014-5793(03)00913-X. PMID\u00a012965218. S2CID\u00a028360765.\n15. **^** Karlheinz Drauz; Ian Grayson; Axel Kleemann; Hans-Peter Krimmer; Wolfgang Leuchtenberger; Christoph Weckbecker (2006). *Ullmann's Encyclopedia of Industrial Chemistry*. Weinheim: Wiley-VCH. doi:10.1002/14356007.a02\\_057.pub2. ISBN\u00a0978-3527306732.\n16. **^** Barger G, Weichselbaum TE (1934). \"*dl*-Methionine\". *Organic Syntheses*. **14**: 58; *Collected Volumes*, vol.\u00a02, p.\u00a0384.\n17. **^** \"Methionine\". *WebMD*.\n18. **^** Cavuoto P, Fenech MF (2012). \"A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension\". *Cancer Treatment Reviews*. **38** (6): 726\u2013736. doi:10.1016/j.ctrv.2012.01.004. PMID\u00a022342103.\n19. **^** Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P (2003). \"Methionine dependency and cancer treatment\". *Cancer Treatment Reviews*. **29** (6): 489\u2013499. doi:10.1016/S0305-7372(03)00118-X. PMID\u00a014585259.\n20. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0.\n21. **^** Finkelstein JD (May 1990). \"Methionine metabolism in mammals\". *The Journal of Nutritional Biochemistry*. **1** (5): 228\u2013237. doi:10.1016/0955-2863(90)90070-2. PMID\u00a015539209. S2CID\u00a032264340.\n22. **^** Palika L (1996). *The Consumer's Guide to Dog Food: What's in Dog Food, Why It's There and How to Choose the Best Food for Your Dog*. New York: Howell Book House. ISBN\u00a0978-0-87605-467-3.\n23. ^ ***a*** ***b*** Grandison RC, Piper MD, Partridge L (December 2009). \"Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila\". *Nature*. **462** (7276): 1061\u20131064. Bibcode:2009Natur.462.1061G. doi:10.1038/nature08619. PMC\u00a02798000. PMID\u00a019956092.\n\n\t* \"Longer lives for vegetarians?\". *NHS Choices*. December 3, 2009. Archived from the original on 2009-12-08.\n24. **^** Miller RA, Buehner G, Chang Y, Harper JM, Sigler R, Smith-Wheelock M (June 2005). \"Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance\". *Aging Cell*. **4** (3): 119\u2013125. doi:10.1111/j.1474-9726.2005.00152.x. PMC\u00a07159399. PMID\u00a015924568..\n25. **^** Brown-Borg HM, Rakoczy SG, Wonderlich JA, Rojanathammanee L, Kopchick JJ, Armstrong V, Raasakka D (December 2014). \"Growth hormone signaling is necessary for lifespan extension by dietary methionine\". *Aging Cell*. **13** (6): 1019\u20131027. doi:10.1111/acel.12269. PMC\u00a04244257. PMID\u00a025234161.\n26. **^** Brown-Borg HM, Rakoczy S, Wonderlich JA, Borg KE, Rojanathammanee L (April 2018). \"Metabolic adaptation of short-living growth hormone transgenic mice to methionine restriction and supplementation\". *Annals of the New York Academy of Sciences*. **1418** (1): 118\u2013136. Bibcode:2018NYASA1418..118B. doi:10.1111/nyas.13687. PMC\u00a07025433. PMID\u00a029722030.\n27. **^** Grandison RC, Piper MD, Partridge L (December 2009). \"Amino-acid imbalance explains extension of lifespan by dietary restriction in Drosophila\". *Nature*. **462** (7276): 1061\u20131064. Bibcode:2009Natur.462.1061G. doi:10.1038/nature08619. PMC\u00a02798000. PMID\u00a019956092.\n28. **^** \"Amino acid recipe could be right for long life\". *Science News*. December 2, 2009.\n29. **^** Hine C, Harputlugil E, Zhang Y, Ruckenstuhl C, Lee BC, Brace L, Longchamp A, Trevi\u00f1o-Villarreal JH, Mejia P, Ozaki CK, Wang R, Gladyshev VN, Madeo F, Mair WB, Mitchell JR (January 2015). \"Endogenous hydrogen sulfide production is essential for dietary restriction benefits\". *Cell*. **160** (1\u20132): 132\u2013144. doi:10.1016/j.cell.2014.11.048. PMC\u00a04297538. PMID\u00a025542313.\n30. **^** Fang H, Stone KP, Forney LA, Wanders D, Gettys TW (2021). \"Nutritional Regulation of Hepatic FGF21 by Dietary Restriction of Methionine\". *Frontiers in Endocrinology*. **12**: 773975. doi:10.3389/fendo.2021.773975. PMC\u00a08669746. PMID\u00a034917032.\n31. **^** Richie JP, Leutzinger Y, Parthasarathy S, Malloy V, Orentreich N, Zimmerman JA (December 1994). \"Methionine restriction increases blood glutathione and longevity in F344 rats\". *FASEB Journal*. **8** (15): 1302\u20131307. doi:10.1096/fasebj.8.15.8001743. PMID\u00a08001743. S2CID\u00a025198679.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n32. **^** Sun L, Sadighi Akha AA, Miller RA, Harper JM (July 2009). \"Life-span extension in mice by preweaning food restriction and by methionine restriction in middle age\". *The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences*. **64** (7): 711\u2013722. doi:10.1093/gerona/glp051. PMC\u00a02691799. PMID\u00a019414512.\n33. **^** Komninou D, Leutzinger Y, Reddy BS, Richie JP (2006). \"Methionine restriction inhibits colon carcinogenesis\". *Nutrition and Cancer*. **54** (2): 202\u2013208. doi:10.1207/s15327914nc5402\\_6. PMID\u00a016898864. S2CID\u00a027492544.\n34. **^** Cavuoto P, Fenech MF (October 2012). \"A review of methionine dependency and the role of methionine restriction in cancer growth control and life-span extension\". *Cancer Treatment Reviews*. **38** (6): 726\u2013736. doi:10.1016/j.ctrv.2012.01.004. PMID\u00a022342103.\n35. ^ ***a*** ***b*** Haws, Spencer A.; Yu, Deyang; Ye, Cunqi; Wille, Coral K.; Nguyen, Long C.; Krautkramer, Kimberly A.; Tomasiewicz, Jay L.; Yang, Shany E.; Miller, Blake R.; Liu, Wallace H.; Igarashi, Kazuhiko (2020-03-13). \"Methyl-Metabolite Depletion Elicits Adaptive Responses to Support Heterochromatin Stability and Epigenetic Persistence\". *Molecular Cell*. **78** (2): 210\u2013223.e8. doi:10.1016/j.molcel.2020.03.004. ISSN\u00a01097-4164. PMC\u00a07191556. PMID\u00a032208170.\n36. **^** Gomez J, Caro P, Sanchez I, Naudi A, Jove M, Portero-Otin M, Lopez-Torres M, Pamplona R, Barja G (June 2009). \"Effect of methionine dietary supplementation on mitochondrial oxygen radical generation and oxidative DNA damage in rat liver and heart\". *Journal of Bioenergetics and Biomembranes*. **41** (3): 309\u2013321. doi:10.1007/s10863-009-9229-3. PMID\u00a019633937. S2CID\u00a024106490.\n37. **^** Oz HS, Chen TS, Neuman M (March 2008). \"Methionine deficiency and hepatic injury in a dietary steatohepatitis model\". *Digestive Diseases and Sciences*. **53** (3): 767\u2013776. doi:10.1007/s10620-007-9900-7. PMC\u00a02271115. PMID\u00a017710550.\n38. **^** Yu D, Yang SE, Miller BR, Wisinski JA, Sherman DS, Brinkman JA, Tomasiewicz JL, Cummings NE, Kimple ME, Cryns VL, Lamming DW (January 2018). \"Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms\". *FASEB Journal*. **32** (6): 3471\u20133482. doi:10.1096/fj.201701211R. PMC\u00a05956241. PMID\u00a029401631.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n39. **^** Casta\u00f1o-Martinez, Teresa; Schumacher, Fabian; Schumacher, Silke; Kochlik, Bastian; Weber, Daniela; Grune, Tilman; Biemann, Ronald; McCann, Adrian; Abraham, Klaus (2019-03-06). \"Methionine restriction prevents onset of type 2 diabetes in NZO mice\". *The FASEB Journal*. **33** (6): 7092\u20137102. doi:10.1096/fj.201900150R. ISSN\u00a01530-6860. PMC\u00a06529347. PMID\u00a030841758.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n40. **^** Wood JM, Decker H, Hartmann H, Chavan B, Rokos H, Spencer JD, et\u00a0al. (July 2009). \"Senile hair graying: H2O2-mediated oxidative stress affects human hair color by blunting methionine sulfoxide repair\". *FASEB Journal*. **23** (7): 2065\u201375. arXiv:0706.4406. doi:10.1096/fj.08-125435. hdl:10454/6241. PMID\u00a019237503. S2CID\u00a016069417.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n41. **^** Pinnen F, et\u00a0al. (2009). \"Codrugs linking L-dopa and sulfur-containing antioxidants: new pharmacological tools against Parkinson's disease\". *Journal of Medicinal Chemistry*. **52** (2): 559\u201363. doi:10.1021/jm801266x. PMID\u00a019093882.\n42. **^** Refsum H, Ueland PM, Nyg\u00e5rd O, Vollset SE (1998). \"Homocysteine and cardiovascular disease\". *Annual Review of Medicine*. **49** (1): 31\u201362. doi:10.1146/annurev.med.49.1.31. PMID\u00a09509248.\n43. **^** Grimshaw, Jane (July 25, 2011) Methionine for Dogs uses and Side Effects. critters360.com\n44. **^** \"Rules and Regulations\". *Federal Register*. **76** (49): 13501\u201313504. March 14, 2011.\n45. **^** Lewis DS, Cuda JP, Stevens BR (December 2011). \"A novel biorational pesticide: efficacy of methionine against *Heraclides (Papilio) cresphontes*, a surrogate of the invasive *Princeps (Papilio) demoleus* (Lepidoptera: Papilionidae)\". *Journal of Economic Entomology*. **104** (6): 1986\u20131990. doi:10.1603/ec11132. PMID\u00a022299361. S2CID\u00a045255198.\n\n## External links\n\n[edit]\n\n* Rudra MN, Chowdhury LM (30 September 1950). \"Methionine Content of Cereals and Legumes\". *Nature*. **166** (568): 568. Bibcode:1950Natur.166..568R. doi:10.1038/166568a0. PMID\u00a014780151. S2CID\u00a03026278.\n\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAntidotes (V03AB)\n |\n| --- |\n| Nervous system | \n\n|  |  |\n| --- | --- |\n| Alcohol intoxication | * Metadoxine\n* Thiamine\n |\n| Barbiturate overdose | * Bemegride\n* Ethamivan\n |\n| Benzodiazepine overdose | * Cyprodenate\n* Flumazenil\n |\n| GHB overdose | * Physostigmine\n* SCH-50911\n |\n| Nerve agent / Organophosphate poisoning | * Atropine#\n* Biperiden\n* Diazepam#\n* Oximes\n\t+ Obidoxime\n\t+ Pralidoxime\n* *see also:* Cholinesterase\n |\n| Opioid overdose | * Diprenorphine\n* Doxapram\n* Nalmefene\n* Nalorphine\n* Naloxone#\n* Naltrexone\n |\n| Reversal of neuromuscular blockade | * Sugammadex\n |\n\n |\n| Circulatory system | \n\n|  |  |\n| --- | --- |\n| Beta blocker | * Glucagon\n |\n| Digoxin toxicity | * Digoxin immune fab\n |\n| Anticoagulants | * against direct Xa inhibitors (Andexanet alfa)\n* against heparin (Protamine#)\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Arsenic poisoning | * Dimercaprol#\n* Succimer\n |\n| Cyanide poisoning | * 4-Dimethylaminophenol\n* Hydroxocobalamin\n* *nitrite*\n\t+ Amyl nitrite\n\t+ Sodium nitrite#\n* Sodium thiosulfate#\n |\n| Hydrofluoric acid | * Calcium gluconate#\n |\n| Methanol / Ethylene glycol poisoning | * Primary alcohols: Ethanol\n* Fomepizole\n |\n| Paracetamol toxicity (Acetaminophen) | * Acetylcysteine#\n* Glutathione\n* Methionine#\n |\n| Toxic metals (cadmium* lead\n* mercury\n* thallium)\n | - Dimercaprol#\n\n- Edetates\n\n- Prussian blue#\n |\n| Other | * *iodine-131*\n\t+ Potassium iodide\n* Methylthioninium chloride#\n* *oxidizing agent*\n\t+ Potassium permanganate\n* Prednisolone/promethazine\n |\n\n |\n| Emetic | * Copper sulfate\n* Ipecacuanha\n\t+ Syrup of ipecac\n |\n| * #WHO-EM\n* \u2021Withdrawn from market\n* Clinical trials:\n\t+ \u2020Phase III\n\t+ \u00a7Never to phase III\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n|  |  |\n| --- | --- |\n| Authority control databases: National ![Edit this at Wikidata](image) | * United States\n* France\n* BnF data\n* Czech Republic\n* Israel\n |\n\n</content>\n</document>",
          "name": "search",
          "tool_call_id": "54edf902-909b-4c57-92c8-4a4b67e9dfa3",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Phenylalanine</title>\n<fragment>\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n\n</fragment>\n<fragment>\n\nThe genetic codon for phenylalanine was first discovered by J. Heinrich Matthaei and Marshall W. Nirenberg in 1961. They showed that by using mRNA to insert multiple uracil repeats into the genome of the bacterium *E. coli*, they could cause the bacterium to produce a polypeptide consisting solely of repeated phenylalanine amino acids. This discovery helped to establish the nature of the coding relationship that links information stored in genomic nucleic acid with protein expression in the living cell.\n\n\n\n## Dietary sources\n\n[edit]\n\nGood sources of phenylalanine are eggs, chicken, liver, beef, milk, and soybeans.[6] Another common source of phenylalanine is anything sweetened with the artificial sweetener aspartame, such as diet drinks, diet foods and medication; the metabolism of aspartame produces phenylalanine as one of the compound's metabolites.[7]\n\n\n\n## Dietary recommendations\n\n[edit]\n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n\n</fragment>\n<fragment>\n1. ^ ***a*** ***b*** Ihlefeldt, Franziska Stefanie; Pettersen, Fredrik Bjarte; von Bonin, Aidan; Zawadzka, Malgorzata; G\u00f6rbitz, Prof. Carl Henrik (2014). \"The Polymorphs of L\u2010Phenylalanine\". *Angew. Chem. Int. Ed.* **53** (49): 13600\u201313604. doi:10.1002/anie.201406886. PMID\u00a025336255.\n2. **^** Dawson RM, et\u00a0al. (1959). *Data for Biochemical Research*. Oxford: Clarendon Press.\n3. **^** \"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.\n4. **^** Thorpe TE (1913). *A Dictionary of Applied Chemistry*. Longmans, Green, and Co. pp.\u00a0191\u2013193. Retrieved 2012-06-04.\n5. **^** Plimmer RH (1912) [1908]. Plimmer RH, Hopkins FG (eds.). *The Chemical Composition of the Proteins*. Monographs on Biochemistry. Vol.\u00a0Part I. Analysis (2nd\u00a0ed.). London: Longmans, Green and Co. pp.\u00a093\u201397. Retrieved 2012-06-04.\n\n</fragment>\n<fragment>\n**Phenylalanine** (symbol **Phe** or **F**)[3] is an essential \u03b1-amino acid with the formula C  \n9H  \n11NO  \n2. It can be viewed as a benzyl group substituted for the methyl group of alanine, or a phenyl group in place of a terminal hydrogen of alanine. This essential amino acid is classified as neutral, and nonpolar because of the inert and hydrophobic nature of the benzyl side chain. The L-isomer is used to biochemically form proteins coded for by DNA. Phenylalanine is a precursor for tyrosine, the monoamine neurotransmitters dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline), and the skin pigment melanin. It is encoded by the codons UUU and UUC.\n\n\n</fragment>\n<fragment>\nThe Food and Nutrition Board (FNB) of the U.S. Institute of Medicine set Recommended Dietary Allowances (RDAs) for essential amino acids in 2002. For phenylalanine plus tyrosine, for adults 19 years and older, 33\u00a0mg/kg body weight/day.[8] In 2005 the DRI is set to 27\u00a0mg/kg per day (with no tyrosine), the FAO/WHO/UNU recommendation of 2007 is 25\u00a0mg/kg per day (with no tyrosine).[9]\n\n\n\n## Other biological roles\n\n[edit]\n\nL-Phenylalanine is biologically converted into L-tyrosine, another one of the DNA-encoded amino acids. L-tyrosine in turn is converted into L-DOPA, which is further converted into dopamine, norepinephrine (noradrenaline), and epinephrine (adrenaline). The latter three are known as the catecholamines.\n\n\n\n\n</fragment>\n<fragment>\n28. **^** M\u00f6ller HE, Weglage J, Bick U, Wiedermann D, Feldmann R, Ullrich K (December 2003). \"Brain imaging and proton magnetic resonance spectroscopy in patients with phenylketonuria\". *Pediatrics*. **112** (6 Pt 2): 1580\u20131583. doi:10.1542/peds.112.S4.1580. hdl:11858/00-001M-0000-0010-A24A-C. PMID\u00a014654669. S2CID\u00a02198040.\n29. **^** Sprenger GA (2007). \"Aromatic Amino Acids\". *Amino Acid Biosynthesis: Pathways, Regulation and Metabolic Engineering* (1st\u00a0ed.). Springer. pp.\u00a0106\u2013113. ISBN\u00a0978-3-540-48595-7.\n\n## External links\n\n[edit]\n\n![](image)\n\nWikimedia Commons has media related to L-Phenylalanine.\n\n* Phenylalanine mass spectrum\n* Phenylalanine at ChemSynthesis\n\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n\n</fragment>\n<fragment>\nType of \u03b1-amino acid\n\n\n\n\nPhenylalanine\n| ![Skeletal formula](image)Skeletal formula of L-phenylalanine\n |\n| ![](image)L-Phenylalanine at physiological pH\n |\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Ball-and-stick model[1]\n | ![](image)Space-filling model[1]\n |\n\n\n</fragment>\n<fragment>\n23. **^** Lehmann, W. D.; Theobald, N.; Fischer, R.; Heinrich, H. C. (1983-03-14). \"Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine\". *Clinica Chimica Acta; International Journal of Clinical Chemistry*. **128** (2\u20133): 181\u2013198. doi:10.1016/0009-8981(83)90319-4. ISSN\u00a00009-8981. PMID\u00a06851137.\n24. **^** Mortell KH, Anderson DJ, Lynch JJ, Nelson SL, Sarris K, McDonald H, Sabet R, Baker S, Honore P, Lee CH, Jarvis MF, Gopalakrishnan M (March 2006). \"Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels\". *Bioorganic & Medicinal Chemistry Letters*. **16** (5): 1138\u20134111. doi:10.1016/j.bmcl.2005.11.108. PMID\u00a016380257.\n\n</fragment>\n<fragment>\n |\n| Names\n |\n| Pronunciation\n | US: /\u02ccf\u025bn\u0259l\u02c8\u00e6l\u0259ni\u02d0n/; UK: /\u02ccfi\u02d0na\u026al-/ |\n| IUPAC name\nPhenylalanine\n |\n| Systematic IUPAC name\n(*S*)-2-Amino-3-phenylpropanoic acid\n |\n| Identifiers\n |\n| CAS Number\n | * L: 63-91-2![check](image)Y\n* D/L: 150-30-1![check](image)Y\n* D: 673-06-3![check](image)Y\n |\n| 3D model (JSmol)\n | * L: Interactive image\n* L Zwitterion: Interactive image\n |\n| ChEBI | * L: CHEBI:17295![check](image)Y\n* D: CHEBI:16998![check](image)Y\n |\n| ChEMBL | * L: ChEMBL301523![check](image)Y\n |\n| ChemSpider | * L: 5910![check](image)Y\n* D/L: 969![check](image)Y\n* D: 64639![check](image)Y\n |\n| DrugBank | * L: DB00120![check](image)Y\n |\n| ECHA InfoCard | 100.000.517 ![Edit this at Wikidata](image) |\n| IUPHAR/BPS\n | * L: 3313\n |\n| KEGG | * L: D00021![check](image)Y\n |\n| PubChem CID\n | * L: 6140\n* D/L: 994\n* D: 71567\n |\n| UNII | * L: 47E5O17Y3R![check](image)Y\n* D/L: 8P946UF12S![check](image)Y\n* D: 032K16VRCU![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * L: DTXSID4040763 ![Edit this at Wikidata](image)\n |\n\n</fragment>\n<fragment>\n10. **^** Eriksson, Johan G; Guzzardi, Maria-Angela; Iozzo, Patricia; Kajantie, Eero; Kautiainen, Hannu; Salonen, Minna K (2017-01-01). \"Higher serum phenylalanine concentration is associated with more rapid telomere shortening in men\". *The American Journal of Clinical Nutrition*. **105** (1): 144\u2013150. doi:10.3945/ajcn.116.130468. ISSN\u00a00002-9165. PMID\u00a027881392.\n11. **^** Broadley KJ (March 2010). \"The vascular effects of trace amines and amphetamines\". *Pharmacology & Therapeutics*. **125** (3): 363\u2013375. doi:10.1016/j.pharmthera.2009.11.005. PMID\u00a019948186.\n12. **^** Lindemann L, Hoener MC (May 2005). \"A renaissance in trace amines inspired by a novel GPCR family\". *Trends in Pharmacological Sciences*. **26** (5): 274\u2013281. doi:10.1016/j.tips.2005.03.007. PMID\u00a015860375.\n13. **^** Wang X, Li J, Dong G, Yue J (February 2014). \"The endogenous substrates of brain CYP2D\". *European Journal of Pharmacology*. **724**: 211\u2013218. doi:10.1016/j.ejphar.2013.12.025. PMID\u00a024374199.\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n| * v\n* t\n* e\nDopamine receptor modulators\n |\n| --- |\n| D1-like | \n\n|  |  |\n| --- | --- |\n| Agonists | * *Benzazepines*: 6-Br-APB\n* Fenoldopam\n* SKF-38,393\n* SKF-77,434\n* SKF-81,297\n* SKF-82,958\n* SKF-83,959\n* Trepipam\n* Zelandopam\n\n\n* *Ergolines*: Cabergoline\n* CY-208,243\n* Dihydroergocryptine\n* LEK-8829\n* Lisuride\n* Pergolide\n* Terguride\n\n\n* *Dihydrexidine derivatives*: A-77636\n* A-86929\n* Adrogolide (ABT-431, DAS-431)\n* Dihydrexidine\n* Dinapsoline\n* Dinoxyline\n* Doxanthrine\n\n\n* *Phenethylamines*: BCO-001\n* Deoxyepinephrine (N-methyldopamine, epinine)\n* Dopexamine\n* Etilevodopa\n* Ibopamine\n* L-DOPA (levodopa)\n* Melevodopa\n* L-Phenylalanine\n* L-Tyrosine\n* XP21279\n\n\n</fragment>\n<fragment>\n6. **^** Ross HM, Roth J (1 April 1991). *The Mood Control Diet: 21 Days to Conquering Depression and Fatigue*. Simon & Schuster. p.\u00a059. ISBN\u00a0978-0-13-590449-7.\n7. **^** Zeratsky, Katherine. \"Phenylalanine in diet soda: Is it harmful?\". *Mayo Clinic*. Retrieved 30 April 2019.\n8. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0.\n9. **^** Elango, Rajavel; Ball, Ronald O.; Pencharz, Paul B. (August 2012). \"Recent advances in determining protein and amino acid requirements in humans\". *British Journal of Nutrition*. **108** (S2): S22\u2013S30. doi:10.1017/S0007114512002504. ISSN\u00a00007-1145. PMID\u00a023107531.\n\n</fragment>\n<fragment>\nPhenylalanine uses the same active transport channel as tryptophan to cross the blood\u2013brain barrier. In excessive quantities, supplementation can interfere with the production of serotonin and other aromatic amino acids[10] as well as nitric oxide due to the overuse (eventually, limited availability) of the associated cofactors, iron or tetrahydrobiopterin. [*citation needed*] The corresponding enzymes for those compounds are the aromatic amino acid hydroxylase family and nitric oxide synthase.\n\n|  |\n| --- |\n| Biosynthetic pathways for catecholamines and trace amines in the human brain[11][12][13]\n\n![Graphic of catecholamine and trace amine biosynthesis](image)\n\n**L-Phenylalanine**\n\nL-Tyrosine\n\nL-DOPA\n\nEpinephrine\n\nPhenethylamine\n\n*p*-Tyramine\n\nDopamine\n\nNorepinephrine\n\n*N*-Methylphenethylamine\n\n*N*-Methyltyramine\n\n*p*-Octopamine\n\nSynephrine\n\n3-Methoxytyramine\n\nAADC\n\nAADC\n\nAADC\n\nprimarypathway\n\nPNMT\n\nPNMT\n\nPNMT\n\nPNMT\n\nAAAH\n\nAAAH\n\nbrainCYP2D6\n\nminorpathway\n\nCOMT\n\nDBH\n\nDBH\n\n\n</fragment>\n<fragment>\nThe stereoisomer D-phenylalanine (DPA) can be produced by conventional organic synthesis, either as a single enantiomer or as a component of the racemic mixture. It does not participate in protein biosynthesis although it is found in proteins in small amounts - particularly aged proteins and food proteins that have been processed. The biological functions of D-amino acids remain unclear, although D-phenylalanine has pharmacological activity at niacin receptor 2.[16]\n\n\n</fragment>\n<fragment>\n25. **^** Glushakov AV, Dennis DM, Morey TE, Sumners C, Cucchiara RF, Seubert CN, Martynyuk AE (2002). \"Specific inhibition of *N*-methyl-D-aspartate receptor function in rat hippocampal neurons by L-phenylalanine at concentrations observed during phenylketonuria\". *Molecular Psychiatry*. **7** (4): 359\u2013367. doi:10.1038/sj.mp.4000976. PMID\u00a011986979.\n26. ^ ***a*** ***b*** Glushakov AV, Dennis DM, Sumners C, Seubert CN, Martynyuk AE (April 2003). \"L-Phenylalanine selectively depresses currents at glutamatergic excitatory synapses\". *Journal of Neuroscience Research*. **72** (1): 116\u2013124. doi:10.1002/jnr.10569. PMID\u00a012645085. S2CID\u00a042087834.\n27. **^** Glushakov AV, Glushakova O, Varshney M, Bajpai LK, Sumners C, Laipis PJ, Embury JE, Baker SP, Otero DH, Dennis DM, Seubert CN, Martynyuk AE (February 2005). \"Long-term changes in glutamatergic synaptic transmission in phenylketonuria\". *Brain*. **128** (Pt 2): 300\u2013307. doi:10.1093/brain/awh354. PMID\u00a015634735.\n\n</fragment>\n<fragment>\n![The image above contains clickable links](image)\nPhenylalanine in humans may ultimately be metabolized into a range of different substances.\n |\n\n  \n\n\n\n\n### In plants\n\n[edit]\n\nPhenylalanine is the starting compound used in the synthesis of flavonoids. Lignan is derived from phenylalanine and from tyrosine. Phenylalanine is converted to cinnamic acid by the enzyme phenylalanine ammonia-lyase.[14]\n\n\n\n## Biosynthesis\n\n[edit]\n\nPhenylalanine is biosynthesized via the shikimate pathway.\n\n\n\n## Phenylketonuria\n\n[edit]\n\nMain article: Phenylketonuria\n\n\n</fragment>\n<fragment>\nL-Phenylalanine is produced for medical, feed, and nutritional applications, such as aspartame, in large quantities by utilizing the bacterium *Escherichia coli*, which naturally produces aromatic amino acids like phenylalanine. The quantity of L-phenylalanine produced commercially has been increased by genetically engineering *E. coli*, such as by altering the regulatory promoters or amplifying the number of genes controlling enzymes responsible for the synthesis of the amino acid.[29]\n\n\n\n## Derivatives\n\n[edit]\n\n**Boronophenylalanine** (BPA) is a dihydroxyboryl derivative of phenylalanine, used in neutron capture therapy.\n\n\n**4-Azido-L-phenylalanine** is a protein-incorporated unnatural amino acid used as a tool for bioconjugation in the field of chemical biology.\n\n\n\n## References\n\n[edit]\n\n\n</fragment>\n<fragment>\n\nA non-food source of phenylalanine is the artificial sweetener aspartame. This compound is metabolized by the body into several chemical byproducts including phenylalanine. The breakdown problems phenylketonurics have with the buildup of phenylalanine in the body also occurs with the ingestion of aspartame, although to a lesser degree. Accordingly, all products in Australia, the U.S. and Canada that contain aspartame must be labeled: \"Phenylketonurics: Contains phenylalanine.\" In the UK, foods containing aspartame must carry ingredient panels that refer to the presence of \"aspartame or E951\"[15] and they must be labeled with a warning \"Contains a source of phenylalanine.\" In Brazil, the label \"Cont\u00e9m Fenilalanina\" (Portuguese for \"Contains Phenylalanine\") is also mandatory in products which contain it. These warnings are placed to help individuals avoid such foods.\n\n\n\n## D-, L- and DL-phenylalanine\n\n[edit]\n\n\n</fragment>\n<fragment>\n\nPhenylalanine is found naturally in the milk of mammals. It is used in the manufacture of food and drink products and sold as a nutritional supplement for its analgesic and antidepressant effects. It is a direct precursor to the neuromodulator phenethylamine, a commonly used dietary supplement. As an essential amino acid, phenylalanine is not synthesized de novo in humans and other animals, who must ingest phenylalanine or phenylalanine-containing proteins.\n\n\n\n\n## History\n\n[edit]\n\nThe first description of phenylalanine was made in 1879, when Schulze and Barbieri identified a compound with the empirical formula, C9H11NO2, in yellow lupine (*Lupinus luteus*) seedlings. In 1882, Erlenmeyer and Lipp first synthesized phenylalanine from phenylacetaldehyde, hydrogen cyanide, and ammonia.[4][5]\n\n\n</fragment>\n<fragment>\n19. **^** Beckmann, Helmut; Athen, Dieter; Olteanu, Margit; Zimmer, Reinhild (1979). \"DL-Phenylalanine versus imipramine: A double-blind controlled study\". *Archiv f\u00fcr Psychiatrie und Nervenkrankheiten*. **227** (1). Springer Science and Business Media LLC: 49\u201358. doi:10.1007/bf00585677. ISSN\u00a00003-9373. PMID\u00a0387000. S2CID\u00a023531579.\n20. **^** \"D-Phenylalanine: Clinical data\". *The IUPHAR/BPS Guide to PHARMACOLOGY*. Retrieved 27 December 2018.\n21. **^** Christianson DW, Mangani S, Shoham G, Lipscomb WN (August 1989). \"Binding of D-phenylalanine and D-tyrosine to carboxypeptidase A\" (PDF). *The Journal of Biological Chemistry*. **264** (22): 12849\u201312853. doi:10.1016/S0021-9258(18)51564-7. PMID\u00a02568989.\n22. **^** Jelen, Luke A.; Stone, James M.; Young, Allan H.; Mehta, Mitul A. (2022). \"The opioid system in depression\". *Neuroscience & Biobehavioral Reviews*. **140**. Elsevier BV: 104800. doi:10.1016/j.neubiorev.2022.104800. ISSN\u00a00149-7634. PMC\u00a010166717. PMID\u00a035914624. S2CID\u00a0251163234.\n\n</fragment>\n<fragment>\n\nIn the brain, L-phenylalanine is a competitive antagonist at the glycine binding site of NMDA receptor[25] and at the glutamate binding site of AMPA receptor.[26] At the glycine binding site of NMDA receptor L-phenylalanine has an apparent equilibrium dissociation constant (KB) of 573 \u03bcM estimated by Schild regression[27] which is considerably lower than brain L-phenylalanine concentration observed in untreated human phenylketonuria.[28]\nL-Phenylalanine also inhibits neurotransmitter release at glutamatergic synapses in hippocampus and cortex with IC50 of 980 \u03bcM, a brain concentration seen in classical phenylketonuria, whereas D-phenylalanine has a significantly smaller effect.[26]\n\n\n\n## Commercial synthesis\n\n[edit]\n\n\n</fragment>\n<fragment>\n\nA (rare) \"variant form\" of phenylketonuria called hyperphenylalaninemia is caused by the inability to synthesize a cofactor called tetrahydrobiopterin, which can be supplemented. Pregnant women with hyperphenylalaninemia may show similar symptoms of the disorder (high levels of phenylalanine in blood), but these indicators will usually disappear at the end of gestation. Pregnant women with PKU must control their blood phenylalanine levels even if the fetus is heterozygous for the defective gene because the fetus could be adversely affected due to hepatic immaturity.[*medical citation needed*]\n\n\n</fragment>\n<fragment>\n| InChI\n\n* InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12)/t8-/m0/s1![check](image)Y\nKey:\u00a0COLNVLDHVKWLRT-QMMMGPOBSA-N![check](image)Y\n* L: Key:\u00a0COLNVLDHVKWLRT-QMMMGPOBBC\n* D/L: Key:\u00a0COLNVLDHVKWLRT-UHFFFAOYSA-N\n* D: Key:\u00a0COLNVLDHVKWLRT-MRVPVSSYSA-N\n |\n| SMILES\n\n* L: c1ccc(cc1)C[C@@H](C(=O)O)N\n* L Zwitterion: [NH3+][C@@H](CC1=CC=CC=C1)C([O-])=O\n |\n| Properties\n |\n| Chemical formula\n | C9H11NO2 |\n| Molar mass | 165.192\u00a0g\u00b7mol\u22121 |\n| Acidity (p*K*a)\n | 1.83 (carboxyl), 9.13 (amino)[2] |\n| Hazards\n |\n| **NFPA 704** (fire\u00a0diamond)\n | ![NFPA 704 four-colored diamond](image)\n2\n1\n0\n |\n| Supplementary data page\n |\n| Phenylalanine (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n\n</fragment>\n<fragment>\n14. **^** Nelson DL, Cox MM (2000). *Lehninger, Principles of Biochemistry* (3rd\u00a0ed.). New York: Worth Publishing. ISBN\u00a01-57259-153-6.\n15. **^** \"Aspartame\". UK: Food Standards Agency. Archived from the original on 2012-02-21. Retrieved 2007-06-19.\n16. **^** \"D-Phenylalanine: Biological activity\". *The IUPHAR/BPS Guide to PHARMACOLOGY*. Retrieved 27 December 2018.\n17. ^ ***a*** ***b*** Wood, David R.; Reimherr, Fred W.; Wender, Paul H. (1985). \"Treatment of attention deficit disorder with DL-phenylalanine\". *Psychiatry Research*. **16** (1). Elsevier BV: 21\u201326. doi:10.1016/0165-1781(85)90024-1. ISSN\u00a00165-1781. PMID\u00a03903813. S2CID\u00a03077060.\n18. **^** Beckmann, H.; Strauss, M. A.; Ludolph, E. (1977). \"DL-Phenylalanine in depressed patients: An open study\". *Journal of Neural Transmission*. **41** (2\u20133). Springer Science and Business Media LLC: 123\u2013134. doi:10.1007/bf01670277. ISSN\u00a00300-9564. PMID\u00a0335027. S2CID\u00a05849451.\n\n</fragment>\n<fragment>\n |\n| Others | * *Enkephalinase inhibitors:* Amastatin\n* BL-2401\n* Candoxatril\n* D -Phenylalanine\n* Dexecadotril (retorphan)\n* Ecadotril (sinorphan)\n* Kelatorphan\n* Racecadotril (acetorphan)\n* RB-101\n* RB-120\n* RB-3007\n* Opiorphan\n* Selank\n* Semax\n* Spinorphin\n* Thiorphan\n* Tynorphin\n* Ubenimex (bestatin)\n\n\n* *Propeptides:* \u03b2-Lipotropin (proendorphin)\n* Prodynorphin\n* Proenkephalin\n* Pronociceptin\n* Proopiomelanocortin (POMC)\n\n\n* *Others:* Kyotorphin (met-enkephalin releaser/degradation stabilizer)\n |\n\n| * v\n* t\n* e\nPhenethylamines\n |\n| --- |\n| Phenethylamines | * *Psychedelics:* 25B-NBOMe\n* 25C-NBOMe\n* 25D-NBOMe\n* 25I-NBOMe\n* 25N-NBOMe\n\n\n</fragment>\n<fragment>\nThe genetic disorder phenylketonuria (PKU) is the inability to metabolize phenylalanine because of a lack of the enzyme phenylalanine hydroxylase. Individuals with this disorder are known as \"phenylketonurics\" and must regulate their intake of phenylalanine. Phenylketonurics often use blood tests to monitor the amount of phenylalanine in their blood. Lab results may report phenylalanine levels using either mg/dL and \u03bcmol/L. One mg/dL of phenylalanine is approximately equivalent to 60 \u03bcmol/L.\n\n\n</fragment>\n<fragment>\n\n* 2C-B\n* 2C-B-AN\n* 2C-Bn\n* 2C-Bu\n* 2C-C\n* 2C-CN\n* 2C-CP\n* 2C-D\n* 2C-E\n* 2C-EF\n* 2C-F\n* 2C-G\n* 2C-G-1\n* 2C-G-2\n* 2C-G-3\n* 2C-G-4\n* 2C-G-5\n* 2C-G-6\n* 2C-G-N\n* 2C-H\n* 2C-I\n* 2C-iP\n* 2C-N\n* 2C-NH2\n* 2C-O\n* 2C-O-4\n* 2C-P\n* 2C-Ph\n* 2C-SE\n* 2C-T\n* 2C-T-2\n* 2C-T-3\n* 2C-T-4\n* 2C-T-5\n* 2C-T-6\n* 2C-T-7\n* 2C-T-8\n* 2C-T-9\n* 2C-T-10\n* 2C-T-11\n* 2C-T-12\n* 2C-T-13\n* 2C-T-14\n* 2C-T-15\n* 2C-T-16\n* 2C-T-17\n* 2C-T-18\n* 2C-T-19\n* 2C-T-20\n* 2C-T-21\n* 2C-T-22\n* 2C-T-22.5\n* 2C-T-23\n* 2C-T-24\n* 2C-T-25\n* 2C-T-27\n* 2C-T-28\n* 2C-T-30\n* 2C-T-31\n* 2C-T-32\n* 2C-T-33\n* 2C-TFE\n* 2C-TFM\n* 2C-YN\n* 2C-V\n\n\n* Allylescaline\n* DESOXY\n* Escaline\n* Isoproscaline\n* Jimscaline\n* Macromerine\n* MEPEA\n* Mescaline\n* Metaescaline\n* Methallylescaline\n* Proscaline\n* Psi-2C-T-4\n* TCB-2\n\n\n*Stimulants:* Phenylethanolamine\n\n* Hordenine\n* Phenethylamine\n* Phenpromethamine\n* \u03b1-Methylphenethylamine (amphetamine)\n* \u03b2-Methylphenethylamine\n* *m*-Methylphenethylamine\n* *N*-Methylphenethylamine\n* *o*-Methylphenethylamine\n* *p*-Methylphenethylamine\n* Methylphenidate\n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| Agonists | * (Arg14,Lys15)Nociceptin\n* ((pF)Phe4)Nociceptin(1-13)NH2\n* (Phe1\u03a8(CH2-NH)Gly2)Nociceptin(1-13)NH2\n* Ac-RYYRWK-NH2\n* Ac-RYYRIK-NH2\n* BU08070\n* Buprenorphine\n* Cebranopadol\n* Dihydroetorphine\n* Etorphine\n* JNJ-19385899\n* Levomethorphan\n* Levorphanol\n* Lexanopadol\n* MCOPPB\n* MT-7716\n* NNC 63-0532\n* Nociceptin (orphanin FQ)\n* Nociceptin (1-11)\n* Nociceptin (1-13)NH2\n* Norbuprenorphine\n* Racemethorphan\n* Racemorphan\n* Ro64-6198\n* Ro65-6570\n* SCH-221510\n* SCH-486757\n* SR-8993\n* SR-16435\n* Sunobinop (S-117957)\n* TH-030418\n |\n| Antagonists | * (Nphe1)Nociceptin(1-13)NH2\n* AT-076\n* BAN-ORL-24\n* BTRX-246040 (LY-2940094)\n* J-113,397\n* JTC-801\n* NalBzOH\n* Nociceptin (1-7)\n* Nocistatin\n* SB-612,111\n* SR-16430\n* Thienorphine\n* Trap-101\n* UFP-101\n |\n\n\n</fragment>\n<fragment>\n\n* *Others*: A-68930\n* Apomorphine\n* Isocorypalmine\n* Nuciferine\n* PF-6649751\n* PF 6669571\n* Propylnorapomorphine\n* Rotigotine\n* SKF-89,145\n* SKF-89,626\n* Stepholidine\n* Tavapadon\n* Tetrahydropalmatine\n |\n| PAMs[*clarification needed*] | * *Tetrahydroisoquinolines*: DETQ\n* DPTQ\n* Mevidalen\n |\n| Antagonists | * *Typical antipsychotics*: Butaclamol\n* Chlorpromazine\n* Chlorprothixene\n* Flupentixol (flupenthixol) (+melitracen)\n* Fluphenazine\n* Loxapine\n* Perphenazine (+amitriptyline)\n* Pifluthixol\n* Thioridazine\n* Thiothixene\n* Trifluoperazine (+tranylcypromine)\n* Zuclopenthixol\n\n\n* *Atypical antipsychotics*: Asenapine\n* Clorotepine\n* Clotiapine\n* Clozapine\n* DHA-clozapine\n* Fluperlapine\n* Iloperidone\n* Norclozapine\n* Norquetiapine\n* Olanzapine (+fluoxetine)\n* Paliperidone\n* Quetiapine\n* Risperidone\n* Tefludazine\n* Zicronapine\n* Ziprasidone\n* Zotepine\n\n\n* *Others*: Berupipam\n* Ecopipam\n* EEDQ\n* Metitepine (methiothepin)\n* Odapipam\n* Perlapine\n* SCH-23390\n |\n\n |\n| D2-like | \n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| Agonists | * *Adamantanes*: Amantadine\n* Memantine\n* Rimantadine\n\n\n* *Aminotetralins*: 5-OH-DPAT\n* 7-OH-DPAT\n* 8-OH-PBZI\n* Rotigotine\n* UH-232\n\n\n* *Ergolines*: Bromocriptine\n* Cabergoline\n* Chanoclavine\n* Dihydroergocryptine\n* Epicriptine\n* Ergocornine\n* Lergotrile\n* Lisuride\n* LSD\n* Pergolide\n* Terguride\n\n\n* *Dihydrexidine derivatives*: 2-OH-NPA\n* Ciladopa\n* Dihydrexidine\n* Dinoxyline\n* N,N-Propyldihydrexidine\n\n\n* *Phenethylamines*: Deoxyepinephrine (N-methyldopamine, epinine)\n* Dopexamine\n* Etilevodopa\n* Ibopamine\n* L-DOPA (levodopa)\n* L-Phenylalanine\n* L-Tyrosine\n* Melevodopa\n* XP21279\n\n\n* *Atypical antipsychotics*: Alentemol (U-66444B)\n* Aripiprazole (+sertraline)\n* Aripiprazole lauroxil\n* Bifeprunox\n* Brexpiprazole\n* Brilaroxazine\n* Cariprazine\n* F-15063\n* Lumateperone\n* Norclozapine\n\n\n</fragment>\n<fragment>\nD-Phenylalanine is absorbed from the small intestine and transported to the liver via the portal circulation. A small amount of D-phenylalanine appears to be converted to L-phenylalanine. D-Phenylalanine is distributed to the various tissues of the body via the systemic circulation. It appears to cross the blood\u2013brain barrier less efficiently than L-phenylalanine, and so a small amount of an ingested dose of D-phenylalanine is excreted in the urine without penetrating the central nervous system.[23]\n\n\nL-Phenylalanine is an antagonist at \u03b12\u03b4 Ca2+ calcium channels with a Ki of 980 nM.[24]\n\n\n</fragment>\n<fragment>\n* Proglumide\n* Racemethorphan\n* Racemorphan\n* RWJ-394674\n* Samidorphan\n* SB-235863\n* SNC-80\n* SNC-162\n* TAN-67 (SB-205,607)\n* TH-030418\n* Thebaine\n* Thiobromadol (C-8813)\n* Tonazocine\n* Tramadol\n* TRV250\n* Xorphanol\n* Zenazocine\n |\n| Antagonists | * 4',7-Dihydroxyflavone\n* 5'-NTII\n* 6\u03b2-Naltrexol\n* 6\u03b2-Naltrexol-d4\n* \u03b1-Santolol\n* \u03b2-Chlornaltrexamine\n* Apigenin\n* AT-076\n* Axelopran\n* Bevenopran\n* BNTX\n* Catechin\n* Catechin gallate\n* Clocinnamox\n* Diacetylnalorphine\n* Diprenorphine\n* ECG\n* EGC\n* Eluxadoline\n* Epicatechin\n* ICI-154129\n* ICI-174864\n* LY-255582\n* LY-2196044\n* Methylnaltrexone\n* Methylnaltrindole\n* N-Benzylnaltrindole\n* Nalmefene\n* Nalorphine\n* Naltrexone\n* Naltriben\n* Naltrindole\n* Naloxone\n* Naringenin\n* Noribogaine\n* Pawhuskin A\n* Quadazocine\n* SDM25N\n* SoRI-9409\n* Taxifolin\n* Thienorphine\n |\n\n |\n| \u03ba-opioid(KOR) | \n\n\n</fragment>\n<fragment>\n* Cathinone\n* Dimethylcathinone\n* Ethcathinone\n* Eutylone\n* Hydroxybupropion\n* Methcathinone\n* Methedrone\n* NEB\n* N-Ethylhexedrone\n* N-Ethylpentedrone\n* Pentedrone\n* Pentylone\n* Radafaxine*Entactogens:* 3,4-DMMC\n* 3-MMC\n* Butylone\n* Ethylone\n* Methylone\n* Methylenedioxycathinone\n* Mephedrone\n |\n| Phenylisobutylamines | * *Entactogens:* 4-CAB\n* 4-MAB\n* Ariadne\n* BDB\n* Butylone\n* EBDB\n* Eutylone\n* MBDB*Stimulants:* Phenylisobutylamine\n |\n| Phenylalkylpyrrolidines | * *Stimulants:* \u03b1-PBP\n* \u03b1-PHP\n* \u03b1-PPP\n* \u03b1-PVP\n* MDPBP\n* MDPPP\n* MDPV\n* 4-MePBP\n* 4-MePHP\n* 4-MePPP\n* MOPPP\n* MOPVP\n* MPBP\n* MPHP\n* MPPP\n* Naphyrone\n* PEP\n* Prolintane\n* Pyrovalerone\n |\n| Catecholamines(and close relatives) | * 6-FNE\n* 6-OHDA\n* a-Me-DA\n* a-Me-TRA\n* Adrenochrome\n* Ciladopa\n* D-DOPA (Dextrodopa)\n* Dimetofrine\n* Dopamine\n* Epinephrine\n* Epinine\n* Etilefrine\n* Ethylnorepinephrine\n* Fenclonine\n* Ibopamine\n* Isoprenaline\n* Isoetarine\n* L-DOPA (Levodopa)\n* L-DOPS (Droxidopa)\n* L-Phenylalanine\n* L-Tyrosine\n* *m*-Tyramine\n* Metanephrine\n\n</fragment>\n<fragment>\n* Metaraminol\n* Metaterol\n* Metirosine\n* Methyldopa\n* N,N-Dimethyldopamine\n* Nordefrin (Levonordefrin)\n* Norepinephrine\n* Norfenefrine (*m*-Octopamine)\n* Normetanephrine\n* Orciprenaline\n* *p*-Octopamine\n* *p*-Tyramine\n* Phenylephrine\n* Synephrine\n |\n| Miscellaneous | * AL-LAD\n* Amidephrine\n* Arbutamine\n* Cafedrine\n* Denopamine\n* Desvenlafaxine\n* Diphenidine\n* Dizocilpine\n* Dobutamine\n* Dopexamine\n* Ephenidine\n* Etafedrine\n* ETH-LAD\n* Famprofazone\n* Fluorolintane\n* Hexapradol\n* IP-LAD\n* Lysergic acid amide\n* Lysergic acid 2-butyl amide\n* Lysergic acid 2,4-dimethylazetidide\n* Lysergic acid diethylamide\n* Methoxamine\n* Methoxphenidine\n* MT-45\n* PARGY-LAD\n* Phenibut\n* PRO-LAD\n* Pronethalol\n* Salbutamol (Levosalbutamol)\n* Solriamfetol\n* Theodrenaline\n* Thiamphenicol\n* UWA-101\n* Venlafaxine\n |\n\n\n</fragment>\n<fragment>\n* AT-076\n* Aticaprant\n* Axelopran\n* AZ-MTAB\n* Binaltorphimine\n* BU09059\n* Buprenorphine\n* Catechin\n* Catechin gallate\n* CERC-501 (LY-2456302)\n* Clocinnamox\n* CVL-354\n* Cyclofoxy\n* Dezocine\n* DIPPA\n* EGC\n* ECG\n* Epicatechin\n* Hyperoside\n* JDTic\n* LY-255582\n* LY-2196044\n* LY-2444296\n* LY-2459989\n* LY-2795050\n* MeJDTic\n* Methylnaltrexone\n* ML190\n* ML350\n* MR-2266\n* N-Fluoropropyl-JDTic\n* Naloxone\n* Naltrexone\n* Naltrindole\n* Naringenin\n* Navacaprant\n* Norbinaltorphimine\n* Noribogaine\n* Pawhuskin A\n* PF-4455242\n* RB-64\n* Quadazocine\n* Taxifolin\n* UPHIT\n* Zyklophin\n |\n\n |\n| Nociceptin(NOP) | \n\n\n</fragment>\n<fragment>\n* Salsolinol\n* SC-17599\n* Sinomenine\n* Sufentanil\n* Tapentadol\n* Tetrahydropapaveroline\n* TH-030418\n* Thebaine\n* Thienorphine\n* Tianeptine\n* Tilidine\n* Tramadol\n* Trimebutine\n* TRIMU 5\n* TRV734\n* Tubotaiwine\n* U-47700\n* Valorphin\n* Viminol\n* Xorphanol\n |\n| Antagonists | * (3S,4S)-Picenadol\n* 2-(S)-N,N-(R)-Viminol\n* 3CS-nalmefene\n* 4-Caffeoyl-1,5-quinide\n* 4\u2032-Hydroxyflavanone\n* 4',7-Dihydroxyflavone\n* 6\u03b2-Naltrexol\n* 6\u03b2-Naltrexol-d4\n* 18-MC\n* \u03b1-Gliadin\n* \u03b2-Chlornaltrexamine\n* \u03b2-Funaltrexamine\n* Akuammine\n* Alvimopan\n* AM-251\n* Apigenin\n* AT-076\n* Axelopran\n* Bevenopran\n* Catechin\n* Catechin gallate\n* Clocinnamox\n* CTAP\n* CTOP\n* Cyclofoxy\n* Cyprodime\n* Diacetylnalorphine\n* Diprenorphine\n* ECG\n* EGC\n* Epicatechin\n* Eptazocine\n* Gemazocine\n* Ginsenoside R\n* Hyperoside\n* Ibogaine\n* JDTic\n* Levallorphan\n* Lobeline\n* LY-255582\n* LY-2196044\n* Methocinnamox\n* Methylnaltrexone\n* Methylsamidorphan chloride\n* Naldemedine\n* Nalmefene\n* Nalodeine (N-allylnorcodeine)\n* Nalorphine\n* Nalorphine dinicotinate\n* Naloxazone\n\n</fragment>\n<fragment>\nDL-Phenylalanine (DLPA) is marketed as a nutritional supplement for its purported analgesic and antidepressant activities, which have been supported by clinical trials.[17][18][19] DL-Phenylalanine is a mixture of D-phenylalanine and L-phenylalanine. The reputed analgesic activity of DL-phenylalanine may be explained by the possible blockage by D-phenylalanine of enkephalin degradation by the enzyme carboxypeptidase A.[20][21] Enkephalins act as agonists of the mu and delta opioid receptors, and agonists of these receptors are known to produce antidepressant effects.[22] The mechanism of DL-phenylalanine's supposed antidepressant activity may also be accounted for in part by the precursor role of L-phenylalanine in the synthesis of the neurotransmitters norepinephrine and dopamine, though clinical trials have not found an antidepressant effect from L-phenylalanine alone.[17] Elevated brain levels of norepinephrine and dopamine are thought to have an antidepressant effect. \n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| Agonists(abridged; full list) | * 3-HO-PCP\n* 7-Acetoxymitragynine\n* 7-Hydroxymitragynine\n* \u03c8-Akuammigine\n* \u03b1-Chlornaltrexamine\n* \u03b1-Narcotine\n* Acetyldihydrocodeine\n* Acetylfentanyl\n* Acrylfentanyl\n* Adrenorphin (metorphamide)\n* AH-7921\n* Akuammicine\n* Akuammidine\n* Alfentanil\n* Anileridine\n* Apparicine\n* \u03b2-Endorphin\n* BAM-12P\n* BAM-18P\n* BAM-22P\n* Benzhydrocodone\n* Benzylmorphine\n* Bezitramide\n* Biphalin\n* BU08070\n* Buprenorphine\n* Butorphan\n* Butorphanol\n* Butyrfentanyl\n* BW373U86\n* Carfentanil\n* Casokefamide\n* Cebranopadol\n* Chloroxymorphamine\n* Codeine\n* DADLE\n* DAMGO (DAGO)\n* Dermorphin\n* Desmetramadol (desmethyltramadol)\n* Desomorphine\n* Dextromoramide\n* Dextropropoxyphene (propoxyphene)\n* Dezocine\n* Dimenoxadol\n* Dimethylaminopivalophenone\n* Eluxadoline\n* Diamorphine (heroin)\n* Dihydrocodeine\n* Dihydroetorphine\n* Dihydromorphine\n* Dinalbuphine sebacate\n* Diphenoxylate\n* Dipipanone\n* Dynorphin A\n* Embutramide\n* Endomorphin-1\n* Endomorphin-2\n* Eseroline\n* Ethylmorphine\n* Etorphine\n\n</fragment>\n<fragment>\n* Naloxegol\n* Naloxol\n* Naloxonazine\n* Naloxone\n* Naltrexazone\n* Naltrexonazine\n* Naltrexone\n* Naltrindole\n* Naringenin\n* Noribogaine\n* Oxilorphan\n* Pawhuskin A\n* Rimonabant\n* Quadazocine\n* Samidorphan\n* Taxifolin\n |\n\n |\n| \u03b4-opioid(DOR) | \n\n\n</fragment>\n<fragment>\n\n* *Atypical antipsychotics*: Amisulpride\n* Asenapine\n* BL-1020\n* Blonanserin\n* Carpipramine\n* Cinuperone\n* Clocapramine\n* Clorotepine\n* Clotiapine (clothiapine)\n* Clozapine\n* Cyamemazine\n* DHA-clozapine\n* Dixyrazine\n* Elopiprazole\n* Flumezapine\n* Fluperlapine\n* Gevotroline\n* Iloperidone\n* Lurasidone\n* Mazapertine\n* Melperone\n* Molindone\n* Mosapramine\n* Ocaperidone\n* Olanzapine (+fluoxetine)\n* Paliperidone\n* Perospirone\n* Piperacetazine\n* Pipotiazine\n* Piquindone\n* Quetiapine\n* Remoxipride\n* Risperidone\n* Sertindole\n* Tefludazine\n* Tenilapine\n* Tiospirone\n* Veralipride\n* Zicronapine\n* Ziprasidone\n* Zotepine\n\n\n* *Antiemetics/gastroprokinetics/sedatives*: Aceprometazine\n* AS-8112\n* Alimemazine\n* Alizapride\n* Benzquinamide\n* Bromopride\n* Clebopride\n* Deudomperidone\n* Domperidone\n* Eticlopride\n* Hydroxyzine\n* Itopride\n* Metoclopramide\n* Metopimazine\n* Promethazine\n* Thiethylperazine\n* Trazpiroben\n* Trimethobenzamide\n\n\n* *Antidepressants*: Amoxapine\n* Nefazodone\n* Opipramol\n* Propiomazine\n* Trimipramine\n\n\n</fragment>\n</document>",
          "name": "search",
          "tool_call_id": "4b6223fb-5b1e-4ef9-9203-d8dabbdbb7c8",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Threonine</title>\n<content>\nAmino acid\n\nNot to be confused with Theanine.\n\n\n\n\nThreonine\n| ![Skeletal formula](image)Skeletal formula of L-threonine\n |\n| \n\n|  |  |\n| --- | --- |\n| ![Ball-and-stick model](image)Ball-and-stick modelBall-and-stick model\n | ![Space-filling model](image)Space-filling modelSpace-filling model\n |\n\n |\n| Names\n |\n| IUPAC name\nThreonine\n |\n| Other names\n2-Amino-3-hydroxybutanoic acid\n |\n| Identifiers\n |\n| CAS Number\n | * L: 72-19-5![check](image)Y\n* D/L: 80-68-2![check](image)Y\n |\n| 3D model (JSmol)\n | * L: Interactive image\n* L Zwitterion: Interactive image\n |\n| ChEBI | * L: CHEBI:16857![check](image)Y\n |\n| ChEMBL | * L: ChEMBL291747![check](image)Y\n |\n| ChemSpider | * L: 6051![check](image)Y\n |\n| DrugBank | * L: DB00156![check](image)Y\n |\n| ECHA InfoCard | 100.000.704 ![Edit this at Wikidata](image) |\n| EC Number | * L: 200-774-1\n |\n| IUPHAR/BPS\n | * L: 4785\n |\n| KEGG | * L: D00041\n |\n| PubChem CID\n | * L: 6288\n |\n| UNII | * L: 2ZD004190S![check](image)Y\n* D/L: TFM6DU5S6A![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * L: DTXSID70893087 DTXSID2046412, DTXSID70893087 ![Edit this at Wikidata](image)\n |\n| InChI\n\n* InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1![check](image)Y\nKey:\u00a0AYFVYJQAPQTCCC-GBXIJSLDSA-N![check](image)Y\n* D/L: Key:\u00a0AYFVYJQAPQTCCC-FGNFWGHYNA-N\n |\n| SMILES\n\n* L: C[C@H]([C@@H](C(=O)O)N)O\n* L Zwitterion: C[C@H]([C@@H](C(=O)[O-])[NH3+])O\n |\n| Properties\n |\n| Chemical formula\n | C4H9NO3 |\n| Molar mass | 119.120\u00a0g\u00b7mol\u22121 |\n| Solubility in water\n | (H2O, g/dl) 10.6(30\u00b0),14.1(52\u00b0),19.0(61\u00b0)\n |\n| Acidity (p*K*a)\n | 2.63 (carboxyl), 10.43 (amino)[1] |\n| Supplementary data page\n |\n| Threonine (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n**Threonine** (symbol **Thr** or **T**)[2] is an amino acid that is used in the biosynthesis of proteins. It contains an \u03b1-amino group (which is in the protonated \u2212NH+  \n3 form under biological conditions), a carboxyl group (which is in the deprotonated \u2212COO\u2212 form under biological conditions), and a side chain containing a hydroxyl group, making it a polar, uncharged amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Threonine is synthesized from aspartate in bacteria such as *E. coli*.[3] It is encoded by all the codons starting AC (ACU, ACC, ACA, and ACG).\n\n\nThreonine sidechains are often hydrogen bonded; the most common small motifs formed are based on interactions with serine: ST turns, ST motifs (often at the beginning of alpha helices) and ST staples (usually at the middle of alpha helices).\n\n\n\n\n## Modifications\n\n[edit]\n\nThe threonine residue is susceptible to numerous posttranslational modifications. The hydroxyl side-chain can undergo *O*-linked glycosylation. In addition, threonine residues undergo phosphorylation through the action of a threonine kinase. In its phosphorylated form, it can be referred to as phosphothreonine. Phosphothreonine has three potential coordination sites (carboxyl, amine and phosphate group) and determination of the mode of coordination between phosphorylated ligands and metal ions occurring in an organism is important to explain the function of the phosphothreonine in biological processes.[4]\n\n\n\n## History\n\n[edit]\n\nThreonine was the last of the 20 common proteinogenic amino acids to be discovered. It was discovered in 1936 by William Cumming Rose,[5] collaborating with Curtis Meyer. The amino acid was named threonine because it was similar in structure to threonic acid, a four-carbon monosaccharide with molecular formula C4H8O5[6]\n\n\n\n## Stereoisomers\n\n[edit]\n\n\n\n|  |\n| --- |\n| ![](image)\u00a0![](image) |\n| L-Threonine (2*S*,3*R*) and D-Threonine (2*R*,3*S*) |\n| ![](image)\u00a0![](image) |\n| L-Allothreonine (2*S*,3*S*) and D-Allothreonine (2*R*,3*R*)\n |\n\n\nThreonine is one of two proteinogenic amino acids with two stereogenic centers, the other being isoleucine. Threonine can exist in four possible stereoisomers with the following configurations: (2*S*,3*R*), (2*R*,3*S*), (2*S*,3*S*) and (2*R*,3*R*). However, the name L-threonine is used for one single stereoisomer, (2*S*,3*R*)-2-amino-3-hydroxybutanoic acid. The stereoisomer (2*S*,3*S*), which is rarely present in nature, is called L-allothreonine.[7]\n\n\n\n## Biosynthesis\n\n[edit]\n\nAs an essential amino acid, threonine is not synthesized in humans, and needs to be present in proteins in the diet. Adult humans require about 20\u00a0mg/kg body weight/day.[8] In plants and microorganisms, threonine is synthesized from aspartic acid via \u03b1-aspartyl-semialdehyde and homoserine. Homoserine undergoes *O*-phosphorylation; this phosphate ester undergoes hydrolysis concomitant with relocation of the OH group.[9] Enzymes involved in a typical biosynthesis of threonine include:\n\n\n\n1. aspartokinase\n2. \u03b2-aspartate semialdehyde dehydrogenase\n3. homoserine dehydrogenase\n4. homoserine kinase\n5. threonine synthase.\n\n\n![](image)Threonine biosynthesis\n## Metabolism\n\n[edit]\n\nThreonine is metabolized in at least three ways:\n\n\n\n* In many animals it is converted to pyruvate via threonine dehydrogenase. An intermediate in this pathway can undergo thiolysis with CoA to produce acetyl-CoA and glycine.\n* In humans the gene for threonine dehydrogenase is an inactive pseudogene,[10] so threonine is converted to \u03b1-ketobutyrate. The mechanism of the first step is analogous to that catalyzed by serine dehydratase, and the serine and threonine dehydratase reactions are probably catalyzed by the same enzyme.[11]\n* In many organisms it is O-phosphorylated by a kinase preparatory to further metabolism. This is especially important in bacteria as part of the biosynthesis of cobalamin (Vitamin B12), as the product is converted to (R)-1-aminopropan-2-ol for incorporation into the vitamin's sidechain.[12]\n* Threonine is used to synthesize glycine during the endogenous production of L-carnitine in the brain and liver of rats.[13][14]\n\n\n## Metabolic diseases\n\n[edit]\n\n\n\n|  |  |\n| --- | --- |\n| ![](image)\n | This section **does not cite any sources**. Please help improve this section by adding citations to reliable sources. Unsourced material may be challenged and removed. *(November 2023)* *(Learn how and when to remove this message)*\n |\n\n\nThe degradation of threonine is impaired in the following metabolic diseases:\n\n\n\n* Combined malonic and methylmalonic aciduria (CMAMMA)\n* Methylmalonic acidemia\n* Propionic acidemia\n\n\n## Sources\n\n[edit]\n\nFoods high in threonine include cottage cheese, poultry, fish, meat, lentils, black turtle bean[15] and sesame seeds.[16]\n\n\nRacemic threonine can be prepared from crotonic acid by alpha-functionalization using mercury(II) acetate.[17]\n\n\n\n## References\n\n[edit]\n\n1. **^** Dawson, R.M.C., et al., *Data for Biochemical Research*, Oxford, Clarendon Press, 1959.\n2. **^** \"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.\n3. **^** Ra\u00efs, Badr; Chassagnole, Christophe; Lettelier, Thierry; Fell, David; Mazat, Jean-Pierre (2001). \"Threonine synthesis from aspartate in Escherichia coli cell-free extracts: pathway dynamics\". *Biochem J*. **356** (Pt 2): 425\u201332. doi:10.1042/bj3560425. PMC\u00a01221853. PMID\u00a011368769.\n4. **^** Jastrzab, Renata (2013). \"Studies of new phosphothreonine complexes formed in binary and ternary systems including biogenic amines and copper(II)\". *Journal of Coordination Chemistry*. 66 (1): 98\u2013113. doi:10.1080/00958972.2012.746678\n5. **^** *A Dictionary of scientists*. Daintith, John., Gjertsen, Derek. Oxford: Oxford University Press. 1999. p.\u00a0459. ISBN\u00a09780192800862. OCLC\u00a044963215.`{{cite book}}`: CS1 maint: others (link)\n6. **^** Meyer, Curtis (20 July 1936). \"The Spatial Configuation of Alpha-Amino-Beta-Hydroxy-n-Butyric Acid\" (PDF). *Journal of Biological Chemistry*. **115** (3): 721\u2013729. doi:10.1016/S0021-9258(18)74711-X.\n7. **^** \"Nomenclature and symbolism for amino acids and peptides (Recommendations 1983)\". *Pure and Applied Chemistry*. **56** (5): 601, 603, 608. 1 January 1984. doi:10.1351/pac198456050595.\n8. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0.\n9. **^** Lehninger, Albert L.; Nelson, David L.; Cox, Michael M. (2000). *Principles of Biochemistry* (3rd\u00a0ed.). New York: W.\u00a0H. Freeman. ISBN\u00a01-57259-153-6..\n10. **^** Stipanuk, Martha H.; Caudill, Marie A. (2013). *Biochemical, Physiological, and Molecular Aspects of Human Nutrition \u2013 E-Book*. Elsevier Health Sciences. ISBN\u00a09780323266956.\n11. **^** Bhardwaj, Uma; Bhardwaj, Ravindra. *Biochemistry for Nurses*. Pearson Education India. ISBN\u00a09788131795286.\n12. **^** Fang, H; Kang, J; Zhang, D (30 January 2017). \"Microbial production of vitamin B12: a review and future perspectives\". *Microbial Cell Factories*. **16** (1): 15. doi:10.1186/s12934-017-0631-y. PMC\u00a05282855. PMID\u00a028137297.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n13. **^** Adeva-Andany, M; Souto-Adeva, G; Ameneiros-Rodr\u00edguez, E; Fern\u00e1ndez-Fern\u00e1ndez, C; Donapetry-Garc\u00eda, C; Dom\u00ednguez-Montero, A (January 2018). \"Insulin resistance and glycine metabolism in humans\". *Amino Acids*. **50** (1): 11\u201327. doi:10.1007/s00726-017-2508-0. PMID\u00a029094215. S2CID\u00a03708658.\n14. **^** Dalangin, R; Kim, A; Campbell, RE (27 August 2020). \"The Role of Amino Acids in Neurotransmission and Fluorescent Tools for Their Detection\". *International Journal of Molecular Sciences*. **21** (17): 6197. doi:10.3390/ijms21176197. PMC\u00a07503967. PMID\u00a032867295.\n15. **^** \"Error\". *ndb.nal.usda.gov*. Archived from the original on 2018-11-16. Retrieved 2013-05-29.\n16. **^** \"SELF Nutrition Data - Food Facts, Information & Calorie Calculator\". *nutritiondata.self.com*. Retrieved 27 March 2018.\n17. **^** Carter, Herbert E.; West, Harold D. (1940). \"dl-Threonine\". *Organic Syntheses*. **20**: 101; *Collected Volumes*, vol.\u00a03, p.\u00a0813..\n\n## External links\n\n[edit]\n\n* Threonine biosynthesis\n* CID 205\n* CID 6288\n\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n| * v\n* t\n* e\nGlycine receptor modulators\n |\n| --- |\n| Receptor(ligands) | \n\n|  |  |\n| --- | --- |\n| GlyRTooltip Glycine receptor | * **Agonists:** \u03b2-Alanine\n* \u03b2-ABA (BABA)\n* \u03b2-AIBA\n* Caesium\n* D-Alanine\n* D-Serine\n* GABA\n* Glycine\n* Hypotaurine\n* Ivermectin\n* L-Alanine\n* L-Proline\n* L-Serine\n* L-Threonine\n* MDL-27531\n* Milacemide\n* Picolinic acid\n* Propofol\n* Quisqualamine\n* Sarcosine\n* Taurine\n\n\n* **Positive modulators:** Alcohols (e.g., brometone, chlorobutanol (chloretone), ethanol (alcohol), *tert*-butanol (2M2P), tribromoethanol, trichloroethanol, trifluoroethanol)\n* Alkylbenzene sulfonate\n* Anandamide\n* Barbiturates (e.g., pentobarbital, sodium thiopental)\n* Chlormethiazole\n* D12-116\n* Dihydropyridines (e.g., nicardipine)\n* Etomidate\n* Ginseng constituents (e.g., ginsenosides (e.g., ginsenoside-Rf))\n* Glutamic acid (glutamate)\n* Ivermectin\n* Ketamine\n* Neuroactive steroids (e.g., alfaxolone, pregnenolone (eltanolone), pregnenolone acetate, minaxolone, ORG-20599)\n* Nitrous oxide\n* Penicillin G\n* Propofol\n* Tamoxifen\n* Tetrahydrocannabinol\n* Triclofos\n* Tropeines (e.g., atropine, bemesetron, cocaine, LY-278584, tropisetron, zatosetron)\n* Volatiles/gases (e.g., chloral hydrate, chloroform, desflurane, diethyl ether (ether), enflurane, halothane, isoflurane, methoxyflurane, sevoflurane, toluene, trichloroethane (methyl chloroform), trichloroethylene)\n* Xenon\n* Zinc\n\n\n* **Antagonists:** 2-Aminostrychnine\n* 2-Nitrostrychnine\n* 4-Phenyl-4-formyl-N-methylpiperidine\n* \u03b1EMBTL\n* Bicuculline\n* Brucine\n* Cacotheline\n* Caffeine\n* Colchicine\n* Colubrine\n* Cyanotriphenylborate\n* Dendrobine\n* Diaboline\n* Endocannabinoids (e.g., 2-AG, anandamide (AEA))\n* Gaboxadol (THIP)\n* Gelsemine\n* iso-THAZ\n* Isobutyric acid\n* Isonipecotic acid\n* Isostrychnine\n* Laudanosine\n* N-Methylbicuculline\n* N-Methylstrychnine\n* N,N-Dimethylmuscimol\n* Nipecotic acid\n* Pitrazepin\n* Pseudostrychnine\n* Quinolines (e.g., 4-hydroxyquinoline, 4-hydroxyquinoline-3-carboxylic acid, 5,7-CIQA, 7-CIQ, 7-TFQ, 7-TFQA)\n* RU-5135\n* Sinomenine\n* Strychnine\n* Thiocolchicoside\n* Tutin\n\n\n* **Negative modulators:** Amiloride\n* Benzodiazepines (e.g., bromazepam, clonazepam, diazepam, flunitrazepam, flurazepam)\n* Corymine\n* Cyanotriphenylborate\n* Daidzein\n* Dihydropyridines (e.g., nicardipine, nifedipine, nitrendipine)\n* Furosemide\n* Genistein\n* Ginkgo constituents (e.g., bilobalide, ginkgolides (e.g., ginkgolide A, ginkgolide B, ginkgolide C, ginkgolide J, ginkgolide M))\n* Imipramine\n* NBQX\n* Neuroactive steroids (e.g., 3\u03b1-androsterone sulfate, 3\u03b2-androsterone sulfate, deoxycorticosterone, DHEA sulfate, pregnenolone sulfate, progesterone)\n* Opioids (e.g., codeine, dextromethorphan, dextrorphan, levomethadone, levorphanol, morphine, oripavine, pethidine, thebaine)\n* Picrotoxin (i.e., picrotin and picrotoxinin)\n* PMBA\n* Riluzole\n* Tropeines (e.g., bemesetron, LY-278584, tropisetron, zatosetron)\n* Verapamil\n* Zinc\n |\n| NMDARTooltip N-Methyl-D-aspartate receptor | * See here instead.\n |\n\n |\n| Transporter(blockers) | \n\n|  |  |\n| --- | --- |\n| GlyT1Tooltip Glycine transporter 1 | * ACPPB\n* ALX-5407 (NFPS)\n* ASP2535\n* Bitopertin (RG1678/RO4917838)\n* CP-802079\n* Ethanol (alcohol)\n* Glycyldodecylamide\n* GSK1018921\n* Iclepertin\n* LY-2365109\n* Mardepodect\n* ORG-24598\n* ORG-25935 (SCH-900435)\n* Pesampator (BIIB-104, PF-04958242)\n* PF-03463275\n* Sarcosine\n* SNG-12 (Synapsinae)\n* SSR-103,800\n* SSR-504,734\n* Tilapertin\n |\n| GlyT2Tooltip Glycine transporter 2 | * ALX-1393\n* Amoxapine\n* Ethanol (alcohol)\n* NAGly\n* Opiranserin (VVZ-149)\n* ORG-25543\n* VVZ-368\n |\n\n |\n| See also\n*Receptor/signaling modulators*\n*GABA receptor modulators*\n*GABAA receptor positive modulators*\n*Ionotropic glutamate receptor modulators*\n |\n\n</content>\n</document>",
          "name": "search",
          "tool_call_id": "573132ef-c28c-48e3-bd92-e1e3609c1c97",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Tryptophan</title>\n<fragment>\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n\n</fragment>\n<fragment>\n32. **^** Kimura T, Bier DM, Taylor CL (December 2012). \"Summary of workshop discussions on establishing upper limits for amino acids with specific attention to available data for the essential amino acids leucine and tryptophan\". *The Journal of Nutrition*. **142** (12): 2245S\u20132248S. doi:10.3945/jn.112.160846. PMID\u00a023077196.\n33. ^ ***a*** ***b*** Howland RH (June 2012). \"Dietary supplement drug therapies for depression\". *Journal of Psychosocial Nursing and Mental Health Services*. **50** (6): 13\u20136. doi:10.3928/02793695-20120508-06. PMID\u00a022589230.\n34. **^** Hopkins FG, Cole SW (December 1901). \"A contribution to the chemistry of proteids: Part I. A preliminary study of a hitherto undescribed product of tryptic digestion\". *The Journal of Physiology*. **27** (4\u20135): 418\u2013428. doi:10.1113/jphysiol.1901.sp000880. PMC\u00a01540554. PMID\u00a016992614.\n35. **^** Cox, G.J.; King, H. (1930). \"L-Tryptophane\". *Org. Synth*. **10**: 100. doi:10.15227/orgsyn.010.0100.\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n\n</fragment>\n<fragment>\n**Tryptophan** (symbol **Trp** or **W**)[3]\nis an \u03b1-amino acid that is used in the biosynthesis of proteins. Tryptophan contains an  \u03b1-amino group, an \u03b1-carboxylic acid group, and a side chain indole, making it a polar molecule with a non-polar aromatic beta carbon substituent. Tryptophan is also a precursor to the neurotransmitter serotonin, the hormone melatonin, and vitamin B3.[4] It is encoded by the codon UGG.\n\n\nLike other amino acids, tryptophan is a zwitterion at physiological pH where the amino group is protonated (\u2013NH+  \n3; pKa = 9.39) and the carboxylic acid is deprotonated ( \u2013COO\u2212; pKa = 2.38).[5]\n\n\nHumans and many animals cannot synthesize tryptophan: they need to obtain it through their diet, making it an essential amino acid. In 2023, the emission spectrum of tryptophan was discovered in the interstellar gas of the star cluster IC 348.[6]\n\n\n\n\n## Function\n\n[edit]\n\n\n</fragment>\n<fragment>\n36. **^** Radwanski ER, Last RL (1995). \"Tryptophan biosynthesis and metabolism: biochemical and molecular genetics\". *The Plant Cell*. **7** (7): 921\u201334. doi:10.1105/tpc.7.7.921. PMC\u00a0160888. PMID\u00a07640526.\n37. **^** Ikeda M (2002). \"Amino acid production processes\". *Microbial Production of l-Amino Acids*. Advances in Biochemical Engineering/Biotechnology. Vol.\u00a079. pp.\u00a01\u201335. doi:10.1007/3-540-45989-8\\_1. ISBN\u00a0978-3-540-43383-5. PMID\u00a012523387.\n38. **^** Becker J, Wittmann C (2012). \"Bio-based production of chemicals, materials and fuels -Corynebacterium glutamicum as versatile cell factory\". *Current Opinion in Biotechnology*. **23** (4): 631\u201340. doi:10.1016/j.copbio.2011.11.012. PMID\u00a022138494.\n39. **^** Conrado RJ, Varner JD, DeLisa MP (2008). \"Engineering the spatial organization of metabolic enzymes: mimicking nature's synergy\". *Current Opinion in Biotechnology*. **19** (5): 492\u20139. doi:10.1016/j.copbio.2008.07.006. PMID\u00a018725290.\n\n</fragment>\n<fragment>\n62. **^** Maher TJ, Glaeser BS, Wurtman RJ (May 1984). \"Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake\". *The American Journal of Clinical Nutrition*. **39** (5): 722\u20139. doi:10.1093/ajcn/39.5.722. PMID\u00a06538743.\n63. ^ ***a*** ***b*** Fernstrom JD, Wurtman RJ (1971). \"Brain serotonin content: increase following ingestion of carbohydrate diet\". *Science*. **174** (4013): 1023\u20135. Bibcode:1971Sci...174.1023F. doi:10.1126/science.174.4013.1023. PMID\u00a05120086. S2CID\u00a014345137.\n64. **^** Jackson RW (1930). \"A synthesis of tryptophol\" (PDF). *Journal of Biological Chemistry*. **88** (3): 659\u2013662. doi:10.1016/S0021-9258(18)76755-0.\n65. **^** Young SN (September 2013). \"Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects\". *Journal of Psychiatry & Neuroscience*. **38** (5): 294\u2013305. doi:10.1503/jpn.120209. PMC\u00a03756112. PMID\u00a023428157.\n\n</fragment>\n<fragment>\n* \"KEGG PATHWAY: Tryptophan metabolism - Homo sapiens\". KEGG: Kyoto Encyclopedia of Genes and Genomes. 23 August 2006. Retrieved 20 April 2008.\n* G. P. Moss. \"Tryptophan Catabolism (early stages)\". Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Archived from the original on 13 September 2003. Retrieved 20 April 2008.\n* G. P. Moss. \"Tryptophan Catabolism (later stages)\". Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Archived from the original on 13 September 2003. Retrieved 20 April 2008.\n* B. Mikkelson; D. P. Mikkelson (22 November 2007). \"Turkey Causes Sleepiness\". *Urban Legends Reference Pages*. Snopes.com. Retrieved 20 April 2008.\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n| * v\n* t\n* e\nNeurotransmitter metabolic intermediates\n |\n| --- |\n| Catecholamines | \n\n|  |  |\n| --- | --- |\n| Anabolism | * Phenylalanine \u2192 Tyrosine \u2192 DOPA (levodopa) \u2192 Dopamine \u2192 Norepinephrine \u2192 Epinephrine\n |\n| Catabolism | \n\n\n</fragment>\n<fragment>\n![](image)Metabolism of l-tryptophan into serotonin and melatonin (left) and niacin (right). Transformed functional groups after each chemical reaction are highlighted in red.\nAmino acids, including tryptophan, are used as building blocks in protein biosynthesis, and proteins are required to sustain life. Tryptophan is among the less common amino acids found in proteins, but it plays important structural or functional roles whenever it occurs. For instance, tryptophan and tyrosine residues play special roles in \"anchoring\" membrane proteins within the cell membrane. Tryptophan, along with other aromatic amino acids, is also important in glycan-protein interactions. In addition, tryptophan functions as a biochemical precursor for the following compounds:\n\n\n\n\n</fragment>\n<fragment>\n1. ^ ***a*** ***b*** G\u00f6rbitz, C. H.; T\u00f6rnroos, K. W.; Day, G. M. (2012). \"Single-crystal investigation of L-tryptophan with *Z\u2032* = 16\". *Acta Crystallogr. B*. **68** (Pt 5): 549\u2013557. doi:10.1107/S0108768112033484. PMID\u00a022992800.\n2. **^** Dawson RM, et\u00a0al. (1969). *Data for Biochemical Research*. Oxford: Clarendon Press. ISBN\u00a00-19-855338-2.\n3. **^** \n\"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 2 December 2021. Retrieved 22 October 2022.\n4. **^** Slominski A, Semak I, Pisarchik A, Sweatman T, Szczesniewski A, Wortsman J (2002). \"Conversion of L-tryptophan to serotonin and melatonin in human melanoma cells\". *FEBS Letters*. **511** (1\u20133): 102\u20136. doi:10.1016/s0014-5793(01)03319-1. PMID\u00a011821057. S2CID\u00a07820568.\n5. **^** \"L-tryptophan | C11H12N2O2 - PubChem\". *pubchem.ncbi.nlm.nih.gov*. Retrieved 22 December 2016.\n\n</fragment>\n<fragment>\nTryptophan (Trp) content of various foods[24][25]\n| Food\n | Tryptophan [g/100 g of food]\n | Protein [g/100 g of food]\n | Tryptophan/protein [%]\n |\n| --- | --- | --- | --- |\n| Egg white, dried | 1.00 | 81.10 | 1.23\n |\n| Spirulina, dried | 0.92 | 57.47 | 1.62\n |\n| Cod, Atlantic, dried | 0.70 | 62.82 | 1.11\n |\n| Soybeans, raw | 0.59 | 36.49 | 1.62\n |\n| Cheese, Parmesan | 0.56 | 37.90 | 1.47\n |\n| Chia seeds, dried | 0.436 | 16.5 | 2.64\n |\n| Sesame seed | 0.37 | 17.00 | 2.17\n |\n| Cheese, Cheddar | 0.32 | 24.90 | 1.29\n |\n| Sunflower seed | 0.30 | 17.20 | 1.74\n |\n| Pork, chop | 0.25 | 19.27 | 1.27\n |\n| Turkey | 0.24 | 21.89 | 1.11\n |\n| Chicken | 0.24 | 20.85 | 1.14\n |\n| Beef | 0.23 | 20.13 | 1.12\n |\n| Oats | 0.23 | 16.89 | 1.39\n |\n| Salmon | 0.22 | 19.84 | 1.12\n |\n| Lamb, chop | 0.21 | 18.33 | 1.17\n |\n| Perch, Atlantic | 0.21 | 18.62 | 1.12\n |\n| Chickpeas, raw | 0.19 | 19.30 | 0.96\n |\n| Egg | 0.17 | 12.58 | 1.33\n |\n| Wheat flour, white | 0.13 | 10.33 | 1.23\n |\n| Baking chocolate, unsweetened | 0.13 | 12.9 | 1.23\n |\n\n</fragment>\n<fragment>\nThe isolation of tryptophan was first reported by Frederick Hopkins in 1901.[34] Hopkins recovered tryptophan from hydrolysed casein, recovering 4\u20138 g of tryptophan from 600 g of crude casein.[35]\n\n\n\n## Biosynthesis and industrial production\n\n[edit]\n\nAs an essential amino acid, tryptophan is not synthesized from simpler substances in humans and other animals, so it needs to be present in the diet in the form of tryptophan-containing proteins. Plants and microorganisms commonly synthesize tryptophan from shikimic acid or anthranilate:[36] anthranilate condenses with phosphoribosylpyrophosphate (PRPP), generating pyrophosphate as a by-product. The ring of the ribose moiety is opened and subjected to reductive decarboxylation, producing indole-3-glycerol phosphate; this, in turn, is transformed into indole. In the last step, tryptophan synthase catalyzes the formation of tryptophan from indole and the amino acid serine.\n\n\n\n\n</fragment>\n<fragment>\n11. **^** Bartoli, F; Misiak, B; Callovini, T; Cavaleri, D; Cioni, RM; Crocamo, C; Savitz, JB; Carr\u00e0, G (19 October 2020). \"The kynurenine pathway in bipolar disorder: a meta-analysis on the peripheral blood levels of tryptophan and related metabolites\". *Molecular Psychiatry*. **26** (7): 3419\u20133429. doi:10.1038/s41380-020-00913-1. PMID\u00a033077852. S2CID\u00a0224314102.\n12. **^** Ikeda M, Tsuji H, Nakamura S, Ichiyama A, Nishizuka Y, Hayaishi O (1965). \"Studies on the biosynthesis of nicotinamide adenine dinucleotide. II. A role of picolinic carboxylase in the biosynthesis of nicotinamide adenine dinucleotide from tryptophan in mammals\". *The Journal of Biological Chemistry*. **240** (3): 1395\u2013401. doi:10.1016/S0021-9258(18)97589-7. PMID\u00a014284754.\n13. **^** Palme K, Nagy F (2008). \"A new gene for auxin synthesis\". *Cell*. **133** (1): 31\u20132. doi:10.1016/j.cell.2008.03.014. PMID\u00a018394986. S2CID\u00a09949830.\n\n</fragment>\n<fragment>\n* Serotonin (a neurotransmitter), synthesized by tryptophan hydroxylase.[7][8]\n* Melatonin (a neurohormone) is in turn synthesized from serotonin, via N-acetyltransferase and 5-hydroxyindole-O-methyltransferase enzymes.[9]\n* Kynurenine, to which tryptophan is mainly (more than 95%) metabolized. Two enzymes, namely indoleamine 2,3-dioxygenase (IDO) in the immune system and the brain, and tryptophan 2,3-dioxygenase (TDO) in the liver, are responsible for the synthesis of kynurenine from tryptophan. The kynurenine pathway of tryptophan catabolism is altered in several diseases, including psychiatric disorders such as schizophrenia,[10] major depressive disorder,[10] and bipolar disorder.[10][11]\n* Niacin, also known as vitamin B3, is synthesized from tryptophan via kynurenine and quinolinic acids.[12]\n* Auxins (a class of phytohormones) are synthesized from tryptophan.[13]\n\n\n</fragment>\n<fragment>\n48. **^** Kilbourne EM, Philen RM, Kamb ML, Falk H (October 1996). \"Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome\". *The Journal of Rheumatology. Supplement*. **46**: 81\u20138, discussion 89\u201391. PMID\u00a08895184.\n49. **^** Mayeno AN, Lin F, Foote CS, Loegering DA, Ames MM, Hedberg CW, Gleich GJ (December 1990). \"Characterization of \"peak E,\" a novel amino acid associated with eosinophilia-myalgia syndrome\". *Science*. **250** (4988): 1707\u20138. Bibcode:1990Sci...250.1707M. doi:10.1126/science.2270484. PMID\u00a02270484.\n50. **^** Ito J, Hosaki Y, Torigoe Y, Sakimoto K (January 1992). \"Identification of substances formed by decomposition of peak E substance in tryptophan\". *Food and Chemical Toxicology*. **30** (1): 71\u201381. doi:10.1016/0278-6915(92)90139-C. PMID\u00a01544609.\n\n</fragment>\n<fragment>\n |\n| Names\n |\n| IUPAC name\nTryptophan\n |\n| Systematic IUPAC name\n(2*S*)-2-amino-3-(1*H*-indol-3-yl)propanoic acid\n |\n| Other names\n2-Amino-3-(1*H*-indol-3-yl)propanoic acid\n |\n| Identifiers\n |\n| CAS Number\n | * 73-22-3![check](image)Y\n |\n| 3D model (JSmol)\n | * Interactive image\n* Zwitterion: Interactive image\n |\n| ChEBI | * CHEBI:16828\n |\n| ChEMBL | * ChEMBL54976![check](image)Y\n |\n| ChemSpider | * 6066![check](image)Y\n |\n| DrugBank | * DB00150![check](image)Y\n |\n| ECHA InfoCard | 100.000.723 ![Edit this at Wikidata](image) |\n| IUPHAR/BPS\n | * 717\n |\n| KEGG | * D00020![check](image)Y\n |\n| PubChem CID\n | * 6305\n |\n| UNII | * 8DUH1N11BX![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * DTXSID5021419 ![Edit this at Wikidata](image)\n |\n| InChI\n\n* InChI=1S/C11H12N2O2/c12-9(11(14)15)5-7-6-13-10-4-2-1-3-8(7)10/h1-4,6,9,13H,5,12H2,(H,14,15)/t9-/m0/s1![check](image)Y\nKey:\u00a0QIVBCDIJIAJPQS-VIFPVBQESA-N![check](image)Y\n |\n| SMILES\n\n\n</fragment>\n<fragment>\nTryptophan is present in most protein-based foods or dietary proteins. It is particularly plentiful in chocolate, oats, dried dates, milk, yogurt, cottage cheese, red meat, eggs, fish, poultry, sesame, chickpeas, almonds, sunflower seeds, pumpkin seeds, Hemp Seeds, buckwheat, spirulina, and peanuts. Contrary to the popular belief[22][23] that cooked turkey contains an abundance of tryptophan, the tryptophan content in turkey is typical of poultry.[24]\n\n\n\n\n\n\n</fragment>\n<fragment>\n|  |  |\n| --- | --- |\n| Dopamine | * 3,4-Dihydroxyphenylacetaldehyde (DOPAL)\n* 3,4-Dihydroxyphenylacetic acid (DOPAC)\n* Homovanillyl alcohol\n* Hydroxytyrosol (3,4-dihydroxyphenylethanol; DOPET)\n* 3-Methoxytyramine (3-MT)\n* Homovanillic acid (HVA)\n |\n| Norepinephrine | * 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL, DHMAL)\n* 3,4-Dihydroxymandelic acid (DHMA)\n* Normetanephrine\n* 3-Methoxy-4-hydroxymandelaldehyde (MHMAL)\n* Vanillylmandelic acid (VMA)\n* 3,4-Dihydroxyphenylethylene glycol (DOPEG, DHPG)\n* 3-Methoxy-4-hydroxyphenylglycol (MHPG, MOPEG)\n |\n| Epinephrine | * 3,4-Dihydroxyphenylglycolaldehyde (DOPEGAL, DHMAL)\n* Metanephrine\n* 3-Methoxy-4-hydroxymandelaldehyde (MHMAL)\n |\n\n |\n\n |\n| Tryptophan\u2192Serotonin | \n\n|  |  |\n| --- | --- |\n| Anabolism | * Tryptophan\n* 5-Hydroxytryptophan (5-HTP)\n |\n| Catabolism | * 5-Hydroxyindoleacetaldehyde (5-HIAL)\n* 5-Hydroxyindoleacetic acid (5-HIAA)\n* 5-Hydroxytryptophol (5-HTOL)\n |\n\n\n</fragment>\n<fragment>\n51. **^** Smith MJ, Garrett RH (November 2005). \"A heretofore undisclosed crux of eosinophilia-myalgia syndrome: compromised histamine degradation\". *Inflammation Research*. **54** (11): 435\u201350. doi:10.1007/s00011-005-1380-7. PMID\u00a016307217. S2CID\u00a07785345.\n52. **^** Michael Predator Carlton. \"Molecular Biology and Genetic Engineering explained by someone who's done it\". Archived from the original on 24 June 2007.\n53. **^** Allen, JA; Peterson, A; Sufit, R; Hinchcliff, ME; Mahoney, JM; Wood, TA; Miller, FW; Whitfield, ML; Varga, J (November 2011). \"Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan\". *Arthritis and Rheumatism*. **63** (11): 3633\u20139. doi:10.1002/art.30514. PMC\u00a03848710. PMID\u00a021702023.\n54. **^** Mayeno AN, Gleich GJ (September 1994). \"Eosinophilia-myalgia syndrome and tryptophan production: a cautionary tale\". *Trends in Biotechnology*. **12** (9): 346\u201352. doi:10.1016/0167-7799(94)90035-3. PMID\u00a07765187.\n\n</fragment>\n<fragment>\n6. **^** Iglesias-Groth S (August 2023). \"A search for tryptophan in the gas of the IC 348 star cluster of the Perseus molecular cloud\". *Monthly Notices of the Royal Astronomical Society*. **523** (2): 2876\u20132886. Bibcode:2023MNRAS.523.2876I. doi:10.1093/mnras/stad1535.`{{cite journal}}`: CS1 maint: unflagged free DOI (link)\n7. **^** Fernstrom JD (1983). \"Role of precursor availability in control of monoamine biosynthesis in brain\". *Physiological Reviews*. **63** (2): 484\u2013546. doi:10.1152/physrev.1983.63.2.484. PMID\u00a06132421.\n8. **^** Schaechter JD, Wurtman RJ (1990). \"Serotonin release varies with brain tryptophan levels\" (PDF). *Brain Research*. **532** (1\u20132): 203\u201310. doi:10.1016/0006-8993(90)91761-5. PMID\u00a01704290. S2CID\u00a08451316. Archived from the original (PDF) on 9 August 2020. Retrieved 30 May 2014.\n\n</fragment>\n<fragment>\n |\n| Serotonin\u2192Melatonin | * *N*-Acetylserotonin (NAS; normelatonin)\n* 5-Methoxytryptamine (5-MT)\n* 5-Methoxyindoleacetaldehyde (5-MIAL)\n |\n| Trace amines | * 3-Methoxy-4-hydroxyphenylacetaldehyde (HMPAL)\n* 4-Hydroxyphenylacetaldehyde (HPAL)\n* Indoleacetaldehyde (IAL)\n* Phenacetaldehyde (PAL)\n |\n| GABA | * Glutamate\n* Putrescine\n* \u03b3-Aminobutyraldehyde (GABAL)\n* *N*-Acetylputrescine\n* *N*-Acetyl-\u03b3-aminobutyraldehyde (*N*-acetyl-GABAL)\n* *N*-Acetyl-\u03b3-aminobutyric acid (*N*-acetyl-GABA)\n |\n\n| * v\n* t\n* e\nSerotonin receptor modulators\n |\n| --- |\n| 5-HT1 | \n\n|  |  |  |  |  |\n| --- | --- | --- | --- | --- |\n| 5-HT1A | \n\n\n</fragment>\n<fragment>\n17. ^ ***a*** ***b*** ***c*** ***d*** ***e*** ***f*** ***g*** ***h*** ***i*** Zhang LS, Davies SS (April 2016). \"Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions\". *Genome Med*. **8** (1): 46. doi:10.1186/s13073-016-0296-x. PMC\u00a04840492. PMID\u00a027102537. *Lactobacillus* spp. convert tryptophan to indole-3-aldehyde (I3A) through unidentified enzymes [125]. *Clostridium sporogenes* convert tryptophan to IPA [6], likely via a tryptophan deaminase.\u00a0... IPA also potently scavenges hydroxyl radicals  \nTable 2: Microbial metabolites: their synthesis, mechanisms of action, and effects on health and disease  \nFigure 1: Molecular mechanisms of action of indole and its metabolites on host physiology and disease\n\n</fragment>\n<fragment>\n\nTryptophan affects brain serotonin synthesis when given orally in a purified form and is used to modify serotonin levels for research.[28] Low brain serotonin level is induced by administration of tryptophan-poor protein in a technique called acute tryptophan depletion.[65] Studies using this method have evaluated the effect of serotonin on mood and social behavior, finding that serotonin reduces aggression and increases agreeableness.[66]\n\n\n\n### Fluorescence\n\n[edit]\n\nMain article: Fluorescence spectroscopy \u00a7\u00a0Tryptophan fluorescence\n\nTryptophan is an important intrinsic fluorescent probe (amino acid), which can be used to estimate the nature of the microenvironment around the tryptophan residue. Most of the intrinsic fluorescence emissions of a folded protein are due to excitation of tryptophan residues.\n\n\n\n## See also\n\n[edit]\n\n* 5-Hydroxytryptophan (5-HTP)\n* Acree\u2013Rosenheim reaction\n* Adamkiewicz reaction\n* Attenuator (genetics)\n* *N*,*N*-Dimethyltryptamine\n* Hopkins\u2013Cole reaction\n* Serotonin\n* Tryptamine\n\n\n</fragment>\n<fragment>\n55. **^** Raphals P (November 1990). \"Does medical mystery threaten biotech?\". *Science*. **250** (4981): 619. Bibcode:1990Sci...250..619R. doi:10.1126/science.2237411. PMID\u00a02237411.\n56. **^** \"Food & mood. (neuroscience professor Richard Wurtman) (Interview)\". *Nutrition Action Healthletter*. September 1992.[*dead link*]\n57. ^ ***a*** ***b*** Lyons PM, Truswell AS (March 1988). \"Serotonin precursor influenced by type of carbohydrate meal in healthy adults\". *The American Journal of Clinical Nutrition*. **47** (3): 433\u20139. doi:10.1093/ajcn/47.3.433. PMID\u00a03279747.\n58. ^ ***a*** ***b*** ***c*** Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ (January 2003). \"Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios\". *The American Journal of Clinical Nutrition*. **77** (1): 128\u201332. doi:10.1093/ajcn/77.1.128. PMID\u00a012499331.\n\n</fragment>\n<fragment>\n* c1[nH]c2ccccc2c1C[C@H](N)C(=O)O\n* Zwitterion: c1[nH]c2ccccc2c1C[C@H]([NH3+])C(=O)[O-]\n |\n| Properties\n |\n| Chemical formula\n | C11H12N2O2 |\n| Molar mass | 204.229\u00a0g\u00b7mol\u22121 |\n| Solubility in water\n | Soluble: 0.23 g/L at 0\u00a0\u00b0C,\n11.4 g/L at 25\u00a0\u00b0C,\n17.1 g/L at 50\u00a0\u00b0C,\n27.95 g/L at 75\u00a0\u00b0C\n |\n| Solubility | Soluble in hot alcohol, alkali hydroxides; insoluble in chloroform.\n |\n| Acidity (p*K*a)\n | 2.38 (carboxyl), 9.39 (amino)[2] |\n| Magnetic susceptibility (\u03c7)\n | -132.0\u00b710\u22126 cm3/mol\n |\n| Pharmacology\n |\n| ATC code\n | N06AX02 (WHO) \n |\n| Supplementary data page\n |\n| Tryptophan (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n\n</fragment>\n<fragment>\n![](image)\nThe industrial production of tryptophan is also biosynthetic and is based on the fermentation of serine and indole using either wild-type or genetically modified bacteria such as *B. amyloliquefaciens*, *B. subtilis*, *C. glutamicum* or *E. coli*. These strains carry mutations that prevent the reuptake of aromatic amino acids or multiple/overexpressed trp operons. The conversion is catalyzed by the enzyme tryptophan synthase.[37][38][39]\n\n\n\n## Society and culture\n\n[edit]\n\n### Showa Denko contamination scandal\n\n[edit]\n\nThere was a large outbreak of eosinophilia-myalgia syndrome (EMS) in the U.S. in 1989, with more than 1,500 cases reported to the CDC and at least 37 deaths.[40] After preliminary investigation revealed that the outbreak was linked to intake of tryptophan, the U.S. Food and Drug Administration (FDA) recalled tryptophan supplements in 1989 and banned most public sales in 1990,[41][42][43] with other countries following suit.[44][45]\n\n\n</fragment>\n<fragment>\nThis diagram shows the biosynthesis of bioactive compounds (indole and certain other derivatives) from tryptophan by bacteria in the gut.[17] Indole is produced from tryptophan by bacteria that express tryptophanase.[17] *Clostridium sporogenes* metabolizes tryptophan into indole and subsequently 3-indolepropionic acid (IPA),[18] a highly potent neuroprotective antioxidant that scavenges hydroxyl radicals.[17][19][20] IPA binds to the pregnane X receptor (PXR) in intestinal cells, thereby facilitating mucosal homeostasis and barrier function.[17] Following absorption from the intestine and distribution to the brain, IPA confers a neuroprotective effect against cerebral ischemia and Alzheimer's disease.[17] Lactobacillaceae (*Lactobacillus* s.l.) species metabolize tryptophan into indole-3-aldehyde (I3A) which acts on the aryl hydrocarbon receptor (AhR) in intestinal immune cells, \n</fragment>\n<fragment>\n21. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08525-0.\n22. ^ ***a*** ***b*** Ballantyne C (21 November 2007). \"Does Turkey Make You Sleepy?\". *Scientific American*. Retrieved 6 June 2013.\n23. ^ ***a*** ***b*** McCue K. \"Chemistry.org: Thanksgiving, Turkey, and Tryptophan\". Archived from the original on 4 April 2007. Retrieved 17 August 2007.\n24. ^ ***a*** ***b*** ***c*** Holden, Joanne. \"USDA National Nutrient Database for Standard Reference, Release 22\". Nutrient Data Laboratory, Agricultural Research Service, United States Department of Agriculture. Retrieved 29 November 2009.\n\n</fragment>\n<fragment>\n\nThe disorder fructose malabsorption causes improper absorption of tryptophan in the intestine, reduced levels of tryptophan in the blood,[14] and depression.[15]\n\n\nIn bacteria that synthesize tryptophan, high cellular levels of this amino acid activate a repressor protein, which binds to the trp operon.[16] Binding of this repressor to the tryptophan operon prevents transcription of downstream DNA that codes for the enzymes involved in the biosynthesis of tryptophan. So high levels of tryptophan prevent tryptophan synthesis through a negative feedback loop, and when the cell's tryptophan levels go down again, transcription from the trp operon resumes. This permits tightly regulated and rapid responses to changes in the cell's internal and external tryptophan levels.\n\n\n\n|  |\n| --- |\n| Tryptophan metabolism by human gastrointestinal microbiota (* v\n* t\n* e\n)\n\n![Tryptophan metabolism diagram](image)\n\nTryptophan\n\n*Clostridiumsporogenes*\n\nLacto-bacilli\n\nTryptophanase-expressingbacteria\n\nIPA\n\nI3A\n\nIndole\n\nLiver\n\n\n</fragment>\n<fragment>\nThe resulting increased tryptophan ratio reduces competition at the large neutral amino acid transporter (which transports both BCAA and aromatic amino acids), resulting in more uptake of tryptophan across the blood\u2013brain barrier into the cerebrospinal fluid (CSF).[60][61][62] Once in the CSF, tryptophan is converted into serotonin in the raphe nuclei by the normal enzymatic pathway.[58][63] The resultant serotonin is further metabolised into melatonin by the pineal gland.[9] Hence, these data suggest that \"feast-induced drowsiness\"\u2014or postprandial somnolence\u2014may be the result of a heavy meal rich in carbohydrates, which indirectly increases the production of melatonin in the brain, and thereby promotes sleep.[57][58][59][63]\n\n\n\n## Research\n\n[edit]\n\nIn 1912 Felix Ehrlich demonstrated that yeast metabolizes the natural amino acids essentially by splitting off carbon dioxide and replacing the amino group with a hydroxyl group. By this reaction, tryptophan gives rise to tryptophol.[64]\n\n\n</fragment>\n<fragment>\nBrain\n\nIPA\n\nI3A\n\nIndole\n\nIndoxylsulfate\n\nAST-120\n\nAhR\n\nIntestinalimmunecells\n\nIntestinalepithelium\n\nPXR\n\nMucosal homeostasis:\u2193TNF-\u03b1\u2191Junction protein-coding mRNAs\n\nL cell\n\nGLP-1\n\nT J\n\nNeuroprotectant:\u2193Activation of glial cells and astrocytes\u21934-Hydroxy-2-nonenal levels\u2193DNA damage\u2013Antioxidant\u2013Inhibits \u03b2-amyloid fibril formation\n\nMaintains mucosal reactivity:\u2191IL-22 production\n\nAssociated with vascular disease:\u2191Oxidative stress\u2191Smooth muscle cell proliferation\u2191Aortic wall thickness and calcification\n\nAssociated with chronic kidney disease:\u2191Renal dysfunction\u2013Uremic toxin\n\nKidneys\n\n\n</fragment>\n<fragment>\n44. **^** Castot, A; Bidault, I; Bournerias, I; Carlier, P; Efthymiou, ML (1991). \"[\"Eosinophilia-myalgia\" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases]\". *Th\u00e9rapie*. **46** (5): 355\u201365. PMID\u00a01754978.\n45. **^** \"COT Statement on Tryptophan and the Eosinophilia-Myalgia Syndrome\" (PDF). UK Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. June 2004.\n46. **^** Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW (July 1990). \"Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer\". *JAMA*. **264** (2): 213\u20137. doi:10.1001/jama.264.2.213. PMID\u00a02355442.\n47. **^** Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM (April 1993). \"Risk factors for developing eosinophilia myalgia syndrome among L-tryptophan users in New York\". *The Journal of Rheumatology*. **20** (4): 666\u201372. PMID\u00a08496862.\n\n</fragment>\n<fragment>\n14. **^** Ledochowski M, Widner B, Murr C, Sperner-Unterweger B, Fuchs D (2001). \"Fructose malabsorption is associated with decreased plasma tryptophan\" (PDF). *Scandinavian Journal of Gastroenterology*. **36** (4): 367\u201371. doi:10.1080/003655201300051135. PMID\u00a011336160. Archived from the original (PDF) on 19 April 2016.\n15. **^** Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D (June 1998). \"Fructose malabsorption is associated with early signs of mental depression\". *European Journal of Medical Research*. **3** (6): 295\u20138. PMID\u00a09620891.\n16. **^** Gollnick P, Babitzke P, Antson A, Yanofsky C (2005). \"Complexity in regulation of tryptophan biosynthesis in Bacillus subtilis\". *Annual Review of Genetics*. **39**: 47\u201368. doi:10.1146/annurev.genet.39.073003.093745. PMID\u00a016285852.\n\n</fragment>\n<fragment>\n40. **^** Allen, J.A.; Varga, J (2014). \"Eosinophilia\u2013Myalgia Syndrome\". In Wexler, Philip (ed.). *Encyclopedia of Toxicology* (3rd\u00a0ed.). Burlington: Elsevier Science. ISBN\u00a0978-0-12-386455-0.\n41. ^ ***a*** ***b*** ***c*** ***d*** \"Information Paper on L-tryptophan and 5-hydroxy-L-tryptophan\". FU. S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements. 1 February 2001. Archived from the original on 25 February 2005. Retrieved 8 February 2012.\n42. **^** \"L-tryptophan: Uses and Risks\". *WebMD*. 12 May 2017. Retrieved 5 June 2017.\n43. **^** Altman, Lawrence K. (27 April 1990). \"Studies Tie Disorder to Maker of Food Supplement\". *The New York Times*.\n\n</fragment>\n<fragment>\n18. **^** Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G (March 2009). \"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites\". *Proc. Natl. Acad. Sci. U.S.A*. **106** (10): 3698\u20133703. Bibcode:2009PNAS..106.3698W. doi:10.1073/pnas.0812874106. PMC\u00a02656143. PMID\u00a019234110. Production of IPA was shown to be completely dependent on the presence of gut microflora and could be established by colonization with the bacterium *Clostridium sporogenes*.  \nIPA metabolism diagram\n19. **^** \"3-Indolepropionic acid\". *Human Metabolome Database*. University of Alberta. Retrieved 12 June 2018.\n\n</fragment>\n<fragment>\n|  |\n| --- |\n| * *Agonists:* 2Cs (e.g., 2C-B, 2C-E, 2C-I, 2C-T-2, 2C-T-7, 2C-T-21)\n* 5-Methoxytryptamines (5-MeO-DET, 5-MeO-DiPT, 5-MeO-DMT, 5-MeO-DPT, 5-MT)\n* \u03b1-Alkyltryptamines (e.g., 5-Cl-\u03b1MT, 5-Fl-\u03b1MT, 5-MeO-\u03b1ET, 5-MeO-\u03b1MT, \u03b1-Me-5-HT, \u03b1ET, \u03b1MT)\n* A-372159\n* AL-38022A\n* Alstonine\n* CP-809101\n* Dimemebfe\n* DOx (e.g., DOB, DOC, DOI, DOM)\n* Ergolines (e.g., ALD-52, cabergoline, dihydroergotamine, ergine (LSA), ergotamine, lisuride, LA-SS-Az, LSB, LSD, LSD-Pip, LSH, LSP, pergolide)\n* Flumexadol\n* Lorcaserin\n* MDxx (e.g., MDA (tenamfetamine), MDMA (midomafetamine), MDOH, MMDA)\n* MK-212\n* ORG-12962\n* ORG-37684\n* Oxaflozane\n* PHA-57378\n* Phenethylamines (e.g., lophophine, mescaline)\n* Piperazines (e.g., aripiprazole, BZP, mCPP, quipazine, TFMPP)\n* PNU-22394\n* PNU-181731\n* Ro60-0175\n* Ro60-0213\n* Serotonin (5-HT)\n* Tryptamines (e.g., 5-BT, 5-CT, bufotenin, DET, DiPT, DMT, DPT, psilocin, psilocybin, tryptamine)\n* Vabicaserin\n* WAY-629\n* WAY-161503\n* YM-348\n |\n| * *Antagonists:* Adatanserin\n* Agomelatine\n\n</fragment>\n<fragment>\n* Psilocybin (4-PO-DMT)\n* Pyr-T\n* RS134-49\n* Serotonin (5-HT)\n* Solypertine\n* ST-1936\n* Tryptamine\n* Tryptophan\n* Yuremamine\n* Z2876442907\n |\n| *N*-Acetyltryptamines | * 2-Iodomelatonin\n* 2-Phenylmelatonin\n* 5-Methoxyluzindole\n* 6-Chloromelatonin\n* 6-Fluoromelatonin\n* 6-Hydroxymelatonin\n* 6-Methoxymelatonin\n* 6,7-Dichloro-2-methylmelatonin\n* \u03b1-Methylmelatonin\n* Luzindole\n* Melatonin\n* Normelatonin (*N*-acetylserotonin; NAS)\n* *N*-Acetyltryptamine\n* *N*-Butanoylmelatonin\n* *N*-Propionylmelatonin\n* Piromelatine\n* TIK-301\n |\n| \u03b1-Alkyltryptamines | * 2,\u03b1-DMT\n* 4-HO-\u03b1MT\n* 4-HO-MPMI (lucigenol)\n* 4-Me-\u03b1ET\n* 4-Me-\u03b1MT\n* 5-Chloro-\u03b1MT\n* 5-Ethoxy-\u03b1MT\n* 5-Fluoro-\u03b1ET\n* 5-Fluoro-\u03b1MT\n* 5-iPrO-\u03b1MT\n* 5-MeO-\u03b1ET\n* 5-MeO-\u03b1MT\n* 5-MeO-MPMI\n* 5-Methyl-\u03b1ET\n* 6-Fluoro-\u03b1MT\n* 7-Chloro-\u03b1MT\n* 7-Methyl-\u03b1ET\n* \u03b1-Methyl-5-HTP\n* \u03b1-Methylmelatonin\n* \u03b1-Methylserotonin (5-HO-\u03b1MT)\n* \u03b1-Methyltryptophan (\u03b1MTP)\n* \u03b1,*N*-DMT (*N*-methyl-\u03b1MT)\n* \u03b1,*N*,*N*-TMT\n* \u03b1,*N*,*O*-TMS\n* \u03b1ET (etryptamine)\n* \u03b1MT\n* AL-37350A (4,5-DHP-\u03b1MT)\n* BNC-210\n* BW-723C86\n\n</fragment>\n<fragment>\n25. **^** Rambali B, Van Andel I, Schenk E, Wolterink G, van de Werken G, Stevenson H, Vleeming W (2002). \"[The contribution of cocoa additive to cigarette smoking addiction]\" (PDF). *RIVM* (report 650270002/2002). The National Institute for Public Health and the Environment (Netherlands). Archived from the original (PDF) on 8 November 2005.\n26. **^** Soh NL, Walter GT (2011). \"Tryptophan and depression: can diet alone be the answer?\". *Acta Neuropsychiatrica*. **23** (1): 1601\u20135215. doi:10.1111/j.1601-5215.2010.00508.x. S2CID\u00a0145779393.\n27. **^** Fernstrom JD (2012). \"Effects and side effects associated with the non-nutritional use of tryptophan by humans\". *The Journal of Nutrition*. **142** (12): 2236S\u20132244S. doi:10.3945/jn.111.157065. PMID\u00a023077193.\n28. ^ ***a*** ***b*** Wurtman RJ, Hefti F, Melamed E (1980). \"Precursor control of neurotransmitter synthesis\". *Pharmacological Reviews*. **32** (4): 315\u201335. PMID\u00a06115400.\n\n</fragment>\n<fragment>\nin turn increasing interleukin-22 (IL-22) production.[17] Indole itself triggers the secretion of glucagon-like peptide-1 (GLP-1) in intestinal L cells and acts as a ligand for AhR.[17] Indole can also be metabolized by the liver into indoxyl sulfate, a compound that is toxic in high concentrations and associated with vascular disease and renal dysfunction.[17] AST-120 (activated charcoal), an intestinal sorbent that is taken by mouth, adsorbs indole, in turn decreasing the concentration of indoxyl sulfate in blood plasma.[17]\n |\n\n\n## Recommended dietary allowance\n\n[edit]\n\nIn 2002, the U.S. Institute of Medicine set a Recommended Dietary Allowance (RDA) of 5\u00a0mg/kg body weight/day of Tryptophan for adults 19 years and over.[21]\n\n\n\n### Dietary sources\n\n[edit]\n\n\n</fragment>\n<fragment>\n9. ^ ***a*** ***b*** Wurtman RJ, Anton-Tay F (1969). \"The mammalian pineal as a neuroendocrine transducer\" (PDF). *Recent Progress in Hormone Research*. **25**: 493\u2013522. doi:10.1016/b978-0-12-571125-8.50014-4. ISBN\u00a09780125711258. PMID\u00a04391290. Archived from the original (PDF) on 31 May 2014.\n10. ^ ***a*** ***b*** ***c*** Marx, Wolfgang; McGuinness, Amelia J.; Rocks, Tetyana; Ruusunen, Anu; Cleminson, Jasmine; Walker, Adam J.; Gomes-da-Costa, Susana; Lane, Melissa; Sanches, Marsal; Diaz, Alexandre P.; Tseng, Ping-Tao (23 November 2020). \"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies\". *Molecular Psychiatry*. **26** (8): 4158\u20134178. doi:10.1038/s41380-020-00951-9. ISSN\u00a01476-5578. PMID\u00a033230205. S2CID\u00a0227132820.\n\n</fragment>\n</document>",
          "name": "search",
          "tool_call_id": "a0ee5f9f-4f4f-4bb2-9eb7-dcdbb27260e8",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "function",
          "content": "<document>\n<title>Valine</title>\n<content>\nValine\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Skeletal formula of neutral valine\n | ![](image)Zwitterionic valine\n |\n\n |\n| \n\n|  |  |\n| --- | --- |\n| ![](image)Ball-and-stick model\n | ![](image)Space-filling model\n |\n\n |\n| Names\n |\n| IUPAC name\nValine\n |\n| Other names\n2-Amino-3-methylbutanoic acid2-Aminoisovaleric acidValic acid\n |\n| Identifiers\n |\n| CAS Number\n | * L: 72-18-4![check](image)Y\n* D/L: 516-06-3![check](image)Y\n* D: 640-68-6![check](image)Y\n |\n| 3D model (JSmol)\n | * L: Interactive image\n* L Zwitterion: Interactive image\n |\n| ChEBI | * L: CHEBI:16414![check](image)Y\n |\n| ChEMBL | * L: ChEMBL43068![check](image)Y\n |\n| ChemSpider | * L: 6050![check](image)Y\n* D/L: 1148![check](image)Y\n* D: 64635![check](image)Y\n |\n| DrugBank | * L: DB00161![check](image)Y\n |\n| ECHA InfoCard | 100.000.703 ![Edit this at Wikidata](image) |\n| EC Number | * L: 200-773-6\n |\n| IUPHAR/BPS\n | * L: 4794\n |\n| KEGG | * L: D00039![check](image)Y\n |\n| PubChem CID\n | * L: 6287\n* D/L: 1182\n* D: 71563\n |\n| UNII | * L: HG18B9YRS7![check](image)Y\n* D/L: 4CA13A832H![check](image)Y\n* D: Y14I1443UR![check](image)Y\n |\n| CompTox Dashboard (EPA)\n | * L: DTXSID40883233 ![Edit this at Wikidata](image)\n |\n| InChI\n\n* InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1![check](image)Y\nKey:\u00a0KZSNJWFQEVHDMF-BYPYZUCNSA-N![check](image)Y\n* D/L: Key:\u00a0KZSNJWFQEVHDMF-UHFFFAOYSA-N\n* D: Key:\u00a0KZSNJWFQEVHDMF-SCSAIBSYSA-N\n |\n| SMILES\n\n* L: CC(C)[C@@H](C(=O)O)N\n* L Zwitterion: CC(C)[C@@H](C(=O)[O-])[NH3+]\n |\n| Properties[3] |\n| Chemical formula\n | C5H11NO2 |\n| Molar mass | 117.148\u00a0g\u00b7mol\u22121 |\n| Density | 1.316 g/cm3 |\n| Melting point | 298\u00a0\u00b0C (568\u00a0\u00b0F; 571\u00a0K) (decomposition)\n |\n| Solubility in water\n | soluble, 85 g/L [1] |\n| Acidity (p*K*a)\n | 2.32 (carboxyl), 9.62 (amino)[2] |\n| Magnetic susceptibility (\u03c7)\n | -74.3\u00b710\u22126 cm3/mol\n |\n| Supplementary data page\n |\n| Valine (data page) |\n| Except where otherwise noted, data are given for materials in their standard state (at 25\u00a0\u00b0C [77\u00a0\u00b0F], 100\u00a0kPa).\n\n\nInfobox references\n |\n\nChemical compound\n\n**Valine** (symbol **Val** or **V**)[4] is an \u03b1-amino acid that is used in the biosynthesis of proteins. It contains an \u03b1-amino group (which is in the protonated \u2212NH3+ form under biological conditions), an \u03b1-carboxylic acid group (which is in the deprotonated \u2212COO\u2212 form under biological conditions), and a side chain isopropyl group, making it a non-polar aliphatic amino acid. It is essential in humans, meaning the body cannot synthesize it: it must be obtained from the diet. Human dietary sources are foods that contain protein, such as meats, dairy products, soy products, beans and legumes. It is encoded by all codons starting with GU (GUU, GUC, GUA, and GUG).\n\n\n\n\n## History and etymology\n\n[edit]\n\nValine was first isolated from casein in 1901 by Hermann Emil Fischer.[5] The name valine comes from valeric acid, which in turn is named after the plant valerian due to the presence of the acid in the roots of the plant.[6][7]\n\n\n\n## Nomenclature\n\n[edit]\n\nAccording to IUPAC, carbon atoms forming valine are numbered sequentially starting from 1 denoting the carboxyl carbon, whereas 4 and 4' denote the two terminal methyl carbons.[8]\n\n\n\n## Metabolism\n\n[edit]\n\n### Source and biosynthesis\n\n[edit]\n\nValine, like other branched-chain amino acids, is synthesized by plants, but not by animals.[9] It is therefore an essential amino acid in animals, and needs to be present in the diet. Adult humans require about 24\u00a0mg/kg body weight daily.[10] It is synthesized in plants and bacteria via several steps starting from pyruvic acid. The initial part of the pathway also leads to leucine. The intermediate \u03b1-ketoisovalerate undergoes reductive amination with glutamate. Enzymes involved in this biosynthesis include:[11]\n\n\n\n1. Acetolactate synthase (also known as acetohydroxy acid synthase)\n2. Acetohydroxy acid isomeroreductase\n3. Dihydroxyacid dehydratase\n4. Valine aminotransferase\n\n\n### Degradation\n\n[edit]\n\nLike other branched-chain amino acids, the catabolism of valine starts with the removal of the amino group by transamination, giving alpha-ketoisovalerate, an alpha-keto acid, which is converted to isobutyryl-CoA through oxidative decarboxylation by the branched-chain \u03b1-ketoacid dehydrogenase complex.[12] This is further oxidised and rearranged to succinyl-CoA, which can enter the citric acid cycle.\n\n\n\n## Synthesis\n\n[edit]\n\nRacemic valine can be synthesized by bromination of isovaleric acid followed by amination of the \u03b1-bromo derivative[13]\n\n\n\nHO2CCH2CH(CH3)2 + Br2 \u2192 HO2CCHBrCH(CH3)2 + HBr\nHO2CCHBrCH(CH3)2 + 2 NH3 \u2192 HO2CCH(NH2)CH(CH3)2 + NH4Br\n## Medical significance\n\n[edit]\n\n### Metabolic diseases\n\n[edit]\n\nThe degradation of valine is impaired in the following metabolic diseases:\n\n\n\n* Combined malonic and methylmalonic aciduria (CMAMMA)\n* Maple syrup urine disease (MSUD)\n* Methylmalonic acidemia\n* Propionic acidemia\n\n\n### Insulin resistance\n\n[edit]\n\nLower levels of serum valine, like other branched-chain amino acids, are associated with weight loss and decreased insulin resistance: higher levels of valine are observed in the blood of diabetic mice, rats, and humans.[14] Mice fed a BCAA-deprived diet for one day had improved insulin sensitivity, and feeding of a valine-deprived diet for one week significantly decreases blood glucose levels.[15] In diet-induced obese and insulin resistant mice, a diet with decreased levels of valine and the other branched-chain amino acids resulted in a rapid reversal of the adiposity and an improvement in glucose-level control.[16] The valine catabolite 3-hydroxyisobutyrate promotes insulin resistance in mice by stimulating fatty acid uptake into muscle and lipid accumulation.[17] In mice, a BCAA-restricted diet decreased fasting blood glucose levels and improved body composition.[18]\n\n\n\n### Hematopoietic stem cells\n\n[edit]\n\nDietary valine is essential for hematopoietic stem cell (HSC) self-renewal, as demonstrated by experiments in mice.[19] Dietary valine restriction selectively depletes long-term repopulating HSC in mouse bone marrow. Successful stem cell transplantation was achieved in mice without irradiation after 3 weeks on a valine restricted diet. Long-term survival of the transplanted mice was achieved when valine was returned to the diet gradually over a 2-week period to avoid refeeding syndrome.\n\n\n\n## See also\n\n[edit]\n\n* Valinol\n\n\n## References\n\n[edit]\n\n1. **^** \"Physicochemical Information\". emdmillipore. 2022. Retrieved 17 November 2022.\n2. **^** Dawson RM, Elliott DC, Elliott WH, Jones KM, eds. (1959). *Data for Biochemical Research*. Oxford: Clarendon Press. ASIN\u00a0B000S6TFHA. OCLC\u00a0859821178.\n3. **^** Weast RC, ed. (1981). *CRC Handbook of Chemistry and Physics* (62nd\u00a0ed.). Boca Raton, FL: CRC Press. p.\u00a0C-569. ISBN\u00a00-8493-0462-8.\n4. **^** \"Nomenclature and Symbolism for Amino Acids and Peptides\". IUPAC-IUB Joint Commission on Biochemical Nomenclature. 1983. Archived from the original on 9 October 2008. Retrieved 5 March 2018.\n5. **^** \"Valine\". *Encyclop\u00e6dia Britannica Online*. Retrieved 6 December 2015.\n6. **^** \"Valine\". *Merriam-Webster Online Dictionary*. Retrieved 6 December 2015.\n7. **^** \"Valeric acid\". *Merriam-Webster Online Dictionary*. Retrieved 6 December 2015.\n8. **^** Jones JH, ed. (1985). *Amino Acids, Peptides and Proteins*. Specialist Periodical Reports. Vol.\u00a016. London: Royal Society of Chemistry. p.\u00a0389. ISBN\u00a0978-0-85186-144-9.\n9. **^** Basuchaudhuri P (2016). *Nitrogen metabolism in rice*. Boca Raton, Florida: CRC Press. p.\u00a0159. ISBN\u00a0978-1-4987-4668-7. OCLC\u00a0945482059.\n10. **^** Institute of Medicine (2002). \"Protein and Amino Acids\". *Dietary Reference Intakes for Energy, Carbohydrates, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids*. Washington, DC: The National Academies Press. pp.\u00a0589\u2013768. doi:10.17226/10490. ISBN\u00a0978-0-309-08537-3.\n11. **^** Lehninger, Albert L.; Nelson, David L.; Cox, Michael M. (2000). *Principles of Biochemistry* (3rd\u00a0ed.). New York: W.\u00a0H. Freeman. ISBN\u00a01-57259-153-6..\n12. **^** Mathews CK (2000). *Biochemistry*. Van Holde, K. E., Ahern, Kevin G. (3rd\u00a0ed.). San Francisco, Calif.: Benjamin Cummings. p.\u00a0776. ISBN\u00a0978-0-8053-3066-3. OCLC\u00a042290721.\n13. **^** Marvel CS (1940). \"*dl*-Valine\". *Organic Syntheses*. **20**: 106; *Collected Volumes*, vol.\u00a03, p.\u00a0848..\n14. **^** Lynch CJ, Adams SH (December 2014). \"Branched-chain amino acids in metabolic signalling and insulin resistance\". *Nature Reviews. Endocrinology*. **10** (12): 723\u201336. doi:10.1038/nrendo.2014.171. PMC\u00a04424797. PMID\u00a025287287.\n15. **^** Xiao F, Yu J, Guo Y, Deng J, Li K, Du Y, et\u00a0al. (June 2014). \"Effects of individual branched-chain amino acids deprivation on insulin sensitivity and glucose metabolism in mice\". *Metabolism*. **63** (6): 841\u201350. doi:10.1016/j.metabol.2014.03.006. PMID\u00a024684822.\n16. **^** Cummings NE, Williams EM, Kasza I, Konon EN, Schaid MD, Schmidt BA, et\u00a0al. (February 2018). \"Restoration of metabolic health by decreased consumption of branched-chain amino acids\". *The Journal of Physiology*. **596** (4): 623\u2013645. doi:10.1113/JP275075. PMC\u00a05813603. PMID\u00a029266268.\n17. **^** Jang C, Oh SF, Wada S, Rowe GC, Liu L, Chan MC, et\u00a0al. (April 2016). \"A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance\". *Nature Medicine*. **22** (4): 421\u20136. doi:10.1038/nm.4057. PMC\u00a04949205. PMID\u00a026950361.\n18. **^** Fontana L, Cummings NE, Arriola Apelo SI, Neuman JC, Kasza I, Schmidt BA, et\u00a0al. (July 2016). \"Decreased Consumption of Branched-Chain Amino Acids Improves Metabolic Health\". *Cell Reports*. **16** (2): 520\u2013530. doi:10.1016/j.celrep.2016.05.092. PMC\u00a04947548. PMID\u00a027346343.\n19. **^** Taya Y, Ota Y, Wilkinson AC, Kanazawa A, Watarai H, Kasai M, et\u00a0al. (December 2016). \"Depleting dietary valine permits nonmyeloablative mouse hematopoietic stem cell transplantation\". *Science*. **354** (6316): 1152\u20131155. Bibcode:2016Sci...354.1152T. doi:10.1126/science.aag3145. PMID\u00a027934766. S2CID\u00a045815137.\n\n## External links\n\n[edit]\n\n* Valine MS Spectrum\n* Isoleucine and valine biosynthesis\n* Valine's relationship to prions\n\n\n| * v\n* t\n* e\nEncoded (proteinogenic) amino acids\n |\n| --- |\n| General topics | * Protein\n* Peptide\n* Genetic code\n | ![](image)\n |\n| By properties | \n\n|  |  |\n| --- | --- |\n| Aliphatic | * Branched-chain amino acids (Valine\n* Isoleucine\n* Leucine)\n* Methionine\n* Alanine\n* Proline\n* Glycine\n |\n| Aromatic | * Histidine\n* Tyrosine\n* Tryptophan\n* Phenylalanine\n |\n| Polar, uncharged | * Asparagine\n* Glutamine\n* Serine\n* Threonine\n |\n| Positive charge (p*K*a) | * Lysine (\u224810.8)\n* Arginine (\u224812.5)\n* Histidine (\u22486.1)\n* Pyrrolysine\n |\n| Negative charge (p*K*a) | * Aspartic acid (\u22483.9)\n* Glutamic acid (\u22484.1)\n* Selenocysteine (\u22485.4)\n* Cysteine (\u22488.3)\n* Tyrosine (\u224810.1)\n |\n\n |\n| * **Amino acids types**: Encoded (proteins)\n* Essential\n* Non-proteinogenic\n* Ketogenic\n* Glucogenic\n* Secondary amino\n* Imino acids\n* D-amino acids\n* Dehydroamino acids\n |\n\n| * v\n* t\n* e\nAmino acid metabolism metabolic intermediates\n |\n| --- |\n| K\u2192acetyl-CoA | \n\n|  |  |\n| --- | --- |\n| lysine\u2192 | * Saccharopine\n* Allysine\n* \u03b1-Aminoadipic acid\n* 2-Oxoadipic acid\n* Glutaryl-CoA\n* Glutaconyl-CoA\n* Crotonyl-CoA\n* \u03b2-Hydroxybutyryl-CoA\n |\n| leucine\u2192 | * \u03b2-Hydroxy \u03b2-methylbutyric acid\n* \u03b2-Hydroxy \u03b2-methylbutyryl-CoA\n* Isovaleryl-CoA\n* \u03b1-Ketoisocaproic acid\n* \u03b2-Ketoisocaproic acid\n* \u03b2-Ketoisocaproyl-CoA\n* \u03b2-Leucine\n* \u03b2-Methylcrotonyl-CoA\n* \u03b2-Methylglutaconyl-CoA\n* \u03b2-Hydroxy \u03b2-methylglutaryl-CoA\n |\n| tryptophan\u2192alanine\u2192 | * *N*\u2032-Formylkynurenine\n* Kynurenine\n* Anthranilic acid\n* 3-Hydroxykynurenine\n* 3-Hydroxyanthranilic acid\n* 2-Amino-3-carboxymuconic semialdehyde\n* 2-Aminomuconic semialdehyde\n* 2-Aminomuconic acid\n* Glutaryl-CoA\n |\n\n |\n| G | \n\n|  |  |  |  |\n| --- | --- | --- | --- |\n| G\u2192pyruvate\u2192 citrate | \n\n|  |  |\n| --- | --- |\n| glycine\u2192serine\u2192 | * 3-Phosphoglyceric acid\n\n\n* glycine\u2192creatine: Glycocyamine\n* Phosphocreatine\n* Creatinine\n |\n\n |\n| G\u2192glutamate\u2192\u03b1-ketoglutarate | \n\n|  |  |\n| --- | --- |\n| histidine\u2192 | * Urocanic acid\n* Imidazol-4-one-5-propionic acid\n* Formiminoglutamic acid\n* Glutamate-1-semialdehyde\n |\n| proline\u2192 | * 1-Pyrroline-5-carboxylic acid\n |\n| arginine\u2192 | * Agmatine\n* Ornithine\n* Citrulline\n* Cadaverine\n* Putrescine\n |\n| other | * cysteine+glutamate\u2192glutathione: \u03b3-Glutamylcysteine\n |\n\n |\n| G\u2192propionyl-CoA\u2192succinyl-CoA | \n\n|  |  |\n| --- | --- |\n| valine\u2192 | * \u03b1-Ketoisovaleric acid\n* Isobutyryl-CoA\n* Methacrylyl-CoA\n* 3-Hydroxyisobutyryl-CoA\n* 3-Hydroxyisobutyric acid\n* 2-Methyl-3-oxopropanoic acid\n |\n| isoleucine\u2192 | * 2,3-Dihydroxy-3-methylpentanoic acid\n* 2-Methylbutyryl-CoA\n* Tiglyl-CoA\n* 2-Methylacetoacetyl-CoA\n |\n| methionine\u2192 | * *generation of homocysteine:* *S*-Adenosyl methionine\n* *S*-Adenosyl-L-homocysteine\n* Homocysteine\n\n\n* *conversion to cysteine:* Cystathionine\n* \u03b1-Ketobutyric acid + Cysteine\n |\n| threonine\u2192 | * \u03b1-Ketobutyric acid\n |\n| propionyl-CoA\u2192 | * Methylmalonyl-CoA\n |\n\n |\n| G\u2192fumarate | \n\n|  |  |\n| --- | --- |\n| phenylalanine\u2192tyrosine\u2192 | * 4-Hydroxyphenylpyruvic acid\n* Homogentisic acid\n* 4-Maleylacetoacetic acid\n |\n\n |\n| G\u2192oxaloacetate | * *see urea cycle*\n |\n\n |\n| Other | \n\n|  |  |\n| --- | --- |\n| Cysteine metabolism | * Cysteine sulfinic acid\n |\n\n |\n\n</content>\n</document>",
          "name": "search",
          "tool_call_id": "8ba5c58f-46f9-4d06-a6ab-0191f7784ccd",
          "tool_calls": null,
          "is_tool_call_error": false
        },
        {
          "role": "assistant",
          "content": "Sorry, I can't perform that action. Could you please simplify or break down the task?",
          "name": null,
          "tool_call_id": null,
          "tool_calls": [],
          "is_tool_call_error": null
        }
      ],
      "state": "stopped",
      "name": "root",
      "engine_type": "MixtralFunctionCallingAdapter",
      "engine_repr": "MixtralFunctionCallingAdapter(engine=VLLMEngine(model=<vllm.engine.async_llm_engine.AsyncLLMEngine object at 0x7f083be68910>, tokenizer=CachedLlamaTokenizerFast(name_or_path='mistralai/Mistral-Large-Instruct-2407', vocab_size=32768, model_max_length=1000000000000000019884624838656, is_fast=True, padding_side='left', truncation_side='left', special_tokens={'bos_token': '<s>', 'eos_token': '</s>', 'unk_token': '<unk>'}, clean_up_tokenization_spaces=False),  added_tokens_decoder={\n\t0: AddedToken(\"<unk>\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n\t1: AddedToken(\"<s>\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n\t2: AddedToken(\"</s>\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=True),\n\t3: AddedToken(\"[INST]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t4: AddedToken(\"[/INST]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t5: AddedToken(\"[TOOL_CALLS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t6: AddedToken(\"[AVAILABLE_TOOLS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t7: AddedToken(\"[/AVAILABLE_TOOLS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t8: AddedToken(\"[TOOL_RESULTS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t9: AddedToken(\"[/TOOL_RESULTS]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t10: AddedToken(\"[IMG]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t11: AddedToken(\"[PREFIX]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t12: AddedToken(\"[MIDDLE]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t13: AddedToken(\"[SUFFIX]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t14: AddedToken(\"[IMG_BREAK]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t15: AddedToken(\"[IMG_END]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t16: AddedToken(\"[control_14]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t17: AddedToken(\"[control_15]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t18: AddedToken(\"[control_16]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t19: AddedToken(\"[control_17]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t20: AddedToken(\"[control_18]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t21: AddedToken(\"[control_19]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t22: AddedToken(\"[control_20]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t23: AddedToken(\"[control_21]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t24: AddedToken(\"[control_22]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t25: AddedToken(\"[control_23]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t26: AddedToken(\"[control_24]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t27: AddedToken(\"[control_25]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t28: AddedToken(\"[control_26]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t29: AddedToken(\"[control_27]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t30: AddedToken(\"[control_28]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t31: AddedToken(\"[control_29]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t32: AddedToken(\"[control_30]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t33: AddedToken(\"[control_31]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t34: AddedToken(\"[control_32]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t35: AddedToken(\"[control_33]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t36: AddedToken(\"[control_34]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t37: AddedToken(\"[control_35]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t38: AddedToken(\"[control_36]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t39: AddedToken(\"[control_37]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t40: AddedToken(\"[control_38]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t41: AddedToken(\"[control_39]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t42: AddedToken(\"[control_40]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t43: AddedToken(\"[control_41]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t44: AddedToken(\"[control_42]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t45: AddedToken(\"[control_43]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t46: AddedToken(\"[control_44]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t47: AddedToken(\"[control_45]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t48: AddedToken(\"[control_46]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t49: AddedToken(\"[control_47]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t50: AddedToken(\"[control_48]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t51: AddedToken(\"[control_49]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t52: AddedToken(\"[control_50]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t53: AddedToken(\"[control_51]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t54: AddedToken(\"[control_52]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t55: AddedToken(\"[control_53]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t56: AddedToken(\"[control_54]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t57: AddedToken(\"[control_55]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t58: AddedToken(\"[control_56]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t59: AddedToken(\"[control_57]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t60: AddedToken(\"[control_58]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t61: AddedToken(\"[control_59]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t62: AddedToken(\"[control_60]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t63: AddedToken(\"[control_61]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t64: AddedToken(\"[control_62]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t65: AddedToken(\"[control_63]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t66: AddedToken(\"[control_64]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t67: AddedToken(\"[control_65]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t68: AddedToken(\"[control_66]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t69: AddedToken(\"[control_67]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t70: AddedToken(\"[control_68]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t71: AddedToken(\"[control_69]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t72: AddedToken(\"[control_70]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t73: AddedToken(\"[control_71]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t74: AddedToken(\"[control_72]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t75: AddedToken(\"[control_73]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t76: AddedToken(\"[control_74]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t77: AddedToken(\"[control_75]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t78: AddedToken(\"[control_76]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t79: AddedToken(\"[control_77]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t80: AddedToken(\"[control_78]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t81: AddedToken(\"[control_79]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t82: AddedToken(\"[control_80]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t83: AddedToken(\"[control_81]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t84: AddedToken(\"[control_82]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t85: AddedToken(\"[control_83]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t86: AddedToken(\"[control_84]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t87: AddedToken(\"[control_85]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t88: AddedToken(\"[control_86]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t89: AddedToken(\"[control_87]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t90: AddedToken(\"[control_88]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t91: AddedToken(\"[control_89]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t92: AddedToken(\"[control_90]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t93: AddedToken(\"[control_91]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t94: AddedToken(\"[control_92]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t95: AddedToken(\"[control_93]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t96: AddedToken(\"[control_94]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t97: AddedToken(\"[control_95]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t98: AddedToken(\"[control_96]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t99: AddedToken(\"[control_97]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t100: AddedToken(\"[control_98]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t101: AddedToken(\"[control_99]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t102: AddedToken(\"[control_100]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t103: AddedToken(\"[control_101]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t104: AddedToken(\"[control_102]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t105: AddedToken(\"[control_103]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t106: AddedToken(\"[control_104]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t107: AddedToken(\"[control_105]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t108: AddedToken(\"[control_106]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t109: AddedToken(\"[control_107]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t110: AddedToken(\"[control_108]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t111: AddedToken(\"[control_109]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t112: AddedToken(\"[control_110]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t113: AddedToken(\"[control_111]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t114: AddedToken(\"[control_112]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t115: AddedToken(\"[control_113]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t116: AddedToken(\"[control_114]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t117: AddedToken(\"[control_115]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t118: AddedToken(\"[control_116]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t119: AddedToken(\"[control_117]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t120: AddedToken(\"[control_118]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t121: AddedToken(\"[control_119]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t122: AddedToken(\"[control_120]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t123: AddedToken(\"[control_121]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t124: AddedToken(\"[control_122]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t125: AddedToken(\"[control_123]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t126: AddedToken(\"[control_124]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t127: AddedToken(\"[control_125]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t128: AddedToken(\"[control_126]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t129: AddedToken(\"[control_127]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t130: AddedToken(\"[control_128]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t131: AddedToken(\"[control_129]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t132: AddedToken(\"[control_130]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t133: AddedToken(\"[control_131]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t134: AddedToken(\"[control_132]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t135: AddedToken(\"[control_133]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t136: AddedToken(\"[control_134]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t137: AddedToken(\"[control_135]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t138: AddedToken(\"[control_136]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t139: AddedToken(\"[control_137]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t140: AddedToken(\"[control_138]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t141: AddedToken(\"[control_139]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t142: AddedToken(\"[control_140]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t143: AddedToken(\"[control_141]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t144: AddedToken(\"[control_142]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t145: AddedToken(\"[control_143]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t146: AddedToken(\"[control_144]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t147: AddedToken(\"[control_145]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t148: AddedToken(\"[control_146]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t149: AddedToken(\"[control_147]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t150: AddedToken(\"[control_148]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t151: AddedToken(\"[control_149]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t152: AddedToken(\"[control_150]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t153: AddedToken(\"[control_151]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t154: AddedToken(\"[control_152]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t155: AddedToken(\"[control_153]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t156: AddedToken(\"[control_154]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t157: AddedToken(\"[control_155]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t158: AddedToken(\"[control_156]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t159: AddedToken(\"[control_157]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t160: AddedToken(\"[control_158]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t161: AddedToken(\"[control_159]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t162: AddedToken(\"[control_160]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t163: AddedToken(\"[control_161]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t164: AddedToken(\"[control_162]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t165: AddedToken(\"[control_163]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t166: AddedToken(\"[control_164]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t167: AddedToken(\"[control_165]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t168: AddedToken(\"[control_166]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t169: AddedToken(\"[control_167]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t170: AddedToken(\"[control_168]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t171: AddedToken(\"[control_169]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t172: AddedToken(\"[control_170]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t173: AddedToken(\"[control_171]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t174: AddedToken(\"[control_172]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t175: AddedToken(\"[control_173]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t176: AddedToken(\"[control_174]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t177: AddedToken(\"[control_175]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t178: AddedToken(\"[control_176]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t179: AddedToken(\"[control_177]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t180: AddedToken(\"[control_178]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t181: AddedToken(\"[control_179]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t182: AddedToken(\"[control_180]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t183: AddedToken(\"[control_181]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t184: AddedToken(\"[control_182]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t185: AddedToken(\"[control_183]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t186: AddedToken(\"[control_184]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t187: AddedToken(\"[control_185]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t188: AddedToken(\"[control_186]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t189: AddedToken(\"[control_187]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t190: AddedToken(\"[control_188]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t191: AddedToken(\"[control_189]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t192: AddedToken(\"[control_190]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t193: AddedToken(\"[control_191]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t194: AddedToken(\"[control_192]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t195: AddedToken(\"[control_193]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t196: AddedToken(\"[control_194]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t197: AddedToken(\"[control_195]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t198: AddedToken(\"[control_196]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t199: AddedToken(\"[control_197]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t200: AddedToken(\"[control_198]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t201: AddedToken(\"[control_199]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t202: AddedToken(\"[control_200]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t203: AddedToken(\"[control_201]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t204: AddedToken(\"[control_202]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t205: AddedToken(\"[control_203]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t206: AddedToken(\"[control_204]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t207: AddedToken(\"[control_205]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t208: AddedToken(\"[control_206]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t209: AddedToken(\"[control_207]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t210: AddedToken(\"[control_208]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t211: AddedToken(\"[control_209]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t212: AddedToken(\"[control_210]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t213: AddedToken(\"[control_211]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t214: AddedToken(\"[control_212]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t215: AddedToken(\"[control_213]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t216: AddedToken(\"[control_214]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t217: AddedToken(\"[control_215]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t218: AddedToken(\"[control_216]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t219: AddedToken(\"[control_217]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t220: AddedToken(\"[control_218]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t221: AddedToken(\"[control_219]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t222: AddedToken(\"[control_220]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t223: AddedToken(\"[control_221]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t224: AddedToken(\"[control_222]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t225: AddedToken(\"[control_223]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t226: AddedToken(\"[control_224]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t227: AddedToken(\"[control_225]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t228: AddedToken(\"[control_226]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t229: AddedToken(\"[control_227]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t230: AddedToken(\"[control_228]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t231: AddedToken(\"[control_229]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t232: AddedToken(\"[control_230]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t233: AddedToken(\"[control_231]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t234: AddedToken(\"[control_232]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t235: AddedToken(\"[control_233]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t236: AddedToken(\"[control_234]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t237: AddedToken(\"[control_235]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t238: AddedToken(\"[control_236]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t239: AddedToken(\"[control_237]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t240: AddedToken(\"[control_238]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t241: AddedToken(\"[control_239]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t242: AddedToken(\"[control_240]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t243: AddedToken(\"[control_241]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t244: AddedToken(\"[control_242]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t245: AddedToken(\"[control_243]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t246: AddedToken(\"[control_244]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t247: AddedToken(\"[control_245]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t248: AddedToken(\"[control_246]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t249: AddedToken(\"[control_247]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t250: AddedToken(\"[control_248]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t251: AddedToken(\"[control_249]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t252: AddedToken(\"[control_250]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t253: AddedToken(\"[control_251]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t254: AddedToken(\"[control_252]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t255: AddedToken(\"[control_253]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t256: AddedToken(\"[control_254]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t257: AddedToken(\"[control_255]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t258: AddedToken(\"[control_256]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t259: AddedToken(\"[control_257]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t260: AddedToken(\"[control_258]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t261: AddedToken(\"[control_259]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t262: AddedToken(\"[control_260]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t263: AddedToken(\"[control_261]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t264: AddedToken(\"[control_262]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t265: AddedToken(\"[control_263]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t266: AddedToken(\"[control_264]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t267: AddedToken(\"[control_265]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t268: AddedToken(\"[control_266]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t269: AddedToken(\"[control_267]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t270: AddedToken(\"[control_268]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t271: AddedToken(\"[control_269]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t272: AddedToken(\"[control_270]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t273: AddedToken(\"[control_271]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t274: AddedToken(\"[control_272]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t275: AddedToken(\"[control_273]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t276: AddedToken(\"[control_274]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t277: AddedToken(\"[control_275]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t278: AddedToken(\"[control_276]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t279: AddedToken(\"[control_277]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t280: AddedToken(\"[control_278]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t281: AddedToken(\"[control_279]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t282: AddedToken(\"[control_280]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t283: AddedToken(\"[control_281]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t284: AddedToken(\"[control_282]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t285: AddedToken(\"[control_283]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t286: AddedToken(\"[control_284]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t287: AddedToken(\"[control_285]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t288: AddedToken(\"[control_286]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t289: AddedToken(\"[control_287]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t290: AddedToken(\"[control_288]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t291: AddedToken(\"[control_289]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t292: AddedToken(\"[control_290]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t293: AddedToken(\"[control_291]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t294: AddedToken(\"[control_292]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t295: AddedToken(\"[control_293]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t296: AddedToken(\"[control_294]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t297: AddedToken(\"[control_295]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t298: AddedToken(\"[control_296]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t299: AddedToken(\"[control_297]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t300: AddedToken(\"[control_298]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t301: AddedToken(\"[control_299]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t302: AddedToken(\"[control_300]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t303: AddedToken(\"[control_301]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t304: AddedToken(\"[control_302]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t305: AddedToken(\"[control_303]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t306: AddedToken(\"[control_304]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t307: AddedToken(\"[control_305]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t308: AddedToken(\"[control_306]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t309: AddedToken(\"[control_307]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t310: AddedToken(\"[control_308]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t311: AddedToken(\"[control_309]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t312: AddedToken(\"[control_310]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t313: AddedToken(\"[control_311]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t314: AddedToken(\"[control_312]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t315: AddedToken(\"[control_313]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t316: AddedToken(\"[control_314]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t317: AddedToken(\"[control_315]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t318: AddedToken(\"[control_316]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t319: AddedToken(\"[control_317]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t320: AddedToken(\"[control_318]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t321: AddedToken(\"[control_319]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t322: AddedToken(\"[control_320]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t323: AddedToken(\"[control_321]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t324: AddedToken(\"[control_322]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t325: AddedToken(\"[control_323]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t326: AddedToken(\"[control_324]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t327: AddedToken(\"[control_325]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t328: AddedToken(\"[control_326]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t329: AddedToken(\"[control_327]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t330: AddedToken(\"[control_328]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t331: AddedToken(\"[control_329]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t332: AddedToken(\"[control_330]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t333: AddedToken(\"[control_331]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t334: AddedToken(\"[control_332]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t335: AddedToken(\"[control_333]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t336: AddedToken(\"[control_334]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t337: AddedToken(\"[control_335]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t338: AddedToken(\"[control_336]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t339: AddedToken(\"[control_337]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t340: AddedToken(\"[control_338]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t341: AddedToken(\"[control_339]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t342: AddedToken(\"[control_340]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t343: AddedToken(\"[control_341]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t344: AddedToken(\"[control_342]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t345: AddedToken(\"[control_343]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t346: AddedToken(\"[control_344]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t347: AddedToken(\"[control_345]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t348: AddedToken(\"[control_346]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t349: AddedToken(\"[control_347]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t350: AddedToken(\"[control_348]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t351: AddedToken(\"[control_349]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t352: AddedToken(\"[control_350]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t353: AddedToken(\"[control_351]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t354: AddedToken(\"[control_352]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t355: AddedToken(\"[control_353]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t356: AddedToken(\"[control_354]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t357: AddedToken(\"[control_355]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t358: AddedToken(\"[control_356]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t359: AddedToken(\"[control_357]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t360: AddedToken(\"[control_358]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t361: AddedToken(\"[control_359]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t362: AddedToken(\"[control_360]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t363: AddedToken(\"[control_361]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t364: AddedToken(\"[control_362]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t365: AddedToken(\"[control_363]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t366: AddedToken(\"[control_364]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t367: AddedToken(\"[control_365]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t368: AddedToken(\"[control_366]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t369: AddedToken(\"[control_367]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t370: AddedToken(\"[control_368]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t371: AddedToken(\"[control_369]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t372: AddedToken(\"[control_370]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t373: AddedToken(\"[control_371]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t374: AddedToken(\"[control_372]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t375: AddedToken(\"[control_373]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t376: AddedToken(\"[control_374]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t377: AddedToken(\"[control_375]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t378: AddedToken(\"[control_376]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t379: AddedToken(\"[control_377]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t380: AddedToken(\"[control_378]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t381: AddedToken(\"[control_379]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t382: AddedToken(\"[control_380]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t383: AddedToken(\"[control_381]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t384: AddedToken(\"[control_382]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t385: AddedToken(\"[control_383]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t386: AddedToken(\"[control_384]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t387: AddedToken(\"[control_385]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t388: AddedToken(\"[control_386]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t389: AddedToken(\"[control_387]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t390: AddedToken(\"[control_388]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t391: AddedToken(\"[control_389]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t392: AddedToken(\"[control_390]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t393: AddedToken(\"[control_391]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t394: AddedToken(\"[control_392]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t395: AddedToken(\"[control_393]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t396: AddedToken(\"[control_394]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t397: AddedToken(\"[control_395]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t398: AddedToken(\"[control_396]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t399: AddedToken(\"[control_397]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t400: AddedToken(\"[control_398]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t401: AddedToken(\"[control_399]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t402: AddedToken(\"[control_400]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t403: AddedToken(\"[control_401]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t404: AddedToken(\"[control_402]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t405: AddedToken(\"[control_403]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t406: AddedToken(\"[control_404]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t407: AddedToken(\"[control_405]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t408: AddedToken(\"[control_406]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t409: AddedToken(\"[control_407]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t410: AddedToken(\"[control_408]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t411: AddedToken(\"[control_409]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t412: AddedToken(\"[control_410]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t413: AddedToken(\"[control_411]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t414: AddedToken(\"[control_412]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t415: AddedToken(\"[control_413]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t416: AddedToken(\"[control_414]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t417: AddedToken(\"[control_415]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t418: AddedToken(\"[control_416]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t419: AddedToken(\"[control_417]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t420: AddedToken(\"[control_418]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t421: AddedToken(\"[control_419]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t422: AddedToken(\"[control_420]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t423: AddedToken(\"[control_421]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t424: AddedToken(\"[control_422]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t425: AddedToken(\"[control_423]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t426: AddedToken(\"[control_424]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t427: AddedToken(\"[control_425]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t428: AddedToken(\"[control_426]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t429: AddedToken(\"[control_427]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t430: AddedToken(\"[control_428]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t431: AddedToken(\"[control_429]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t432: AddedToken(\"[control_430]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t433: AddedToken(\"[control_431]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t434: AddedToken(\"[control_432]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t435: AddedToken(\"[control_433]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t436: AddedToken(\"[control_434]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t437: AddedToken(\"[control_435]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t438: AddedToken(\"[control_436]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t439: AddedToken(\"[control_437]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t440: AddedToken(\"[control_438]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t441: AddedToken(\"[control_439]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t442: AddedToken(\"[control_440]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t443: AddedToken(\"[control_441]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t444: AddedToken(\"[control_442]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t445: AddedToken(\"[control_443]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t446: AddedToken(\"[control_444]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t447: AddedToken(\"[control_445]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t448: AddedToken(\"[control_446]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t449: AddedToken(\"[control_447]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t450: AddedToken(\"[control_448]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t451: AddedToken(\"[control_449]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t452: AddedToken(\"[control_450]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t453: AddedToken(\"[control_451]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t454: AddedToken(\"[control_452]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t455: AddedToken(\"[control_453]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t456: AddedToken(\"[control_454]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t457: AddedToken(\"[control_455]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t458: AddedToken(\"[control_456]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t459: AddedToken(\"[control_457]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t460: AddedToken(\"[control_458]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t461: AddedToken(\"[control_459]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t462: AddedToken(\"[control_460]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t463: AddedToken(\"[control_461]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t464: AddedToken(\"[control_462]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t465: AddedToken(\"[control_463]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t466: AddedToken(\"[control_464]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t467: AddedToken(\"[control_465]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t468: AddedToken(\"[control_466]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t469: AddedToken(\"[control_467]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t470: AddedToken(\"[control_468]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t471: AddedToken(\"[control_469]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t472: AddedToken(\"[control_470]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t473: AddedToken(\"[control_471]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t474: AddedToken(\"[control_472]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t475: AddedToken(\"[control_473]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t476: AddedToken(\"[control_474]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t477: AddedToken(\"[control_475]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t478: AddedToken(\"[control_476]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t479: AddedToken(\"[control_477]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t480: AddedToken(\"[control_478]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t481: AddedToken(\"[control_479]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t482: AddedToken(\"[control_480]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t483: AddedToken(\"[control_481]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t484: AddedToken(\"[control_482]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t485: AddedToken(\"[control_483]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t486: AddedToken(\"[control_484]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t487: AddedToken(\"[control_485]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t488: AddedToken(\"[control_486]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t489: AddedToken(\"[control_487]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t490: AddedToken(\"[control_488]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t491: AddedToken(\"[control_489]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t492: AddedToken(\"[control_490]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t493: AddedToken(\"[control_491]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t494: AddedToken(\"[control_492]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t495: AddedToken(\"[control_493]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t496: AddedToken(\"[control_494]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t497: AddedToken(\"[control_495]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t498: AddedToken(\"[control_496]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t499: AddedToken(\"[control_497]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t500: AddedToken(\"[control_498]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t501: AddedToken(\"[control_499]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t502: AddedToken(\"[control_500]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t503: AddedToken(\"[control_501]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t504: AddedToken(\"[control_502]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t505: AddedToken(\"[control_503]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t506: AddedToken(\"[control_504]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t507: AddedToken(\"[control_505]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t508: AddedToken(\"[control_506]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t509: AddedToken(\"[control_507]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t510: AddedToken(\"[control_508]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t511: AddedToken(\"[control_509]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t512: AddedToken(\"[control_510]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t513: AddedToken(\"[control_511]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t514: AddedToken(\"[control_512]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t515: AddedToken(\"[control_513]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t516: AddedToken(\"[control_514]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t517: AddedToken(\"[control_515]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t518: AddedToken(\"[control_516]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t519: AddedToken(\"[control_517]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t520: AddedToken(\"[control_518]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t521: AddedToken(\"[control_519]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t522: AddedToken(\"[control_520]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t523: AddedToken(\"[control_521]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t524: AddedToken(\"[control_522]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t525: AddedToken(\"[control_523]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t526: AddedToken(\"[control_524]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t527: AddedToken(\"[control_525]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t528: AddedToken(\"[control_526]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t529: AddedToken(\"[control_527]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t530: AddedToken(\"[control_528]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t531: AddedToken(\"[control_529]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t532: AddedToken(\"[control_530]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t533: AddedToken(\"[control_531]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t534: AddedToken(\"[control_532]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t535: AddedToken(\"[control_533]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t536: AddedToken(\"[control_534]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t537: AddedToken(\"[control_535]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t538: AddedToken(\"[control_536]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t539: AddedToken(\"[control_537]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t540: AddedToken(\"[control_538]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t541: AddedToken(\"[control_539]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t542: AddedToken(\"[control_540]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t543: AddedToken(\"[control_541]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t544: AddedToken(\"[control_542]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t545: AddedToken(\"[control_543]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t546: AddedToken(\"[control_544]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t547: AddedToken(\"[control_545]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t548: AddedToken(\"[control_546]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t549: AddedToken(\"[control_547]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t550: AddedToken(\"[control_548]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t551: AddedToken(\"[control_549]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t552: AddedToken(\"[control_550]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t553: AddedToken(\"[control_551]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t554: AddedToken(\"[control_552]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t555: AddedToken(\"[control_553]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t556: AddedToken(\"[control_554]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t557: AddedToken(\"[control_555]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t558: AddedToken(\"[control_556]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t559: AddedToken(\"[control_557]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t560: AddedToken(\"[control_558]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t561: AddedToken(\"[control_559]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t562: AddedToken(\"[control_560]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t563: AddedToken(\"[control_561]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t564: AddedToken(\"[control_562]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t565: AddedToken(\"[control_563]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t566: AddedToken(\"[control_564]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t567: AddedToken(\"[control_565]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t568: AddedToken(\"[control_566]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t569: AddedToken(\"[control_567]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t570: AddedToken(\"[control_568]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t571: AddedToken(\"[control_569]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t572: AddedToken(\"[control_570]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t573: AddedToken(\"[control_571]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t574: AddedToken(\"[control_572]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t575: AddedToken(\"[control_573]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t576: AddedToken(\"[control_574]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t577: AddedToken(\"[control_575]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t578: AddedToken(\"[control_576]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t579: AddedToken(\"[control_577]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t580: AddedToken(\"[control_578]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t581: AddedToken(\"[control_579]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t582: AddedToken(\"[control_580]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t583: AddedToken(\"[control_581]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t584: AddedToken(\"[control_582]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t585: AddedToken(\"[control_583]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t586: AddedToken(\"[control_584]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t587: AddedToken(\"[control_585]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t588: AddedToken(\"[control_586]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t589: AddedToken(\"[control_587]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t590: AddedToken(\"[control_588]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t591: AddedToken(\"[control_589]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t592: AddedToken(\"[control_590]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t593: AddedToken(\"[control_591]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t594: AddedToken(\"[control_592]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t595: AddedToken(\"[control_593]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t596: AddedToken(\"[control_594]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t597: AddedToken(\"[control_595]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t598: AddedToken(\"[control_596]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t599: AddedToken(\"[control_597]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t600: AddedToken(\"[control_598]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t601: AddedToken(\"[control_599]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t602: AddedToken(\"[control_600]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t603: AddedToken(\"[control_601]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t604: AddedToken(\"[control_602]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t605: AddedToken(\"[control_603]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t606: AddedToken(\"[control_604]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t607: AddedToken(\"[control_605]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t608: AddedToken(\"[control_606]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t609: AddedToken(\"[control_607]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t610: AddedToken(\"[control_608]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t611: AddedToken(\"[control_609]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t612: AddedToken(\"[control_610]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t613: AddedToken(\"[control_611]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t614: AddedToken(\"[control_612]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t615: AddedToken(\"[control_613]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t616: AddedToken(\"[control_614]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t617: AddedToken(\"[control_615]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t618: AddedToken(\"[control_616]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t619: AddedToken(\"[control_617]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t620: AddedToken(\"[control_618]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t621: AddedToken(\"[control_619]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t622: AddedToken(\"[control_620]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t623: AddedToken(\"[control_621]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t624: AddedToken(\"[control_622]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t625: AddedToken(\"[control_623]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t626: AddedToken(\"[control_624]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t627: AddedToken(\"[control_625]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t628: AddedToken(\"[control_626]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t629: AddedToken(\"[control_627]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t630: AddedToken(\"[control_628]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t631: AddedToken(\"[control_629]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t632: AddedToken(\"[control_630]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t633: AddedToken(\"[control_631]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t634: AddedToken(\"[control_632]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t635: AddedToken(\"[control_633]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t636: AddedToken(\"[control_634]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t637: AddedToken(\"[control_635]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t638: AddedToken(\"[control_636]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t639: AddedToken(\"[control_637]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t640: AddedToken(\"[control_638]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t641: AddedToken(\"[control_639]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t642: AddedToken(\"[control_640]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t643: AddedToken(\"[control_641]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t644: AddedToken(\"[control_642]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t645: AddedToken(\"[control_643]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t646: AddedToken(\"[control_644]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t647: AddedToken(\"[control_645]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t648: AddedToken(\"[control_646]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t649: AddedToken(\"[control_647]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t650: AddedToken(\"[control_648]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t651: AddedToken(\"[control_649]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t652: AddedToken(\"[control_650]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t653: AddedToken(\"[control_651]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t654: AddedToken(\"[control_652]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t655: AddedToken(\"[control_653]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t656: AddedToken(\"[control_654]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t657: AddedToken(\"[control_655]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t658: AddedToken(\"[control_656]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t659: AddedToken(\"[control_657]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t660: AddedToken(\"[control_658]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t661: AddedToken(\"[control_659]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t662: AddedToken(\"[control_660]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t663: AddedToken(\"[control_661]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t664: AddedToken(\"[control_662]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t665: AddedToken(\"[control_663]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t666: AddedToken(\"[control_664]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t667: AddedToken(\"[control_665]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t668: AddedToken(\"[control_666]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t669: AddedToken(\"[control_667]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t670: AddedToken(\"[control_668]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t671: AddedToken(\"[control_669]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t672: AddedToken(\"[control_670]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t673: AddedToken(\"[control_671]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t674: AddedToken(\"[control_672]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t675: AddedToken(\"[control_673]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t676: AddedToken(\"[control_674]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t677: AddedToken(\"[control_675]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t678: AddedToken(\"[control_676]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t679: AddedToken(\"[control_677]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t680: AddedToken(\"[control_678]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t681: AddedToken(\"[control_679]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t682: AddedToken(\"[control_680]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t683: AddedToken(\"[control_681]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t684: AddedToken(\"[control_682]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t685: AddedToken(\"[control_683]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t686: AddedToken(\"[control_684]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t687: AddedToken(\"[control_685]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t688: AddedToken(\"[control_686]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t689: AddedToken(\"[control_687]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t690: AddedToken(\"[control_688]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t691: AddedToken(\"[control_689]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t692: AddedToken(\"[control_690]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t693: AddedToken(\"[control_691]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t694: AddedToken(\"[control_692]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t695: AddedToken(\"[control_693]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t696: AddedToken(\"[control_694]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t697: AddedToken(\"[control_695]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t698: AddedToken(\"[control_696]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t699: AddedToken(\"[control_697]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t700: AddedToken(\"[control_698]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t701: AddedToken(\"[control_699]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t702: AddedToken(\"[control_700]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t703: AddedToken(\"[control_701]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t704: AddedToken(\"[control_702]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t705: AddedToken(\"[control_703]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t706: AddedToken(\"[control_704]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t707: AddedToken(\"[control_705]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t708: AddedToken(\"[control_706]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t709: AddedToken(\"[control_707]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t710: AddedToken(\"[control_708]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t711: AddedToken(\"[control_709]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t712: AddedToken(\"[control_710]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t713: AddedToken(\"[control_711]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t714: AddedToken(\"[control_712]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t715: AddedToken(\"[control_713]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t716: AddedToken(\"[control_714]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t717: AddedToken(\"[control_715]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t718: AddedToken(\"[control_716]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t719: AddedToken(\"[control_717]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t720: AddedToken(\"[control_718]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t721: AddedToken(\"[control_719]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t722: AddedToken(\"[control_720]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t723: AddedToken(\"[control_721]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t724: AddedToken(\"[control_722]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t725: AddedToken(\"[control_723]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t726: AddedToken(\"[control_724]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t727: AddedToken(\"[control_725]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t728: AddedToken(\"[control_726]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t729: AddedToken(\"[control_727]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t730: AddedToken(\"[control_728]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t731: AddedToken(\"[control_729]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t732: AddedToken(\"[control_730]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t733: AddedToken(\"[control_731]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t734: AddedToken(\"[control_732]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t735: AddedToken(\"[control_733]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t736: AddedToken(\"[control_734]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t737: AddedToken(\"[control_735]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t738: AddedToken(\"[control_736]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t739: AddedToken(\"[control_737]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t740: AddedToken(\"[control_738]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t741: AddedToken(\"[control_739]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t742: AddedToken(\"[control_740]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t743: AddedToken(\"[control_741]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t744: AddedToken(\"[control_742]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t745: AddedToken(\"[control_743]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t746: AddedToken(\"[control_744]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t747: AddedToken(\"[control_745]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t748: AddedToken(\"[control_746]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t749: AddedToken(\"[control_747]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t750: AddedToken(\"[control_748]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t751: AddedToken(\"[REFERENCE_DOC_19]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t752: AddedToken(\"[REFERENCE_DOC_18]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t753: AddedToken(\"[REFERENCE_DOC_17]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t754: AddedToken(\"[REFERENCE_DOC_16]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t755: AddedToken(\"[REFERENCE_DOC_15]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t756: AddedToken(\"[REFERENCE_DOC_14]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t757: AddedToken(\"[REFERENCE_DOC_13]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t758: AddedToken(\"[REFERENCE_DOC_12]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t759: AddedToken(\"[REFERENCE_DOC_11]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t760: AddedToken(\"[REFERENCE_DOC_10]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t761: AddedToken(\"[REFERENCE_DOC_9]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t762: AddedToken(\"[REFERENCE_DOC_8]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t763: AddedToken(\"[REFERENCE_DOC_7]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t764: AddedToken(\"[REFERENCE_DOC_6]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t765: AddedToken(\"[REFERENCE_DOC_5]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t766: AddedToken(\"[REFERENCE_DOC_4]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t767: AddedToken(\"[REFERENCE_DOC_3]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t768: AddedToken(\"[REFERENCE_DOC_2]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t769: AddedToken(\"[REFERENCE_DOC_1]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n\t770: AddedToken(\"[REFERENCE_DOC_0]\", rstrip=False, lstrip=False, single_word=False, normalized=False, special=False),\n}, max_context_size=131072, hyperparams={'sampling_params': SamplingParams(n=1, best_of=1, presence_penalty=0.0, frequency_penalty=0.0, repetition_penalty=1.0, temperature=0.7, top_p=1.0, top_k=-1, min_p=0.0, seed=None, use_beam_search=False, length_penalty=1.0, early_stopping=False, stop=[], stop_token_ids=[], include_stop_str_in_output=False, ignore_eos=False, max_tokens=2048, min_tokens=0, logprobs=None, prompt_logprobs=None, skip_special_tokens=True, spaces_between_special_tokens=True, truncate_prompt_tokens=None)}, pipeline=PromptPipeline([TranslateRole(role=<ChatRole.SYSTEM: 'system'>, predicate=None, to=<ChatRole.USER: 'user'>, warn='The Mistral prompt format does not natively support the SYSTEM role. These messages will be sent to the model as USER messages.'),\n MergeConsecutive(role=<ChatRole.USER: 'user'>, predicate=None, sep='\\n\\n', joiner=None, out_role=<ChatRole.USER: 'user'>),\n MergeConsecutive(role=<ChatRole.ASSISTANT: 'assistant'>, predicate=None, sep=' ', joiner=None, out_role=<ChatRole.ASSISTANT: 'assistant'>),\n Wrap(role=<ChatRole.USER: 'user'>, predicate=None, prefix='[INST] ', suffix='[/INST]'),\n EnsureBoundFunctionCalls(id_translator=<function <lambda> at 0x7f083bbd1800>),\n FunctionCallFmt(func=<function json_tool_call at 0x7f083bbd1a80>, prefix='[TOOL_CALLS] [', sep=',', suffix=']'),\n Apply(role=<ChatRole.FUNCTION: 'function'>, predicate=None, func=<function fmt_function_call_result at 0x7f083bbd1940>, func_wrapped=<function Apply.__init__.<locals>.<lambda> at 0x7f083bbd13a0>),\n Apply(role=<ChatRole.USER: 'user'>, predicate=None, func=<function fmt_available_tools at 0x7f083bbd1620>, func_wrapped=<function fmt_available_tools at 0x7f083bbd1620>),\n MacroApply(func=<function ensure_available_tools at 0x7f083bbd16c0>),\n ConversationFmt(prefix='<s>', sep='', suffix='', generation_suffix='', user_prefix='', user_suffix='', assistant_prefix=' ', assistant_suffix='</s>', assistant_suffix_if_last='', system_prefix='', system_suffix='', function_prefix='[TOOL_RESULTS] ', function_suffix='[/TOOL_RESULTS]')]), token_reserve=2))",
      "functions": [
        {
          "name": "delegate",
          "desc": "Ask a capable helper for help looking up a piece of information or performing an action.\nDo not simply repeat what the user said as instructions.\nYou should use this to break up complex user queries into multiple simpler steps.\nNOTE: Helpers cannot see previous parts of your conversation.",
          "auto_retry": true,
          "auto_truncate": null,
          "after": "assistant",
          "json_schema": {
            "properties": {
              "instructions": {
                "description": "Detailed instructions on what your helper should do to help you.",
                "type": "string"
              }
            },
            "required": [
              "instructions"
            ],
            "type": "object"
          }
        },
        {
          "name": "search",
          "desc": "Search Wikipedia for an article with the given title, and get its content. If no such article is found, return similar article names.",
          "auto_retry": true,
          "auto_truncate": null,
          "after": "assistant",
          "json_schema": {
            "properties": {
              "query": {
                "type": "string"
              }
            },
            "required": [
              "query"
            ],
            "type": "object"
          }
        }
      ]
    }
  ]
}